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Abstract
Personalized Biomechanical Heart Modeling for Clinical Applications
The objective of this thesis is the assessment of a biomechanical heart model using exper-
imental data, and the investigation of clinical applications with patient-specific modeling.
At the 1D level we aimed at reproducing physiological experiments with myocardial
fiber contraction. For the 3D validation we performed in co-operation with a clinical
partner an experiment with animals (pigs) in order to obtain data in the healthy stage and
after creating a myocardial infarct. We showed that our model can reproduce the pressures
and motion of a healthy heart and that the infarct can be represented by changing only
the parameters directly related to the pathology.
The objective of the first clinical application was to predict the short-term effect of the
Cardiac Resynchronization Therapy (CRT) by means of an increase of ‘max LV dp/dt’.
The model personalization was performed using patients MRI and pressure data in the
baseline condition – prior to CRT. Then we fixed the values of all parameters and applied
electrical activation patterns according to the pacing modes considered. We obtained a
very good prediction of max LV dp/dt using various pacing patterns in 3 clinical cases.
This preliminary clinical validation shows that the modeling of CRT is a very promising
approach as an assistance to therapy planning.
The second application is based on the adaptation of data assimilation methods devel-
oped in the MACS team at INRIA. We performed joint state-parameter estimation with
real image data. We showed the effectiveness of these algorithms in automatic model per-
sonalization and that the estimated contractility values can serve as an indicator of the
local heart function.
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Mode´lisation biome´canique personnalise´e du cœur et applications cliniques
L’objectif de cette the`se porte sur la validation d’un mode`le biome´canique du cœur a` base
de mesures expe´rimentales, et sur des investigations concernant des applications cliniques
en mode´lisation personnalise´e.
Dans le cadre 1D, nous avons reproduit des expe´riences physiologiques de contraction
d’une fibre cardiaque. Concernant la validation 3D, nous avons effectue´ dans une collab-
oration clinique une expe´rience avec des animaux (cochons), afin d’obtenir des donne´es
saines et apre`s cre´ation d’infarctus. Nous avons de´montre´ que notre mode`le est capable de
repre´senter le cœur sain, et que l’infarctus peut eˆtre correctement mode´lise´ en modifiant
uniquement les parame`tres directement concerne´s par la pathologie.
Dans la premie`re application clinique nous avons de´montre´ que le mode`le est pre´dictif
sur l’effet imme´diat d’une “Cardiac Resynchronization Therapy” (CRT), sur le crite`re du
“max LV dp/dt”. La personnalisation du mode`le a e´te´ re´alise´e au moyen des donne´es
d’IRM et de pressions au stade ‘baseline’ (avant la CRT). Puis, tous les parame`tres du
mode`le e´tant fige´s, nous avons applique´ les sche´mas d’activation e´lectrique correspondant
aux modes de CRT. Nous avons obtenu une pre´diction tre`s proche des indicateurs mesure´s
sur 3 patients avec plusieurs sche´mas d’activation. Cette e´tude clinique pre´liminaire mon-
tre que la mode´lisation de CRT est tre`s prometteuse comme assistance a` la planification
the´rapeutique.
Dans une deuxie`me application nous avons adapte´ des me´thodes d’assimilation de
donne´es developpe´es dans l’Equipe-Projet MACS a` l’INRIA, a` des fins d’aide au diag-
nostic. Nous avons ainsi re´alise´ une estimation conjointe e´tat-parame`tres en utilisant des
donne´es re´elles (IRM). Nous avons demontre´ l’efficacite´ de ces me´thodes, et l’inte´reˆt des
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During the recent years, there has been an increasing impact of mathematics in medicine.
The widespread evidence based medicine – according to which any new treatment must
be proven to be more efficient that the previous ones – is based upon statistical meth-
ods applied in clinical studies. Population dynamics methods are applied for example in
epidemiology. Especially in the end of the 20th century and in the beginning of the 21st
century, the accessibility of heavy computations has increased thanks to a fast techno-
logical development. Medical imaging is a typical example where intensive computing is
used both during data acquisition (especially in some imaging modalities as for instance
magnetic resonance imaging – MRI) and then in image reconstruction and post-processing.
Applied mathematicians – usually engaged in the modeling of physical, mechanical or
engineering problems – have become interested in the modeling of biological phenomena.
However, the problems motivated by medicine are often very large and difficult to analyze
and solve. We will hardly ever be able to create models that would represent all parts of
the studied systems. We need to focus on a particular phenomenon and the ingredients of
the model must be carefully balanced with the expected objectives. This is why detailed
multi-disciplinary interactions are necessary in order to decide on the important parts of
the models representing the living body.
The final goal of any modeling effort is to create models based on physiological and
physical principles, that would represent the reality adequately in order to be predictive in
some aspects. Such models could serve in pre-clinical research in clarifying some physiolog-
ical phenomena or they could even replace experimenting with animals, in some studies. At
the moment, biomechanical modeling is still not adequately recognized as a useful tool in
most branches of clinical medicine. One exception are applications in orthopedics where the
modeling has been used for instance for optimizing the design of new joint endoprosthesis.
It is usually difficult to convince clinicians from other specialities, in which modeling (in
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the sense referred to here) is not traditionally present, that a deep co-operation of math-
ematical and clinical groups can be fruitful. Nevertheless, there are clinical departments
that are highly motivated in such a research, which is also reflected in the thesis.
The modeling of the cardiovascular system – and of the heart in particular – is a
greatly challenging topic for the applied mathematics. The multi-scale complexity of the
heart function involves muscle fiber contraction, electrical activation, nutrition of the my-
ocardium by means of the coronary blood flow and myocardial perfusion, and numerous
regulation circuits. The contraction itself can be studied at the microscopic level (interac-
tion of contractile proteins inside the cells), mesoscopic level (shortening of myofibrils and
of muscle cells) and at the macroscopic level (muscle fiber contraction or the contraction of
the whole 3D organ). All these scales are involved in the biomechanical model of heartbeat
developed at INRIA1, as a part of the CardioSense3D2 initiative.
When using mathematical models, we can consider general basic simulations, physio-
logical, clinical and patient-specific simulations. There is no clear border between these
levels. Some simulations can be called basic in the case of a simpler model but they could
already be categorized as physiological in a more complex model. The following description
is more likely related to the INRIA heart model.
The general (basic) simulations usually do not take into account detailed anatomical
properties or measured values of input quantities. In our model, we often use an ana-
lytically prescribed ellipsoidal geometry representing the heart ventricle or even a simple
1D model of contracting fiber. Markedly lower computational costs make this type of
simulations especially important in the testing and optimization of numerical schemes or
implementation of new model features. These basic simulations with the INRIA heart
model are presented for example in [95].
In the physiological simulations, we often use an accurate geometry representing the
anatomy of the modeled tissue or organ. Although information about some model input
quantities may be missing, we typically use common physiological values. Due to finer
geometrical models (computational meshes), these simulations are more time demanding.
Some instabilities – for instance related to the complex anatomy or to the realistic input
numerical values – can arise. Such simulations with the INRIA heart model were performed
in [23]. While the anatomical model in this work was obtained from real human image
data, the pressure conditions and the electrical activation pattern were not available. When
applying a physiological activation pattern, the model showed a physiological behavior with
respect to some global indicators of heart function (for instance the pressure and volume
changes during cardiac cycle). Furthermore, when the activation pattern was modified in
order to represent some typical electrical activation disorders, the model output changed
in the expected direction. This predictive aspect certainly qualifies the model in the next
level – of clinical simulations.
1Institute National de Recherche en Informatique et en Automatique (French National Institute for
Computer Science and Automatization), http://www.inria.fr
2http://www-sop.inria.fr/CardioSense3D
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In order for models to serve clinical medicine, they need to fit patient data. Patient-
specific modeling is the highest simulation level and we cannot achieve it before the model
is validated at all the previous steps. Besides physiologists, also clinical physicians must be
involved in the work and the approach is becoming even more inter-disciplinary. First of
all, we need to decide about the expected clinical outcomes of a particular patient-specific
model. Then, we need to take into account the availability of certain types of clinical
data that could be used to create the model – including practical questions such as the
invasivity of an acquisition procedure or the expected error in the data. Then, the setup
of the model itself may be quite a delicate problem. It frequently includes post-processing
of the measured data in order to obtain an input suitable for the model. Some other types
of modeling can be involved in these procedures ([92], [96]).
Ideally, we would like a patient-specific model to satisfy all available results of clinical
exams and measurements – that may be of various types. After such a personalization step,
a good model may for example provide some missing information – such as a quantity
non-measurable in the in vivo conditions but with a significant clinical impact. Some
models could even predict future – natural or artificial, such as for various therapeutical
scenarios – evolutions of the system, which may be of a great importance in therapy
planning. Although manual adjustments can be useful in some specific situations, an
automatization of the model personalization is a necessary step in patient-specific modeling.
Data assimilation techniques – such as have been developed in the Team-project MACS3
of INRIA in [80], [81] and [79] – are a very promising way.
There are large groups dealing with modeling of the heart function. We can recall
for instance the laboratory of Peter Hunter in Auckland, New Zeland. Peter Hunter has
been a leading person in cardiac modeling since the very beginning. He started mechanical
modeling of the heart based on the continuum mechanics approach in the 1970s ([53]). His
laboratory does not focus only on the heart mechanics but models various physiological
functions of the body. The international ‘Physiome Project’ – of which he is one of the
main representatives – includes modeling at any level starting from the gene expression (see
[31]). The group of Nic Smith based in London, UK – another participant of the Physiome
Project – is particularly interested in multi-scale modeling of coronary blood flow and
heart perfusion ([100], [68]). The models of the cell microenvironment and for instance
cell-matrix interactions in cardiac mechanical signaling of Andrew McCulloch’s lab (San
Diego, USA, [2]) have a clear macroscopical output – in the contraction of the muscle fiber,
long-term hypertrophy or for instance in post-myocardial infarction remodeling.
Models developed by all these groups offer an insight into cardiac function – in the
healthy and also diseased state. However, in the case of large and complex models it is
very difficult to put them in the patient-specific framework. The MACS team follows a
distinctive path by defining a model of a lower complexity than in the groups mentioned
above, but at each modeled scale satisfying physical and physiological considerations, and
3http://www-roc.inria.fr/MACS
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essential thermomechanical requirements. The physical character predisposes the model
to predictivity. The mechanical character of the model enables using effective estimation
techniques motivated by data assimilation methods developed in the field of structural
mechanics. Indeed, the detailed personalization is a major advantage of the model. Clinical
applications of this model including patient-specific simulations are the main topic of the
thesis.
1.2 Outline of the thesis
This multi-disciplinary doctoral work – performed at INRIA Paris-Rocquencourt in the
MACS team-project under the supervision of Dominique Chapelle – combines the methods
of applied mathematics, cardiovascular physiology, cardiology and also of cardiovascular
imaging. The main objective of the thesis is the validation of the biomechanical heart
model developed at INRIA and its clinical applications in patient-specific modeling. The
document is divided into two parts: the preparatory and the applied modeling parts.
Preparatory part
The first part consists of the basic concepts of cardiovascular physiology and clinical car-
diology, magnetic resonance imaging and biomechanical modeling of the heart function.
In Chapter 2 we give basic medical aspects that are especially important for the model,
in order to represent the function of a healthy heart adequately. Then, we discuss selected
cardiac pathologies and diseases. We focus on the clinical states with which we are directly
confronted in the applied modeling part.
All data used to set up the models in the thesis came either from human patients or
specially designed animal experiments. An experiment with a big animal (a pig), with the
objective to obtain rich data sets consisting of non-invasive and invasive data in the healthy
stage and after creating a controlled myocardial infarction, was performed in a co-operation
with the Radiological and the Cardiological departments of Henri Mondor Hospital in
Cre´teil, France. We actively participated in the definition of the experimental protocol, the
preparation of the imaging setup and in all stages of the experiments themselves. Chapter
3 explains the fundamental principles of magnetic resonance imaging, emphasizing typical
issues arising with cardiac MR imaging, which we had to overcome in order to obtain image
data of an adequate quality.
Finally, in Chapter 4, a description of the biomechanical heart model developed at
INRIA is given. We particularly concentrate on the setup and calibration of the model
using real clinical data sets, hence the patient-specific modeling.
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Applied modeling part
The applied modeling part deals with the model validation at both 1D and 3D levels, and
we engaged in two clinical applications – the first one in the field of therapy planning and
the second one for computer assisted diagnosis.
The objective of Chapter 5 is to validate the model at the fiber level using physiological
experiments of myocardial fiber contraction and to study in detail some parts of the model
that are connected to phenomena well observable in the experiments. The experimen-
tal data were provided by Prof. Yves Lecarpenier, Physiological Department of Hospital
Biceˆtre, France.
In Chapter 6, we set up subject-specific models using the data sets acquired in the
animal experiments mentioned above. Our first objective was to show that the model is
able to represent a healthy heartbeat by means of the motion pattern and simulated cavity
pressure values. Then, we explore a possibility of introducing a myocardial infarction in
the model only by modifying the mechanical parameters directly connected to the type of
pathology and only in the infarcted region. We aim at demonstrating the model predictivity
with respect to the global indicator of the left ventricle volumes and also with respect to
the local motion pattern for this frequent heart disease.
The first clinical application was performed in co-operation with St. Thomas’ Hospital
and King’s College in London, UK and is described in Chapter 7. The patients involved
in the study suffered from a severe chronic heart failure and were indicated for an im-
plantation of a special bi-ventricular pacemaker – the so-called Cardiac Resynchronization
Therapy (CRT). We set up patient-specific models using image and pressure data acquired
by physicians at the hospital before CRT (the baseline stage). The electrical activation
in the model was prescribed according to the invasive electrophysiological measurements
that were post-processed by researchers in the Asclepios team-project of INRIA and at
King’s College London, or using a simplified approach taking into account the non-invasive
data only. In this preclinical study, we aim at demonstrating the model predictivity of LV
pressure and dp/dt changes, when using the model calibrated for the baseline stage and
applying new electrical activation patterns according to the pacing modes tested during
the CRT implantation.
Chapter 8 deals with an application of data assimilation methods developed in the
MACS team. The main objective is to perform state and joint state-parameter estimation
with observations coming from real image data – using once more the data sets obtained
during the experimental animal campaign. The parameters of concern are the contractility
parameters. We would like to illustrate the effectivity of these data-assimilation algorithms
and show that the estimated contractility values can improve the model itself and that they
can serve as an indicator of the local heart function, by means of a detection of hypokinetic
or akinetic regions in the myocardial tissue as typically arises after a myocardial infarction.
In Chapter 9 we conclude the results obtained during the PhD study and suggest some
perspectives of ongoing work related to the thesis.
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As an Appendix, we add a protocol created during the planning of the animal exper-
iments in order to validate the in vivo study by the Institutional Animal Care and Use
Committee of ‘Faculte´ de Cre´teil’, France.
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The main topic of the thesis are clinical applications of a biomechanical model of the heart
function. In this preparatory chapter, we would like to give some basic introduction to the
elements of cardiovascular physiology and cardiology directly related to the type of data
used and the simulations performed in the thesis. Most of this information is inspired by
textbooks of physiology [46] and cardiology [70].
2.2 Basic cardiovascular anatomy
The heart is a muscular organ situated in the thorax between the two lungs in a space
called the mediastinum. The function of the heart is to pump the blood in the circulatory
system.
A longitudinal septum divides the heart into the left and right part, see Figure 2.1.
Each part consists of an atrium and a ventricle. The atrium and the ventricle of either side
are separated by an atrioventricular (AV) valve. The AV valve consists of three cusps on
the right side (the tricuspidal valve), and of two cusps on the left side (the bicuspidal valve,
more often called the mitral valve). Fibrous structures called chordae tendineae prevents
the cusps of the AV valves from folding into the atria during myocardial contraction when
the AV valve are closed. The chordae are fixed to the ventricle wall by the papillary
muscles. The two ventricle extremities are: the base (to which the atria and large vessels
are attached) and the apex (the bottom part of the ventricle). The axis connecting the
apex and the base of the ventricle is called the long axis. Planes perpendicular to the long
axis are the short axis planes.
Histologically, the heart tissue has a direct correspondence with the vessel wall struc-
ture. It consists of the following three layers: the inner layer – the endocardium (a single
layer epithelium with a thin subepithelial connective tissue, similar to the vessel wall en-
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Figure 2.1: Anatomy of the heart, from [84].
dothelium), the thickest layer of cardiac muscle cells (the myocardium), and the outer layer
made of two membranes (the pericardium). The first one is a serous membrane that is
tightly attached to the myocardium (the visceral pericardium, epicardium) and the second
– fibrous membrane – forms the pericardial sac (the parietal pericardium). There is a tiny
space between the two pericardial membranes – the pericardial cavity. A small amount of
pericardial fluid inside the cavity decreases the friction between the pericardial membranes.
This friction can be augmented during some pathological states (e.g. inflammation of the
pericardium, the pericarditis). The myocardium itself can be divided into three layers: the
subendocardial third, the mid-third and the subepicardial third. Each of them has specific
functional properties with respect to the blood supply and also for instance with respect
to the duration of the contraction.
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Atria are filled by blood from the veins and serve as a first-stage pump for the ventricles.
The right atrium receives blood from the systemic veins (superior and inferior venae cavae),
then the right ventricle pumps blood through the pulmonary artery to the lungs where the
blood oxygenation takes place. The oxygenated blood returns via the pulmonary veins to
the left atrium. The left ventricle ejects blood through the main systemic artery – the aorta
– in the body (the systemic circulation). During ejection, the closed AV valves prevent
blood from regurgitating back to the atria. During the period of ventricle filling, the AV
valves are open and the ventricles are being filled by blood from the atria. Reverse blood
flow from the large arteries to the ventricles is prevented by semilunar valves – the aortic
and the pulmonary valve.
The heart is supplied with oxygen and nutrients by three main coronary arteries: The
left anterior descending (LAD), the left circumflex1 (LCx) and the right coronary artery
(RCA). Although there is inter-subject variability, in general each artery supplies the fol-
lowing parts of the ventricles: the anterior wall of the LV and RV and the anterior part
of the septum are supplied by the LAD, the lateral wall of the LV by the LCx and the
inferior wall of both ventricles and the inferior part of the septum by the RCA. The main
coronary arteries are located on the epicardium. Their smaller branches penetrate into the
deeper layers of the myocardium and finally the vessels form the subendocardial capillary
bed. After passing the capillary bed, blood is collected by the coronary veins. Most of the
cardiac blood returns to the right ventricle via the coronary sinus. See Figure 2.2 with the
anatomy of the coronary arteries and veins.
To assess local kinematical properties of the left ventricle (e.g. wall thickening during
contraction) or to describe localization of several pathologies of the ventricles, the following
recommendations of the American Heart Association (AHA) are applied: The left ventricle
is divided into 3 parts with respect to the long axis: the basal third, the mid-cavity and the
apical part. The basal and the mid-third are subdivided into 6 segments each, (segments
#1–6 for the basal third and segments #7–12 for the mid-cavity). The apical third is
subdivided into 4 segments (#13–16). The last segment of the left ventricle – the apex – is
denoted as segment #17.
The segments of the left ventricle are schematically visualized using the so-called bull’s
eye view, see [21] and Figure 2.3. We will be using the subdivision of the LV into 17
regions. Each region will be called AHA segment with the corresponding number. The
region around the valves is excluded from the subdivision since it would be difficult to
assess e.g. the wall thickness in the vicinity of the valves.
1LAD and LCx are two different arteries, clinically speaking. Anatomically, both comes from the short
common left coronary artery.
22
Figure 2.2: Coronary arteries from anterior view (left) and coronary veins from anterior
view (right top) and posterior view (right bottom).
2.3 Basic cardiovascular physiology
2.3.1 Cardiac cycle
The period between two successive heartbeats is called the cardiac cycle. It consists of a
period of ventricle contraction – the systole, and of ventricle relaxation – the diastole, see
Figure 2.4. The duration of a normal cardiac cycle at rest is 0.75–1 sec which corresponds
to a heart rate of 60–80 bpm (beats per minute). The diastole covers approximately two
thirds of the cardiac cycle at rest. Although the heart rate increases during a physical
activity, the length of the systole remains 250–330 ms and it is mostly the diastole that is
getting shorter.
The volume of the left ventricle filled by the blood – the end-diastolic volume (EDV)
– is about 130 mL. The minimum LV volume after ejection – the end-systolic volume
(ESV) – is around 50–60 mL. It means that the relative ejected volume with respect to the
end-diastolic volume of the ventricle – the ejection fraction (EF) – is around 50–60%.
The diastole consists of three parts of approximately same durations at rest: the period
of rapid filling, the diasthasis and the atrial contraction (the atrial systole). The first part
occurs immediately after the AV-valves opening. The ventricles are filled rapidly by blood
from the atria. It accounts for the filling of the ventricles by approximately 70% of the
stroke volume. While the blood flow from the atria follows the pressure gradient, and it
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not-referenced region around the valves
Figure 2.3: Bull’s eye view representing the AHA segments of the LV (from [21]). Each
color represents the coronary artery by which the segment is supplied. The name of each
segment is listed in the table.
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Figure 2.4: Cardiac cycle of the left ventricle (from [46]).
is therefore passive, the relaxation of the ventricle myocardium has an important active
component, as discussed in Section 2.3.2. During the diasthasis, there is a minimal flow
through the AV-valves. The diasthasis gets shorter if the heart rate increases. In the last
third of the diastole, the atria contract and add the final 10–30% of the ventricle filling
(the so-called atrial kick).
The right ventricle pumps blood against a mean pressure of 15 mmHg2 (the low pressure
– pulmonary circulation) and the left ventricle against a mean pressure of 100 mmHg
(the high pressure – systemic circulation). These mechanical features of the circulatory
system have an effect on the thickness of the ventricle walls and on the energetic needs
of the ventricles. While the thickness of the wall of the right ventricle is approximately
3–4 millimeters, the thickness of the left ventricle is 12–15 millimeters and it has higher
energetic needs. This also justifies why an ischemic heart disease (the disease caused by
the lack of supply of the oxygen and nutrients in the myocardium, see Section 2.4.2) often
affects the left ventricle.
The heart of an adult person (the left and right ventricle separately) has to pump
approximately 5 liters of blood each minute, the so-called minute heart volume (MV).
This value can increase sevenfold in a healthy person undergoing a physical activity (the
2Physicians usually represent the blood pressure as a height of mercury column, 1 mmHg corresponds
approximately to 134 Pa.
25
heart rate can increase threefold and the myocardial contractility 2.5 folds). This so-
called cardiac reserve is very limited in the diseased myocardium, which may lead to a
symptomatic cardiac disease under stressful circumstances. The regulation of the heart
function is discussed in detail in Section 2.3.5.
2.3.2 Contraction of the muscle fiber
Muscle contraction is based on an interaction of thick and thin filaments in a sarcomere
– the functional unit of the muscle cell. Thin filaments consist of actin fibers and regulatory
proteins such as tropomyosin and troponin. The main component of the thick filaments is
a myosin protein. Tension created by repeatedly formed cross-bridges between the myosin
heads and the binding sites of the actin can cause sliding of the myosin along the actin
fibrils, which leads to the muscle fiber contraction, see [55] and [56].
Under resting conditions, the binding sites of the actin fibers are blocked by the
troponin–tropomyosin complexes. Calcium ions (Ca2+) cause conformational change of
the complexes and the binding sites become uncovered. Immediately, myosin heads bind
with a high affinity to the actin and form cross-bridges created under tension. The passive
conformational change of the myosin molecule shifts the myosin head towards the centre
of the sarcomere. The re-elongation of the myosin is an active process. It is an ATPase
activity of the myosin head that provides the energy by lysing an adenosin triphosphate
molecule (ATP). The cycle consisting of passive actin–myosin binding and the active myosin
re-elongation is repeated as long as the myosin binding sites on actin are uncovered. The
cytosolic Ca2+ ion concentration decrease to the initial low level is a necessary condition
for the relaxation. See Figure 2.5 with description of the cardiac fiber and the functional
unit of the fiber – the sarcomere – in particular.
Muscle cells have a well developed smooth endoplasmic reticulum, the so-called sar-
coplasmic reticulum (SR). It serves as a storage of the Ca2+ ions. There are two main
mechanisms in the rise of the cytosolic Ca2+ ion concentration after the generation of the
membrane action potential. The first one is based on electrically activated slow reacting
Ca2+ channels (the so-called dihydropyridine receptors, known also as L-Ca2+ channels)
located in the cell membrane (sarcolemma), in particular in folds of the membrane called
T-tubules. The second mechanism is the Ca2+ dependent release of the Ca2+ ions from
the sarcoplasmic reticulum (the channel is part of a complex structure – the ryanodine
receptor). The L-Ca2+ channels account for an increase of the cytosolic Ca2+ only by 10-
20%. Nevertheless, this rise is very important for the consequent activation of the Ca2+
dependent release of Ca2+ which moves a high amount of the Ca2+ ions from the SR into
the cytosol.
The main Ca2+ re-uptake mechanism is via an active transporter in the membrane of
the SR (proteins from group SERCA3). Besides, there are other ways as for example the
Na+ / Ca2+ antiport in the sarcolemma or the ATP-consuming sarcolemmal calcium pump
3SERCA stands for the smooth endoplasmic reticulum calcium re-uptake mechanism.
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Figure 2.5: Myocardial fiber on macroscopical, microscopical and ultramicroscopical level.
From [70].
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(which carries Ca2+ from the intracellular to the extracellular compartment against the
concentration gradient).
Preload and Afterload
Concerning muscle fiber contraction, the preload is defined as the tension in the fiber before
contraction occurs. In a typical physiological experiment (as modeled in Chapter 5), the
preload is given by the load that is attached to the fiber before the fiber is activated. Since
the preload causes a passive extension of the fiber, it is often related to the degree of the
passive extension.
By afterload we mean the tension generated by the fiber during the contraction. In the
physiological experiment, the afterload is given by the weight of the load which is fixed to
the fiber and that the fiber has to overcome. If we apply such an afterload value that the
fiber is able to generate the active stress but it is not able to shorten (or raise the load), we
talk about isometric contraction. If we fix the generated stress and let the fiber contract,
we talk about isotonic contraction.
In the case of heart ventricle as a whole organ the most accurate definition of the
preload and of the afterload would be the wall stress at the end-diastole or at the end-
systole respectively. Since it is not possible to measure the wall stress in the myocardial
tissue in vivo, the preload is usually represented either by the end-diastolic pressure in the
ventricle or by the end-diastolic volume of the ventricle. The latter definition is related
to the stretch of the myocardial fibers. The ventricle afterload is usually represented by
the pressure against which the ventricle pumps the blood. In medical praxis, one usually
takes the aortic pressure (or pulmonary artery pressure) as the afterload of the left (right)
ventricle.
The part of the ventricle contraction (relaxation) when both the AV and the semilu-
nar valves are closed and the ventricle volume is not changing is called the isovolumic
contraction, respectively the isovolumic relaxation.
2.3.3 Electrical activation of the heart
Muscle cells (myocytes) belong to excitable cells, as for instance also neurons. The resting
potential on the membrane4 of the cardiac muscle cells (the cardiomyocytes) is around
-90 mV. An action potential (AP) is generated when the membrane potential increases to a
certain threshold, which is around -40 mV. The neighboring cardiomyocytes are electrically
connected between each other and the action potential can propagate from one cell to
the other. The resulting effect of the action potential is an increase of the Ca2+ ion
concentration in the cytoplasm of the muscle cells (the sarcoplasm) which triggers the
contraction, see Section 2.3.2.
4The so-called resting membrane (or transmembrane) potential.
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Figure 2.6: Typical action potentials in the myocardium of the ventricles and currents
through each type of the ion channels involved in the generation of the action potential in
a cardiomyocyte. From [70].
Resting and action membrane potential
Due to a distribution of ion channels in the cardiomyocyte membrane and due to active
ion-transporting mechanisms (e.g. the Na–K ATPase that exchanges the intracellular Na+
with the extracellular K+) the resting potential on the cardiomyocyte membrane is negative
in the intracellular medium with a value of around -90 mV. If the membrane potential
rises to a certain threshold value (∼-40 mV), a rapid reaction with a positive feedback
mechanism occurs: The higher the membrane potential is, the more fast voltage-gated
Na+ channels opens. The influx of Na+ into the cell causes a sudden increase of the
membrane potential which finally reaches slightly positive values (∼10–30 mV). We talk
about membrane depolarization. The Na+ channels do not remain active for more than a
few milliseconds. At the time when their conductance ceases, another type of channels –
the slow reacting Ca2+ channels – will open. The Ca2+ channels will keep the membrane
in the depolarization stage for a period of another 200–400 ms. This part of the action
potential is called the plateau and is entirely specific for the cardiomyocytes5. Finally, the
eﬄux of the K+ ions through potassium channels will bring the membrane potential back
to its resting value – the so-called repolarization. In the following 250–300 ms a new action
potential cannot be generated, which is the so-called refractory period. See Figure 2.6 for
typical shapes of the action potential in the cardiomyocytes and for the conductances of
each group of the ion channels during action potential generation.
5Neurons or skeletal muscle cells do not have the slow reacting Ca2+ channels, therefore the action
potential does not contain the plateau. This is why the action potential duration (APD) is only 4–6 ms.
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Excitation–contraction coupling
The electrically activated membrane Ca2+ channels cause an increase of the intracellular
Ca2+ ion concentration in the cardiomyocyte. Consequently, the so-called Ca2+ activated
Ca2+ channels will cause further – much higher – increase of the Ca2+ ion concentration,
using reserves in the sarcoplasmic reticulum. The Ca2+ ions act directly in the sarcom-
ere, where they suppress an inhibiting effect of the troponin–tropomyosin complexes and
therefore they activate the contraction. For details see Section 2.3.2.
Conduction system of the heart
Cardiac muscle cells are electrically connected by the so-called intercalated disks, through
which the electrical activation can propagate from one cell to the other, and the myocardial
cells form a functional syncytium.6 The propagation velocity in the working myocardium
is around 0.3–0.5 m/s. There exist myocardial cells specialized for a fast transfer of the
electrical signal, which form pathways of the conduction system of the heart. The propa-
gation velocity through this dedicated system is up to 6 times higher than in the normal
cardiomyocytes and can reach values of 1.5–4.0 m/s.
The primary electrical activation comes from another part of the conduction system –
the so-called pacemaker cells. These are specialized muscle cells that are able to generate
action potentials without any external activation. Their resting potential is higher than in
the non-specialized cardiomyocytes with a value of around -55 mV, which is much closer
to the threshold value for the AP generation. The membrane potential of the pacemaker
cells slowly rises due to a moderate number of opened Na+ channels. When it reaches
the threshold value, the action potential develops and spreads to the other cells. The
pacemaker cells are located in the following parts of the heart (see Figure 2.7, left):
• sinoatrial node (or sinus node, SA node) – in the right atrium in the vicinity of the
superior vena cava opening; the rate of AP self-generation is around 60–80 bpm
• atrioventricular node (AV node) – between the atria and the ventricles; the rate of
AP self-generation is around 30–40 bpm
• cells of the conduction pathways – with a rate of AP self-generation of only 10–30 bpm
The SA node serves normally as a primary pacemaker, since it has the highest rate
of spontaneous depolarization. The electrical signal generated in the SA node propagates
to the AV node through the internodal pathways and activates the myocardium of the
atria. Thanks to a relatively slow propagation in the AV node, the electrical activation
is delayed by approximately 90 ms between the atria and the ventricles. The ventricles
are electrically connected with the atria only by a single conductive network – the bundle
6A true syncytium is formed by cells that are fused together and share the same cytoplasm, plasma
membrane etc. as in skeletal muscle.
30
of His (also called the AV bundle). It divides into the left and right branch that are
located beneath the endocardium and follow the septum until the apex. The left branch
divides into two main subbranches – the anterior and the posterior fascicles. The bundles
progressively divide down to small branches (the so-called Purkinje fibers) that finally
terminate directly on the myocardial cells in the subendocardial part of the heart. Thanks
to this fast conductive system, the whole subendocardial region of the ventricles can be
depolarized in a time period as low as 30 ms after the electrical signal crosses the AV node.
Then, the electrical signal has to propagate from the subendocardial to the subepicardial
region via the normal cardiac muscle cells. This is much slower and takes approximately
the same time period as the activation of the whole subendocardial region (∼ 30 ms).
Therefore under normal conditions the whole ventricle myocardium is activated in about
60–70 ms.
ECG representation
An electrical activation of the heart can be recorded by placing electrodes on the surface
of the body – the method called electrocardiography (ECG). The usual ECG consists of
measuring electrical potentials between standard points on the body surface. It is a repro-
ducible measurement that can show the progress of a cardiac disease or its current status.
The complete ECG analysis is out of scope of this text, therefore we will only show some
basic parts of a typical single derivative-ECG record taken in one cardiac cycle (see Figure
2.7, right):
• P wave: represents the depolarization of the atria
• QRS complex: represents the depolarization of the ventricles (the whole ventricle
myocardium is activated during the period of time that corresponds to the duration
of the QRS complex – QRSd, and is shorter than 120 ms in physiological activation)
• T wave: represents the repolarization of the ventricles
Cardiac Arrhythmias
States in which the electrical activation of the heart does not follow the physiological way
described above are called cardiac arrhythmias. They can be caused by an abnormality on
several levels of the electrical activation–conduction system:
1. abnormality of the pacemaker
2. block in various parts of the conduction system
3. spontaneous generation of electrical impulses in the myocardium
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Figure 2.7: Left: Schematic of the conduction system of the heart (from [46]). Right:
Typical ECG record from one cardiac cycle (from [70]).
Ad 1: Although the patient can have a normal sinus rhythm, the action may be either
too fast (tachycardia) or too slow (bradycardia). If the SA node for some reasons fails, the
pacemaker function is replaced by the AV node – but the heart rate will be considerably
lower (∼30–40 bpm). If also the AV node fails, the cells of the conductive pathways in the
ventricles may give the primary rhythm as well. The heart rate at this point would be very
seriously decreased.
Ad 2: Conductivity in any part of the conduction system may be blocked. It may be
caused e.g. by an ischemic necrosis of the tissue (myocardial infarction), by a dilatation
of the heart chambers (e.g. in dilated cardiomyopathy), by an inflammation of the my-
ocardium (myocarditis) or by some cardiac toxins (e.g. diphtheria toxin). The following
list gives the localization of some blocks:
• sinoatrial block – between the SA node and the atrial myocardium (in this case, the
AV node usually acts as the primary pacemaker).
• atrioventricular block – the block is located either in the AV node or in the bundle
of His. The block can be uncomplete (of several grades) or complete (in which case
the atria and ventricles contract independently). From a mechanical point of view,
the effectivity of the ventricle filling may be reduced due to a limited effect of the
atrial contraction. In the case of a complete AV block, the ventricle action is usually
considerably slower. From the clinical point of view, the problem of AV blocks is
very extended and complex.
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• block in the ventricle conduction causes a dyssynchrony in the contraction of the
ventricles and reduces the effectivity of the heart function. Typically, the left bundle
branch may be blocked (the so-called left bundle branch block, LBBB). In the case
of a right bundle blockage we talk about the right bundle branch block (RBBB).
The left anterior fascicle block (LAFB) and the left posterior fascicle block (LPFB)
represent common partial blocks of the left bundle. A characteristic sign in the ECG
is an extended QRS complex with modified shape of each wave of the QRS. A more
detailed description of the LBBB is given in Section 7.
Ad 3: In any part of the myocardium, a spontaneous action potential may be created.
If the surrounding tissue is in the refractory period, the AP cannot propagate and it burns
out. If the surrounding tissue is not in the refractory period, it can eventually activate
the whole myocardium (the so-called extrasystole). The extrasystole may be of an atrial
or ventricular type. The repetitive discharging of such a focus can cause a regular pattern
– e.g. pairs of extrasystoles (couplets), successions of three extrasystoles (triplets) – or
even an extrasystolic tachycardia. In some cases, the electrical signal may circulate along
some atrial or ventricle pathways – the so-called flutter – or the trajectory may become
completely chaotic – we then talk about atrial or ventricle fibrillation. Ventricular flutter
and ventricle fibrillation cause minimal cardiac output and that is why we talk about
malign arrhythmias, causing sudden cardiac death.
2.3.4 Coronary circulation
The heart is supplied by three main coronary arteries (LAD, LCx and RCA), as was
described in Section 2.2. Now, we will give a few functional remarks about the coronary
circulation.
The flow in the heart at rest is about 225 mL/min, which represents approximately 5%
of the LV output. While the flow in the epicardial part of the heart is almost continuous,
the flow in the subendocardial regions is intermittent. It is considerably reduced during
systole, because of the mechanical squeezing of the subendocardial vessels, see Figure 2.8.
Reducing the length of the diastole – typically by increasing the heart rate – decreases the
blood supply, especially in the subendocardial regions. Therefore, the first symptoms of
an ischemic heart disease often appear subendocardially. There are almost no collaterals
between the main coronary arteries which has critical consequences if one of them becomes
occluded. The tissue behind the occlusion undergoes an ischemic necrosis – the so-called
myocardial infarction (see Section 2.4.2).
Most of the tissues in the body in resting conditions remove approximately 40% of the
oxygen during the passage of the blood through the capillary bed. Therefore, the venous
blood is usually still quite well saturated with oxygen. If there is a need for a higher oxygen
supply, the oxygen uptake from the capillary blood may rise. However, situation differs in
the coronary arteries where the myocardium removes 80–90% of the arterial oxygen even
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Figure 2.8: Intermittent coronary blood flow during a cardiac cycle with the lowest value
in the systole. From [46].
at rest. Therefore, in any situation when the heart has higher oxygen demands (e.g. during
any physical activity), the perfusion of the heart must increase.
2.3.5 Regulation of the heart function
The cardiac output is controlled by the peripheral tissues. Higher metabolic needs in the
tissues cause their increased perfusion thanks to autoregulation mechanisms, which are
controlled by the tissues themselves. The heart reacts immediately on an increased venous
return by increasing the minute output by several mechanisms: The heterotropic regulation
based on the Frank–Starling mechanism occurs during the first minutes of the venous re-
turn increase. Positively inotropic (an increased contractility of the ventricle), chronotropic
(an increased heart rate), dromotopic (an increased conductivity in the conduction system
of the heart) and positively lusitropic activation (an increased rate of the ventricle relax-
ation) account for the most important parts in the regulation of the cardiac output. The
heart function can be regulated in a long-time scale (months–years) by hypertrophy of the
myocardium.
Heterotropic regulation
A phenomenon of an increased stroke volume after increasing the end-diastolic volume of
the ventricle, independently of the homeotropic, chronotropic or lusitropic regulations, was
described already in the end of the 19th and beginning of the 20th century by Otto Frank
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Figure 2.9: Left: Length–tension diagram for a single sarcomere with relative positions of
the actin and myosin filaments depicted at the upper right. Note that the most effective
contraction occurs for sarcomere length between the points B and C. Right: Length–tension
diagram for the whole muscle, both before and during the activation. From [46].
and Ernest Starling.7
One possible explanation could be a better overlap between the actin and the myosin
molecules when the fiber is stretched as is represented in Figure 2.9. It would lead to
a higher number of actin–myosin cross-bridge formation, that would create an increased
active stress in the fiber. Nowadays, it is known that the stretching of the muscle fiber
causes an increased sarcomere Ca2+ sensitivity which increases the contractility. In [20]
is shown that the increase of the contraction force is also related to the increase of the
sarcomere passive tension rather than only to the sarcomere length. A molecule titin plays
the role of an intermolecular sensor.
On an organ level, most of the physiological experiments demonstrating the Frank–
Starling mechanism were performed on isolated heart–lungs preparates perfused by a cer-
tain solution (e.g. solution of albumin) and ventilated by a ventilator. In such experiments,
the heart is extracted from the thorax of an animal without the pericardium. By increasing
the filling pressure, we can directly increase the end-diastolic volume of the ventricle. Then,
a stretching of the muscle cells induces a higher level of contraction via the Frank–Starling
mechanism. The thick curve in Figure 2.10 on the left shows a typical cardiac output
curve of the heart (the minute cardiac output depending on the right atrial pressure or
equivalently on the end-diastolic ventricle filling) without any additional activation. We
can see that the minute volume increases until a limit value is reached (∼12 L/min).
7 Otto Frank (1885): . . . the peak systolic pressure in the frog heart is directly related to resting diastolic
fibre length.
Ernest Starling (1914): . . . cardiac output is directly related to the filling pressure.
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Figure 2.10: Left: Cardiac output curves (Frank–Starling curves) under basic conditions
and for several positively inotropic activations (hypereffective hearts) and negatively in-
otropic regulations (hypoeffective hearts). Right: Cardiac output and venous returns
curves at rest (in black) and during heavy exercise (in red). From [46].
It is difficult to obtain similar results in vivo for the following reasons: First, the heart
is placed in the thoracic cage surrounded by the pericardium that prevents the ventricles
from a higher level of dilatation. Secondly, by increasing the filling of the heart, the
stress in the ventricle walls increases and the consecutive contraction is energetically very
disadvantageous – especially for the failing heart. Nevertheless, the heterotropic regulation
is present in vivo. We can observe it usually as a first reaction regulation – during the first
minutes after increasing the venous return – before the other regulation mechanisms get
activated. The Frank–Starling mechanism is especially important to equilibrate the left
and right ventricle outputs.
Increased chronotropy
By increasing the heart filling, the right atrium is stretched, which leads to an activation
of the vasomotoric centre in the brain stem and an increase of the heart rate (the so-
called Bainbridge reflex). A stretch of the SA node itself increases the heart rate directly,
with the elevation of an order of 20–25%. During physical activity, the main chronotropic
activation is caused by stimulating the SA node by the sympathetic system. The heart
rate can increase 2–3 folds.
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Class Objective Assessment
I Patient with cardiac disease but without any limitations in physical activity
II Comfortable at rest, ordinary physical activity results in fatigue, palpitations,
dyspnea or anginal pain
III Comfortable at rest, but less than ordinary physical activity results in fatigue,
palpitations, dyspnea or anginal pain
IV Symptoms of HF may be present even at rest
Table 2.1: New York heart association classification for the heart failure (NYHA).
Inotropic and lusitropic activation
The contractile properties of the myocardium (the strength of the contraction) can be
increased by the inotropic activation. The ejection fraction of the ventricles is a clinically
measurable indicator of the inotropic state. As an example of inotropic activation, there
are mechanisms that increase the Ca2+ ion concentration in the cytosol (e.g. by increasing
the ryanodine receptor sensitivity). The inotropic stimulation may also be achieved by
increasing the myosin ATPase activity or directly by increasing the rate of cross-bridge
formation, independently on the activity of the ATPase. Lusitropic activation is achieved
by increasing the re-uptake rate of the Ca2+ ions from the sarcoplasm to the sarcoplasmic
reticulum or to the extracellular compartment. These processes are often controlled by the
state of phosphorylation / dephosphorylation of certain proteins initiated e.g. by the stress
hormones epinephrin or norepinephrin. Hence the activation of the sympathetic system
has positively chronotropic, inotropic, lusitropic and also dromotropic effects.
The increased or decreased effectivity of the contraction of the heart caused by the
inotropic activation is depicted in Figure 2.10.
2.4 Cardiological remarks
2.4.1 Heart failure
Heart failure (HF) is a symptom by which the heart is not able to pump the amount of
blood that returns via the venous system. The venous return is directly given by the
metabolic needs of the tissues. That is why the heart failure may also be defined as a state
in which the heart is not able to pump enough blood to supply the peripheral tissues with
an adequate quantity of oxygenated blood. Due to the blood stagnation in front of the
heart ventricles, the patient develops symptoms such as dyspnea and fatigue (typical of
the left ventricle failure) or edemas. HF can be clinically evaluated using a global index as
for instance the NYHA classes, see Table 2.1.
HF may be an acute disorder or the result of a long-term process (that finally leads to
such a situation). Patients suffering from HF may be categorized into 2 groups (approxi-
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mately of the same size): HF with a depressed ejection fraction (the systolic heart failure)
or HF with a preserved ejection fraction (the diastolic heart failure).
Systolic heart failure
Systolic heart failure is characterized by a decreased ejection volume, while the diastolic
ventricle filling is preserved. It can be caused by a decreased contractility either locally
or globally in the whole ventricle. The former case is typically the result of myocardial
infarction (see Section 2.4.2), in which a part of the myocardium becomes hypo– or akinetic.
The latter case may arise from some diseases affecting the whole myocardium, as is the
case for cardiomyopathies (see Section 2.4.3). A dyssynchronous heart contraction or a
stenotic aortic valve are some other examples of diseases that may lead to a systolic heart
failure.
Diastolic heart failure
During diastole, ventricles are relaxing and the pressure decreases from the systolic value
back to the low diastolic value. As soon as it drops below the atrial pressure, the AV valves
open and the blood flows along the pressure gradient to the ventricles. The relaxation of
the myocardium has a passive and an active component.
The passive component of relaxation is given by an elastic recoil of the ventricle. It can
be impaired if the myocardium becomes stiffer (e.g. in a hypertrophied heart with increased
fibrosis). The active component of the relaxation is based on the re-uptake of the Ca2+
ions from the sarcoplasm. It is an ATP–dependent process and is especially important in
the isovolumic phase of the relaxation. It can be altered in any situation when the heart
supply is decreased.
In an early stage of the ischemic heart disease, the ejection fraction can still be normal
thanks to compensation mechanisms that cause an increased contractility of the heart, but
the diastolic phase may be already altered. Later, the diastolic heart failure can be followed
by the systolic heart failure.
Compensated and decompensated heart failure
Under resting conditions, the heart has to provide the tissues with approximately 5 L/min
of blood (cardiac output). In an acute heart failure the cardiac output drops immediately
and the following compensatory mechanisms are activated (see Figure 2.11):
1. An increased sympathetic activation (and parasympathetic inhibition) during the
first minutes.
2. Retention of body fluids by kidneys leading to an increased volume of the circulating
blood (hours–days).
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Figure 2.11: Left: Progressive changes (points A–D) in an acute compensated HF. Note
that the partially recovered heart is able to pump 5 L/min but the cardiac reserve (the
maximum cardiac output) has dropped significantly. Right: Vicious cycle in decompen-
sated heart failure – the heart is not able to react to the progressive fluid retention over a
period of days (points A–F). From [46].
3. Progressive recovery of the heart (months–years).
If the sympathetic response returns the cardiac output to a sufficient level and the
heart is able to sustain an increased load due to the fluid retention by kidneys, we talk
about compensated heart failure. On the contrary, if the heart function is so weak that it
cannot reach the cardiac output of 5 L/min, the kidneys will be still acting in the fluid
retention and a vicious cycle will be set. The heart will be getting still weaker, and the
cardiac output will not be sufficient. This situation is called decompensated heart failure.
2.4.2 Ischemic heart disease
An ischemic heart disease (IHD) arises when there is an insufficient blood supply in a part
of the myocardium. The most usual cause is the atherosclerosis in a coronary artery.
The atherosclerosis is a chronic inflammation in the intimal layer of the arterial wall
caused by activated macrophages. The consequences of the atherosclerotic disease are
either the stenosis of the artery, or the artery occlusion. It is a rupture of an atherosclerotic
plaque followed by the blood coagulation and thrombus formation which actually occludes
the arterial lumen. If the thrombus does not dissolve within a few minutes, the myocardial
tissue behind the occlusion will undergo an ischemic necrosis (the myocardial infarction).
The infarcted region affects the heart function mechanically, since it becomes hypo- or
akinetic, and also electrically. In the first minutes to hours some arrhythmias may appear,
among which ventricle flutter and fibrillation are the most threatening.
The following forms of IHD are recognized:
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• Stable angina pectoris: a transient episode of myocardial ischemia caused by an
increased need of the myocardium (for example due to physical activity) and an
impossible increase of the coronary blood flow (e.g. due to stenosis of the supplying
artery). The chest pain or discomfort are typical clinical symptoms. The pain relieves
by itself in a few minutes or after application of nitroglycerin.
• Unstable angina pectoris: the angina symptoms occur either at rest or they evolve
significantly and last for more than 10 minutes but the myocardium does not undergo
ischemic necrosis. The cause of the symptoms may be an atherosclerotic plaque
rupture (followed by a rapid thrombus dissolution), the spasm of a coronary artery
(Prinzmetal’s variant angina), an advanced and progressing stenosis of the coronary
artery, or an increased myocardial oxygen demand (as for example in anemia or
tachycardia).
• Myocardial infarction: The symptoms of the unstable angina pectoris are followed
by an ischemic necrosis of the myocardium. The first affected regions are situated
in the subendocardial zone because of the most sensitive coronary circulation in
this myocardial part (see Section 2.3.4). The infarcted region may propagate in the
epicardial direction, and can affect the whole myocardium (transmural infarction).
• Sudden cardiac death: Manifestation of the ischemic heart disease by a lethal ar-
rhythmia. It typically occurs in the first minutes after a coronary artery occlusion,
that may be in some cases given just by a reversible coronary spasm.
2.4.3 Cardiomyopathies
Cardiomyopathies (CMs) are diseases affecting primarily the myocardium and resulting in
a cardiac dysfunction. Diseases of the pericardium, valves and coronaries (ischemic heart
disease) as well as congenital heart diseases are excluded from the cardiomyopathies8.
The main morphological types of CMs are listed below. Selected CMs visualized by
magnetic resonance imaging (MRI9) are shown in Figure 2.12.
• Dilated (DCM): DCM is characterized by an increased internal diameter of the LV
with wall thinning. Histologically, the wall is remodeled in the sense of an increased
fibrosis and consequently an increased tissue stiffness. DCM often leads to systolic
heart failure. The conduction system is often affected, which may lead to some
atrio-ventricular, interventricular or intraventricular blocks (e.g. LBBB or RBBB).
The dilated heart may cause a valve disease (e.g. a secondary mitral regurgitation).
Regarding the etiology of the DCM, in some cases it is genetic (including single
8The so-called ischemic cardiomyopathy – an increased myocardial stiffness with fibrosis caused by the
ischemic heart disease (and possibly multiple infarctions) – is not a cardiomyopathy in a right sense.
9Description of Cardiac MRI is given in Chapter 3.
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(a) Dilated cardiomyopathy (DCM) (b) Hypertrophic cardiomy-
opathy (HCM) in the septum
and LVOT
(c) Left ventricle non-
compaction (LVNC)
Figure 2.12: Selected cardiomyopathies in MRI.
gene mutations as for instance in cytoskelet components, actin, etc.). DCM can
follow a myocardial infection (viral myocarditis, it can be caused by diphtheric toxin,
protozoal disease – the Chagas disease). There may occur a reversible reaction on an
acute stress in a form of a balloon-like dilatation (Tako-Tsubo). DCM may also be
induced by some toxic agents (e.g. alcohol abuse, anthracycline anticancer drugs). In
many cases, the ethiology is unknown and the DCM is considered to be idiopathic.
• Hypertrophic (HCM): HCM is characterized macroscopically by an increase of the
LV mass (asymmetric LV hypertrophy – especially in the septal area). The usual
causes of the LV hypertrophy – as for instance the systemic hypertension or the
aortic valve stenosis – are absent. The typical microscopic image shows disarranged
myocardial fibers, which impairs the ventricle contractile function. The ventricle
filling is severely affected, which leads to diastolic heart failure. The hypertrophy in
the area of the LV outflow tract – as can be seen in Figure 2.12(b) – often creates
a barrier for the blood ejection (a pressure gradient between the LV and the aorta).
The most frequent cause of the mortality are malign cardiac arrhythmias.
• Restrictive (RCM): RCM is characterized by an increased stiffness of the subendo-
cardial part of the myocardium, that prevents the ventricle from adequately filling.
RCM therefore leads to diastolic heart failure. RCM develops often secondarily due
to an infiltration of the myocardium e.g. by an amyloid protein (amyloidosis). An
iron overload (as for instance in hemochromatosis or in β-thalasemia) or sarcoidosis
are other causes of RCM.
• Arrhythmogenic right ventricle dysplasia (ARVD): ARVD is a degeneration of the
wall of the RV (and sometimes also of the LV) by means of a fibro-fatty replacement
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of the myocardial tissue. Thinning of the wall and formation of small aneurysms are
the main morphological signs of ARVD, see Figure 3.10. ECG abnormalities, as for
instance ventricle extrasystoles, are present. The most threatening consequences of
ARVD are RV progressive failure and serious arrhythmias, including malign ventricle
fibrillation.
• Left ventricle non-compaction (LVNC): LVNC is given by an arrest of the embryo-
genesis of the myocardium. The myocardium is formed by a spongy network of
myocardial fibers with abundant recesses and sinusoids, as in the lateral LV wall in





Image data used in this thesis for personalization of the model were obtained by magnetic
resonance imaging (MRI). The data were either acquired by specialists at hospitals or in
the case of an animal experiment we actively participated by suggesting the experimental
setup, preparing the imaging sequences and performing the data acquisition. In this chapter
we are going to explain the basis of MRI and discuss imaging of the cardiovascular system
and of the heart in particular. The aim of this chapter is to finally describe a protocol
for cardiac MR data acquisition during an animal experiment, performed during the PhD
study.
This chapter is inspired by the course of MRI given by J. Tintera at Institute for Clinical
and Experimental Medicine (IKEM), Prague, Czech Republic. The presented MR images
were acquired either directly by J. Tintera or with his participation in the setup of MR
sequences.
3.1 History
The first resonance experiments with magnetic properties of nuclei were performed by
Isidor Isaac Rabi1 in 1933. The phenomenon of nuclear magnetic resonance (NMR) was
described independently by Felix Bloch and Edward Mills Purcell in 1946.2 NMR became
a valuable technique used for the chemical and physical analysis of molecules by means of
the NMR spectroscopy. In such applications, the NMR signal is acquired from the entire
volume of the chemical sample and the resulting analysis does not contain any spatially
dependent information. In 1973 Paul Lauterbour and Peter Mansfield3 proposed an idea
1I.I. Rabi was awarded by The Nobel Prize in Physics in 1944 ”for his resonance method for recording
the magnetic properties of atomic nuclei”.
2F. Bloch and E.M. Purcell were awarded by The Nobel Prize in Physics in 1952 ”for their development
of new methods for nuclear magnetic precision measurements and discoveries in connection therewith”.
3P. Lauterbour and P. Mansfield were awarded by The Nobel Prize in Physiology and Medicine in 2003
”for their discoveries concerning magnetic resonance imaging”.
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nucleus concentration in living tissues gyromagnetic ratio (γ)
(mMol) (s−1T−1)
1H 105 2.6752 · 108
31P 101 1.0829 · 108
13C 101 6.7266 · 107
Table 3.1: Concentration and gyromagnetic ratio of selected nuclei.
to focus the acquisition of the NMR signal on small volumes by means of a subdivision of
the imaging body into voxels ([64]). They constructed the first NMR tomograph.
In the second part of the 20th century, the word ‘nuclear’ was not well accepted by
the public mainly because of the threats of the cold war. It is the reason why the name
‘Nuclear Magnetic Resonance’ (NMR) was replaced by the ‘Magnetic Resonance Imaging’
(MRI) in medical applications. The first commercial MR systems appeared in 1985. Since
that time, the development went on in many aspects. One of the most visible progresses
is in field of the acceleration of imaging protocols. While some types of acquisition could
have taken more than 1 hour in the 1980s, it did not take more that a few minutes 10 years
later. Thanks to this fact, the imaging of moving organs – as for the heart – has become
available.
3.2 Basic principles of MRI
3.2.1 Tissue magnetization
Atomic nuclei with different numbers of protons and neutrons have a non-zero magnetic
momentum. Typical examples of such nuclei in living tissues are 1H, 31P or 13C, from
which the nuclei 1H are the easiest to detect by means of the NMR, thanks to their highest
concentration and also due to the fact that they have the largest gyromagnetic ratio4 γ,
see Table 3.1. Therefore from now on we will be considering just the nuclei 1H, each of
them characterized by its magnetic momentum (spin) mi. Since the nuclei
1H consist only
of one proton and they do not have any neutrons, they are often called ‘protons’.
By net tissue magnetization M we mean the sum of all particular nuclear magnetic
spins mi in the imaging volume, hence M =
∑
i mi. While we should use the quantum
mechanics approach to describe the magnetic spins5 mi, the tissue magnetization M is a
macroscopic quantity for which the classical approach can be applied
4The ratio between the angular and magnetic momentum – a property characterizing each type of
nucleus. Higher γ increases the sensitivity of the nucleus to the NMR effect.
5 Since MRI is not the main topic of the thesis, we will be using classical mechanics (including to describe
processes related to the nuclear spins mi) in order to simplify the explication of basic concepts. For the
rigorous quantum approach see e.g. [69].
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magnetic induction of B0 parallel orientation antiparallel orientation
0.5 T 106 + 3 106
1.0 T 106 + 6 106
1.5 T 106 + 9 106
3.0 T 106 + 18 106
Table 3.2: Comparison of counts of 1H nuclei in the parallel (the low-energy state) and
in the antiparallel orientation with respect to the induction (strength) of the external
homogenous magnetic field B0. Note that even for high magnetic fields, there is only a
slight difference between the counts in the two configurations – hence the detectable tissue
magnetization M is very low.
Under normal conditions, the orientation of all nuclear magnetic spins mi is random
and therefore there is a zero net tissue magnetization, M =
∑
i mi = 0. However, if the
tissue is placed in a strong homogenous magnetic field with a magnetic induction given
by vector B0, the spins mi will align either parallel to B0 or in an antiparallel way. The
parallel orientation corresponds to the low-energy state, therefore there will be more nuclei
in the parallel configuration than in the antiparallel one. Hence, the tissue magnetization
will become a non-zero vector, M 6= 0. The ratio of the spins in the parallel vs. antiparallel
state depends on the magnitude of vector B0 that will be denoted by B0 (the strength of
the external magnetic field B0) and is larger in higher magnetic fields, see Table 3.2. Since
the tissue magnetization M is a source of the NMR signal, we can obtain a higher signal
for stronger external magnetic fields.
Remark:






kT , where k stands for the Boltzman constant, T is the thermodynamical
temperature and ∆E represents the energetic difference between the parallel and antiparallel con-
figuration.
Tissue magnetization M can be decomposed into two components: the longitudinal
magnetization M‖, which is parallel to B0, and the transverse magnetization M⊥, which
is perpendicular to B0. Hence, M = M‖ + M⊥. From the point of view of classical
mechanics, the magnetic spins mi (both in the parallel and antiparallel orientations) are
aligned at a slight angle with respect to B0 and precess around the axis given by
6 B0, see
Figure 3.1. The magnitude of the longitudinal component of the net tissue magnetization
M‖ = M0 > 0 due to the fact that there are more spins in the parallel configuration. The
transverse component M⊥ = 0 since the spin phases are random.
6According to Footnote 5 we point out that this argument is not true from the point of view of quantum
mechanics since there are only two states for each spin and the spin precession does not have any sense if
we do not sum a sufficient number of mi.
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Figure 3.1: Vector of tissue magnetization M with contribution of all magnetic spins mi
precessing around the axis given by direction of B0. From [110].
3.2.2 Excitation and relaxation
The frequency of the precession motion of the magnetic spins is given by their gyromagnetic
ratio γ and by the strength of magnetic field B0, the so-called Larmor frequency:
ωL = γB0. (3.1)
Therefore for a given magnetic field B0 there is a specific – Larmor – frequency for each
type of nucleus.
The system of spins precessing with the Larmor frequency ωL is able to absorb an
energy in the form of a radiofrequency pulse7 (RF) of the same frequency – the process
called excitation. Hence, the name of the method – magnetic resonance – comes from
the fact that the energy exchange occurs when the RF pulse is ‘in resonance’ with the
precession frequency of the spins.
After the excitation by the RF pulse of the Larmor frequency (ωL), the full spin sys-
tem will precess in phase and some of the spins will pass from the low-energy parallel
configuration to the high-energy antiparallel state. This is why a transverse component
of the tissue magnetization (M⊥) will appear and the longitudinal component (M‖) will
decrease. While the longitudinal magnetization M‖ is undetectable, the transverse compo-
nent induces a current of a few µA in the receiving coil due to electro-magnetic induction.
7The RF pulse is created by an oscillating magnetic field B1 perpendicular to B0.
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Figure 3.2: Excitation by 90 ◦ RF pulse tilts the magnetization vector in the transverse
plane and brings the spin system into phase. This causes the signal FID to appear. The
drop of FID amplitude is due to spin-spin interactions (T2 relaxation). The 180 ◦ RF pulse
refocuses the spins and a signal in the form of echo re-appears (spin echo, SE). From [110].
The electrical current induced in the receiving coil – the MR signal – has a character of a
damped sinusoid, the so-called Free Induction Decay (FID), see Figure 3.2. An amplitude
decrease of the FID is caused by relaxation processes, which bring the magnetization back
to the non-excited state.
The relaxation has two independent components: a recovery of the longitudinal relax-
ation – the T1 relaxation – and a decay of the transverse magnetization – the T2 relaxation.
The relaxation rates are given by physical properties of the tissue and also by external ef-
fects (e.g. by the strength of the external magnetic field). Finally, the initial magnetization
vector M, with M‖ = M0 and M⊥ = 0, will be recovered.
T1 relaxation
The exponential re-establishment of the longitudinal magnetization is caused by an energy
transfer from the excited nuclei to the surrounding tissue (the lattice) in the form of heat.
Therefore the T1 relaxation is also called the spin–lattice relaxation. The longitudinal
relaxation is characterized by a time constant T1 and can be represented by the following
equation:




The T1 relaxation time constant is given by physical properties of the tissue and it also
depends on the strength of the external field B0 – the T1 relaxation time increases at
higher fields B0. The longitudinal relaxation of biological tissues is around 700–2000 ms,
see Table 3.3.
T2 relaxation
The decay of the detected signal is caused by dephasing of the spins due to their interactions
(spin-spin interactions, see Figure 3.2) and because of the local inhomogeneities of the
magnetic field. The first component (the spin-spin interactions) stands for the true T2
relaxation and it is independent of the strength of B0. It causes an exponential decay of
the transverse component of the magnetization (and therefore of the detected signal) with




The transverse T2 relaxation of biological tissues is around 80–200 ms, see Table 3.3.
In practice, the signal decay is always faster, which is caused by local inhomogeneities








where ∆B represents the inhomogeneities of B0. The larger ∆B is, the faster the T2
∗
relaxation will be. A principle of fast dephasing and refocusing of the spins by a strong
controlled B0 inhomogeneity is used in MR signal detection by the so-called gradient echo
technique. This will be discussed in Section 3.3.4.
In Figure 3.3, we can see direct maps of T1 and T2 relaxation constants in a brain
together with plots of T1 and T2 relaxation curves in grey and white matter. To obtain
the T1 and T2 relaxation constants, we have to fit the exponential curves given by (3.2)
and (3.3). Therefore, we have to perform several measurements and detect the MR signal
in several points of the exponentials. It is rare to estimate directly the relaxation constants
in clinical practice since the acquisition time would be very long. Instead, images with a
contrast preferentially given e.g. by the T1, T2 or T2∗ relaxation rates are acquired just
by one measurement. Such images are called T1, T2 or T2∗ weighted.
3.3 Basic MR sequences
A sequence of tissue excitations by radio-frequency pulses (RF) and modifications of the
external magnetic field, leading to an acquisition of a spatially encoded MR signal is called
an MR pulse sequence (MR sequence, pulse sequence). In this section, we present basic
types of pulse sequences. A detailed setup of the sequences can be found e.g. in [10]. The
spatial encoding step is explained in Section 3.4.
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tissue T1 (ms) at B0 = 1.5 T T1 (ms) at B0 = 0.5 T T2 (ms)
skeletal muscle 870 600 50
liver 490 325 45
fat 260 215 85
white matter (cerebral) 790 540 90
grey matter (cerebral) 920 655 100
cerebrospinal fluid (liquor) >4000 >4000 >2000
Table 3.3: Relaxation times of selected tissues. While T1 relaxation is longer at higher
magnetic fields, the T2 relaxation is independent of B0.
(a) T1 map (b) T2 map




























(c) T1 and T2 relaxation curves for white and grey
matter in brain
Figure 3.3: Relaxation constants in brain (time constants of T1 and T2 relaxations).
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3.3.1 Spin ECHO
Spin ECHO (SE) is the simplest imaging sequence. First, we apply an RF pulse of the Lar-
mor frequency of the energy that exactly cancels the longitudinal magnetization (M‖ will
become zero). At the same, the the RF pulse brings the precessing spins into phase, which
creates the non-zero transverse magnetization (M⊥ > 0). By a geometrical analogy, we
say that the RF pulse has tilted the tissue magnetization vector M by a flip angle α = 90 ◦
into the transverse plane. Therefore, such an RF pulse is called the 90 ◦ pulse.
Immediately after the excitation by the 90 ◦ pulse, an MR signal in the form of a FID
appears. We do not sample the signal at this time and it disappears soon due to spin-
spin interactions and local magnetic field inhomogeneities (the T2∗ decay). The signal
can re-appear after a period TE (time echo) by the following mechanism, illustrated in
Figure 3.2: After a period of time TE/2 we apply an RF pulse of 180 ◦ that flips all the
spins. The local magnetic field inhomogeneities will become exactly opposite with respect
to the previous spin system and therefore the spins will get back into phase in another time
period of TE/2. The 180 ◦ pulse is therefore called the refocusing pulse. At this time point,
we register an MR signal – the echo. The amplitude of the signal will be lower than the
amplitude of the original FID, since the spin-spin interactions (the effect of T2 relaxation)
are irreversible and cannot be inverted by the 180 ◦ refocusing RF pulse. Hence, the peaks
of the FID and of the detected echo lie on the T2 relaxation curve.
We can summarize that the SE is a pulse sequence of the 90 ◦ excitatory RF pulse,
the 180 ◦ refocusing RF pulse and the detected echo: 90 ◦ – 180 ◦ – ECHO. The main
parameters of the SE sequence are as follows: the time echo (TE) – the time period
between the excitation by the 90 ◦ RF pulse and the echo creation, the repetition time
(TR) – the time period between the two consecutive 90 ◦ pulses (the repetition time of the
whole SE sequence).
By varying the parameters TR and TE of the SE sequence, we can obtain different
types of images. The image contrast can be more dependent on the T1 relaxation times
(the T1 weighted images) or the contrast can be mainly given by the T2 relaxation rates
(the T2 weighted images). The image contrast in the so-called proton density weighted
image (the PD-weighted) is given directly by the concentration of 1H nuclei. Hence, three
types of intrinsic8 image contrasts can be easily obtained.
T1 weighted image
When using a short TR, the tissues with a long T1 relaxation will not have enough time
to recover their longitudinal magnetization. After applying other 90 ◦ pulses, the signal
from such tissues will become very low. However, the tissues with fast T1 relaxation can
8The image contrast is given directly by magnetic properties of the tissues themselves (namely by the T1,
T2 relaxation times and concentration of 1H). There is no modification, by means of an external contrast
agent.
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short TE long TE
short TR T1w (TR = 400-600 ms, TE = 10–15 ms) bad contrast
long TR PDw (TR = 2000-5000 ms, TE = 10–15 ms) T2w (TR = 2000-5000 ms, TE = 80–120ms)
Table 3.4: Typical parameters used in SE sequences in order to obtain T1, T2 or PD-
weighted image.
recover almost their whole longitudinal magnetization even during a short time period TR
and the signal will be high even after the successive excitations. The short TE at the same
time will to some extent eliminate the influence of the T2 relaxation. Therefore the image
contrast will be mainly given by differences in the T1 relaxation times and the resulting
image is called the T1 weighted image. The signal will be high in the tissues with a short
T1 relaxation and low in tissues with a long T1 relaxation. See Figure 3.4 with an example
of the T1 weighted image on the left side. Note that the cerebrospinal fluid (CSF) is dark
since the CSF has a long T1 relaxation (see Table 3.3).
T2 weighted image
The T2 weighted image can be acquired using a long TR and a long TE. Thanks to the long
TR, the longitudinal magnetization will be almost fully re-established in all tissues before
applying the next excitation 90 ◦ pulse. Therefore the resulting image will not be influenced
by the T1 relaxation. The acquired signal will strongly depend on the T2 relaxation rate
thanks to the long TE. The tissues with a fast T2 relaxation will not contribute to the
detected signal as much as the tissues with a long T2 relaxation time. See Figure 3.4 (on
the right) with an example of the T2 weighted image. Note that the cerebrospinal fluid
(CSF) is the lightest part of the image, since the CSF has a long T2 relaxation (see Table
3.3).
Proton density (PD) weighted image
The proton density weighted image (PD weighted image) can be obtained by using a long
TR and a short TE. Thanks to the long TR, the longitudinal component will always be
re-established, as in the case of the T2 weighted images. The short TE will eliminate the
influence of the T2 relaxation. Therefore, the image contrast will depend rather directly on
the magnitude of the magnetization vector which is proportional to the 1H concentration.
An example of a PD weighted image is shown in the middle of Figure 3.4.
Parameters of typical SE sequences are summarized in Table 3.4.
3.3.2 Turbo Spin ECHO
The conventional SE sequence consists of the 90 ◦ RF pulse, 180 ◦ RF pulse and the signal
in the form of echo is sampled afterwards. The time period between the echo and the
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Figure 3.4: Spin ECHO sequence: examples of T1, PD and T2 weighted images.
following 90 ◦ excitation RF pulse is unused. Rather than waiting for the period TR to
end, we can apply another 180 ◦ pulse and the signal of another echo can be sampled, see
Figure 3.5. By this mechanism, we can obtain even more echos. Although the signal of the
following echos is getting lower (due to the T2 relaxation), the level of the signal may be
still acceptable. See Figure 3.5 for the sequence setup.
The number of echos obtained during one TR is called the turbo factor (TF) or the
echo train length (ETL) and the SE sequence modified in such a way is called Turbo Spin
ECHO (TSE). The turbo factor TF will accelerate the data acquisition TF-times.
3.3.3 Inversion recovery
Inversion recovery (IR) is another modification of the SE sequence. It can serve for a
suppression of the MR signal in a particular type of tissue, or for increasing the image
contrast in general. In principle, we apply a 180 ◦ RF pre-pulse before the excitation 90 ◦
pulse. The 180 ◦ pre-pulse inverts the tissue magnetization M. Afterwards, M is returning
back to the initial state with a rate depending on the tissue properties and on B0. If the
90 ◦ RF pulse is applied exactly at the moment when the magnetization of a particular
tissue is crossing the transverse plain, the tissue signal will be very low. It is caused by
the fact that the tissue cannot be excited when there is no longitudinal component of the
magnetization. The time period between the 180 ◦ pre-pulse and the 90 ◦ pulse is called the
inversion time (TI). By tuning the TI, we can for instance suppress the following tissues9 :
• fat tissue – TI ∼ 170 ms, the so-called STIR (Short Tau Inversion Recovery)
9The values of TI are taken for a 1.5T MR system. Inversion times are longer at higher fields because
of the longer T1 relaxation.
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Figure 3.5: Turbo Spin ECHO (TSE) sequence with two generated echos. From [110].
• cerebrospinal fluid – TI ∼ 2000–2500 ms, the so-called FLAIR (FLuid Attenuated
Inversion Recovery)
• myocardium – TI ∼ 200 ms – in combination with an extracellular contrast agent
(see Section 3.6); we can obtain the so-called late enhancement images (LE), in which
the signal in the myocardium is suppressed and the tissue with an entrapped contrast
agent gives a high signal (see Section 3.10.1).
See Figure 3.6 for an example of IR TSE sequences with a different TI time.
3.3.4 Gradient ECHO
In the SE sequence, the 90 ◦ RF pulse brings the spins into phase, their dephasing is caused
by the T2∗ relaxation and the refocusing is achieved by applying the 180 ◦ RF pulse. After
excitation by the 90 ◦ RF pulse, we can accelerate the dephasing of the spins by applying an
additional controlled magnetic field inhomogeneity – using gradient magnetic fields10 (the
so-called gradients). Switching on the gradient for a certain period of time will dephase
the spins quickly. Then, by changing the gradient polarity, the spins will get into phase
again and the MR signal in the form of an echo can be sampled. If we apply another pair
of gradients of opposite polarities, we can recover the 2nd (or other) echos. Unlike the SE
sequence, the peak signals in the GE sequence lie on the T2∗ curve instead of on the T2
curve, since the local field inhomogeneities are not compensated.
10Gradient magnetic fields cause linear variation of the external magnetic field B0, e.g. the gradient in
the x-direction (Gx) will change the magnetic field strength to B0 + xGx.
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(a) Suppression of the cere-
brospinal fluid (FLAIR)
(b) Suppression of the fat tissue
(STIR)
(c) Suppression of the my-
ocardium, after administering the
contrast agent – late enhancement
(LE) in the subendocardial part of
the LV anterior and antero-lateral
wall
Figure 3.6: Tissue suppression by inversion recovery (IR).
Instead of using the initial excitation 90 ◦ pulse, we use a lower flip angle α in the GE
sequence. Thanks to such a settings, the longitudinal relaxation will become faster and
we will be able to shorten the repetition time TR. Therefore the acquisition time will be
shorter. For a basic setup of the GE sequence, see Figure 3.7.
In general, there are two groups of GE sequences: the coherent (steady state) and the
non-coherent (spoiled).
Coherent GE sequences
The transverse component of the magnetization (M⊥) is kept at the end of each TR. All
the phase-encoding11 gradients are exactly balanced (symmetric). The resulting signal is
T2/T1 weighted. There are some particular applications:
• Time of Flight (TOF) used in native MR angiography (see Section 3.10.3). Using a
short TR, the static tissue is suppressed and the flowing blood has a high signal (the
GE inflow effect). The parameters of a typical TOF sequence using the balanced GE
sequence (e.g. FISP) are as follows: TR = 20–50 ms, TE set to the minimum value,
α = 10–40 ◦.
• Balanced steady state free precession (bSSFP, trueFISP, FIESTA) – a very fast se-
quence (TR ∼ 1–5 ms). Although the ratio T2/T1 is quite uniform in the tissues, the
11The phase and frequency encoding directions are discussed in Section 3.4.
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Figure 3.7: Settings of Gradient Echo sequence (GE). From [110].
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T2/T1 ratio of blood is quite different from that of the adjacent muscle and vessel
wall, leading to particularly valuable image contrast for cardiovascular applications
(e.g. in native coronary angiography [44] or in cardiac Cine MRI, in which also the
TOF effect plays a role).
Non-coherent GE sequences
The transverse component of the magnetization (M⊥) is canceled at the end of each TR
either by gradient spoiling or by RF spoiling. The sequence does not depend on balancing
the gradients, which is why it is not as sensitive to the B0 inhomogeneities as the balanced
sequences. The resulting signal may be lower, especially if a low TR or high flip angle α is
used. The sequence was published under the name FLASH = Fast Low Angle SHot (see
[39], [40], [49]).
There are several typical applications of the non-coherent GE sequences in cardiac
imaging (see Section 3.10.1 for a more detailed description):
• Cardiac Cine MRI – compared to the balance sequence (bSSFP), the GE sequence
provides a lower signal and the acquisition time is longer; it is sensitive to flowing
blood in the cavities (the signal drop may occur due to a loss of phase coherence,
especially in turbulent flows) but without artifacts caused by the B0 inhomogeneities.
• Magnetization-prepared GE
– Snapshot FLASH (see [47]) – a fast variant of FLASH with a low TR. The low
tissue contrast (due to the short TR) is increased by applying a 90 ◦ or 180 ◦ IR
pre-pulse (see Section 3.3.3). A single shot12 sequence is used e.g. for cardiac
perfusion (first pass of the contrast agent). FLASH with an IR pre-pulse not
in the single shot version can be used in order to obtain high quality13 late
enhancement images of the myocardium (the images acquired approximately 10
minutes after administering a contrast agent).
– SPAMM (SPatial modulation of the Magnetization, see [117], [5], [4]) – used for
the tagged MR images (in Cardiac MRI).
3.4 Concept of k-space
In this section we will describe the reconstruction of a 2-dimensional image in magnetic
resonance imaging (MRI). As in the previous part, only 1H nuclei will be considered.
12The whole k-space is filled during one period TR.
13The balanced sequence is often used in this application – because of the acquisition speed-up. However,
the spatial resolution is worse when using the bSSFP sequence and usage of such images is often limited
only to detect an ischemic damage of the myocardium. The image quality is usually not sufficient to detect
the late enhancement e.g. in some cardiomyopathies.
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Figure 3.8: Slice selection using the additional slice selection gradient of the magnetic field
Gz during the excitation by the 90
◦ RF pulse. From [110].
3.4.1 Slice selection
As discussed in Section 3.2.2, the spin system is excited by applying an RF pulse of the
Larmor frequency, which is given by the product of the gyromagnetic ratio of the nuclei and
of the external magnetic field intensity, ωL = γB0. If we used only the static homogenous
magnetic field B0, the RF pulse would excite all the
1H nuclei inside the magnet. By
varying the magnetic field B0 linearly along the direction perpendicular to the imaging
slice (direction z) by the gradient Gz, the Larmor frequency ωL will become slice-specific.
The imaging slice will be given by the bandwidth of the RF pulse and the actual values of
the magnetic field intensity:
ωL = γ(B0 + zGz). (3.5)
As we can see in equation (3.5), a thin slice can be acquired either by using a very
narrow bandwidth of the excitation pulse RF, or by using a very high value of the slice
selection gradient Gz, see Figure 3.8. Adding the linear gradient magnetic fields in the
NMR system was Paul Lauterbour and Peter Mansfield’s idea for the spatial encoding of
the MR signal which actually moved NMR from spectroscopy to imaging in the early 1970s.
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3.4.2 Reconstruction of the 2D image
Assume that one particular slice was selected by using the slice selection gradient Gz during
an application of the excitation RF pulse. The spins in this particular slice have got into
phase. Each point of the slice is characterized by the MR signal S with an amplitude S0,
which is given by the magnitude of the transverse magnetization of the excited system
(M⊥). If we neglect the T2 relaxation, S0 will be constant at each point during the data
acquisition. Using the MR system, we need to estimate the values of S0 at each point.
These values will correspond to the intensity of the picture elements (pixels) in the final
reconstructed image.





For a given amplitude S0 the rotation of the spins with respect to a reference spin system,




where t stands for the time variable and i is the imaginary unit. As a reference spin
system, we consider the system where only the basic external magnetic field B0 is used,
ωref = ωL = γB0.
The angle velocity of the rotation can be changed by applying gradient magnetic fields
– the gradients Gx or Gy – in the following manner:
ω = ωref + γ(xGx + yGy). (3.8)
Let us assume that we switch on the gradient magnetic fields Gx and Gy for a period τx,
respectively τy. The spin system will be rotating with the angle velocity given by (3.8).
When the gradients are switched off, the spins will be rotating with the angle velocity ωref
again but their phase will have changed. By substituting the angular velocity (3.8) to (3.7)















S(x˜, y˜)eikxx˜eiky y˜dx˜dy˜, (3.10)
kx, ky being variables in the k-space.
Hence, when choosing properly the parameters of the sequence, the measured signal
will be exactly the Fourier transform of the image, and the image can be reconstructed
just by applying the inverse Fourier transform on the acquired raw data.
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Phase encoding
We can choose the appropriate values of kx and ky in the exponents of equation (3.10) by
applying the gradients Gx and Gy for precisely defined combinations of periods τxm and τyn
kx = γGxτxm ,
ky = γGyτyn , (3.11)
where m, n = 0, . . . N − 1 represent the discrete k-space. The combinations of gradients
are applied before the signal sampling and there will be one value of the discrete k-space
related to each gradient combination. It means, that N2 independent repetitions of the
sequence must be performed to fill the whole discrete k-space of the size N ×N . In fact,
this would be a very time demanding acquisition and such an approach is not used in MR
imaging.
Phase and frequency encoding sequences
In this approach, we first apply the phase encoding gradient Gx using the appropriate value
of τxm as in (3.11). The data related to this particular phase encoding gradient will fill
the line m of the k-space. Then, we switch on the gradient Gy and keep it on during the
whole period of signal sampling. At the moment of acquisition of the n-th value in the line
of the k-space corresponding to the gradient Gx, the gradient Gy has been switched on for










where n = 0 . . . N − 1, nξ = τyn corresponds to n-th step in y-direction. Since the whole
line of the k-space is acquired during one sequence repetition, we will have to repeat the
sequence only N times in order to fill the k-space. Figure 3.9 shows a typical setup of a
MR imaging sequence, with the slice encoding gradient Gs, the phase encoding gradient GΦ
and the frequency encoding gradient Gf , also called the readout gradient. Actually, such
an approach is used in all MRI acquisitions.
By oversampling the acquired data in the frequency encoding direction, we do not nearly
extend the acquisition time. However, each step in the phase encoding direction requires
one complete repetition time of the MR sequence (TR). For this reason, we very often
tend to undersample the data acquisition in the phase encoding direction. This can cause
the so-called wrap around artifact discussed in Section 3.9.3, where also some remedies are
suggested.
3.4.3 3D acquisition
The 2D MR image is acquired using the phase and the frequency encoding of the spatial
information, as described above. By measuring several parallel 2D planes we can recon-
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Figure 3.9: A spatial encoding in a single slice selected by the slice selection gradient GS ,
which is applied together with the RF pulse. A line in the k-space is selected by the phase
encoding gradient GΦ. The frequency encoding (readout) gradient Gf is applied during
the whole period of signal sampling, and the corresponding line in the k-space is filled.
struct the 3D object but it is still not a true 3D image. Acquiring a stack of parallel 2D
images is called a multiple 2D sequence (M2D).
The idea of 3D encoding is quite simple: we keep the phase and frequency encoding
gradients for directions x and y and we use an additional phase encoding gradient in the
slice selection direction (z). Compared to the M2D approach, we can get much better
spatial resolution in the z-direction and a higher signal-to-noise ratio (SNR). The major
drawbacks of 3D sequences are long acquisition time and additional artifacts coming from
the phase encoding (wrap around artifacts in both phase encoding directions, see Section
3.9.3).
3.5 Fat suppression
There are several possibilities to suppress fat tissues. We list the most usual ones and give
a few comments. An example from cardiac imaging is shown in Figure 3.10.
• inversion recovery pre-pulse (STIR), discussed in Section 3.3.3.
• spectroscopic saturation of fat (FatSat, ChemSat, CHESS, see below)
• combination of IR and spectroscopic saturation (SPAIR)
The resonance (Larmor) frequency is given by the gyromagnetic ratio of nuclei but it
is influenced also by the molecular structure. Therefore the resonance frequency of 1H
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(a) without fat suppression (b) CHESS
(c) STIR (d) SPAIR
Figure 3.10: Fat suppression techniques, fat tissue in RV in patient with arrhythmogenic
right ventricle dysplasia (ARVD).
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in free water slightly varies from the resonance frequency of 1H bound in lipids. This
difference can be used for a selective suppression of the lipid tissue by means of a tissue
specific spectroscopic saturation RF pre-pulse (sequence usually called FatSat, ChemSat or
CHESS, see [51] and [48]). For an effective saturation, we need to have well distinguishable
peaks of the free water and of the lipids in the MR spectroscopic image – therefore we need
a strong B0. Then, the quality of the fat suppression will depend on the B0 homogeneity,
which is a difficult issue for high magnetic fields.
The STIR technique is very robust and independent of B0 inhomogeneities. However,
the IR pre-pulse extends the measurement and influences all the tissues, not only the fat.
The SPAIR technique uses a lipid specific (spectroscopic) IR pre-pulse. Compared with
STIR, the SPAIR sequence is sensitive to the B0 inhomogeneities but the IR pre-pulse does
not have an influence outside the fat tissues.
3.6 Image contrast and contrast agents
In the previous sections we gave some examples of tissue contrasts that create the MR image
(e.g. the T1 or T2 tissue relaxation rates or density of 1H nuclei). Some other examples
can be for instance local magnetic field inhomogeneities caused e.g. by the degradation
products of hemoglobin after an hemorrhage (the so-called tissue susceptibility effect) or
the contrast given by flow or diffusivity of the spins (see Sections 3.10.3 and 3.11). Besides
those intrinsic tissue contrasts, we can use some external agents that are able to modify the
tissue magnetic properties in a way that they influence the rates of relaxation processes.
Unlike the contrast agents used in X-ray imaging (or computerized tomography), we do not
detect the contrast agent itself in MRI. It is the modification of the relaxation processes in
the tissues that can enhance the signal in particular locations. In the following paragraphs,
we are going to describe some contrast agents routinely used in clinical exams. Figure 3.11
shows several intrinsic MR image contrasts and one image acquired after the administration
of an external contrast agent.
3.6.1 Paramagnetic contrast agents
Paramagnetic agents have no magnetic properties if they are outside the magnetic field.
However, in the magnetic field B0 they partially arrange along the field and generate a
magnetization. They mainly14 shorten the T1 relaxation time and to some extent also the
T2 relaxation time. Therefore, the paramagnetic contrast agents are especially efficient in
the T1 weighted sequences. Typical examples of the paramagnetic agents are cations of
metals, as for example Cr3+, Mn3+, Fe3+, Ni3+, Cu3+, Gd3+. All of them are toxic and
potentially dangerous, therefore they have to be incorporated in a stable chelate complex,
14The level of shortening of the T1 and T2 relaxation times depends e.g. on the actual concentration of
the contrast agent in the tissue.
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(a) T1 weighted image (b) T1 weighted image + con-
trast agent
(c) T2 weighted image
(d) Magnetic field inhomo-
geneities
(e) Flow of the spins (f) Inversion recovery T1
Figure 3.11: Examples of image contrasts in MRI. Only in the mid upper image, the
external contrast agent (extracellular, Gd chelate) was administered.
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e.g. EDTA-Gd. Nevertheless, in some patients with a kidney disease the so-called nephro-
genic systemic fibrosis (NFS), possibly caused by a Gd intoxication, has been developed
(see [45]). Paramagnetic contrast agents can be divided in 3 subgroups:
1. Without a bound on plasma proteins – the most usual, truly extracellular contrast
agents. After first passage through the capillary bed, their blood concentration will be
very low since they remain in the extracellular fluid. Typical examples are Magnevist
(gadopentetate) or Gadovist (gadobutrol).
2. With a weak bound on plasma proteins (MultiHance – gadobenate). The weak bound
with albumin slightly extends the effect of the contrast agent. The application is
almost the same as for the group 1.
3. With a strong bound on plasma proteins – the so-called intravascular contrast agents
(Vasovist – gadofosveset trisodium). Thanks to the strong bound on plasma proteins,
they remain in blood and the signal in vessels can be detected for a long time (up to
tens of minutes). They are used for some angiographic studies. One of their drawback
is that after the first passage, they will be present in the arteries as well as in the
veins, which can cause difficulties in distinguishing between the two types of vessels
(see Figure 3.31(d)).
3.6.2 Superparamagnetic contrast agents
Superparamagnetic agents have a very high magnetic susceptibility and therefore they
mainly shorten the T2 relaxation time (or more specifically, the T2∗ relaxation time).
Typical examples are Fe3+ ions (resovist). They are used in imaging with a desired high T2
contrast (e.g. in some angiographic sequences, imaging of kidneys, liver or gastrointestinal
tract).
3.7 Acceleration techniques
In Cardiac MRI, acquisition time is very limited due to heart and breathing motions.
Therefore, we need to accelerate data acquisition. We have already given an example of
acceleration by means of using sequences based on the gradient echo with low flip angle α
and very short repetition time TR often used in turbo versions (FLASH, Snapshot FLASH,
bSSFP, see Section 3.3.4). Here, we list some other possibilities.
• Non-cartesian trajectories in the k-space (either spiral or radial), in which the gradi-
ent system may work more efficiently and the k-space filling can be faster. Standard
reconstruction algorithms first perform a step of re-gridding (filling of a usual rectan-
gular k-space using an interpolation from the measured data) and the inverse Fourier
transform is performed afterwards. Thanks to non-cartesian trajectories, we can use
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smaller field of view (FOV) while keeping the same voxel size (therefore we can use a
smaller acquisition matrix and obtain a better temporal resolution in dynamic time
sequences). Unfortunately, associated artifacts are sometimes unpredictable.
• Ultra-fast acquisition sequences, as for exampe Echo Planar Imaging (EPI, see [75]).
EPI is an example of the so-called single shot sequences, which can fill the whole
k-space in a single TR period.
• Parallel techniques: Undersampling of the k-space leads to a typical wrap around
artifact (see Section 3.9.3). However, by using a combination of several receiving coils
with known sensitivities, we can reconstruct the missing lines of the k-space. The
reconstruction can take place in the image space (SENsitivity Encoding = SENSE)
or in the k-space (GRAPPA). The shortening of acquisition time is referred to as the
acceleration factor.15
• kt-blast: Uses undersampling both in the spatial and in the temporal domain.
3.8 Hardware
In this section we give some remarks about MRI hardware, in particular with respect to
the requirements of Cardiac MRI in order to obtain an adequate level of MR signal.
Static magnetic field B0
As explained in Section 3.2.1, we can obtain a higher MR signal for higher magnetic fields
(see Table 3.2). Nowadays, MR systems can be subdivided into 3 groups according to the
strength of the external magnetic field: low-field systems (< 0.5 T), high-field systems
(1.5–3.0 T) and systems using ultra high-field (>3.0 T).
Low-field systems are not meant for cardiac imaging since the resulting spatial and
temporal resolution with a reasonable signal-to-noise ratio (SNR) would be rather low.
Ultra high-field systems are used mainly in MR spectroscopy (MRS) in order to obtain
more distinct peaks in MR spectra, and in functional MRI (fMRI16) to obtain a higher
BOLD signal. Some of the difficulties in heart imaging at very high fields would be related
to the homogeneity of B0. Interfaces between different tissues in the thorax make the
shimming17 process less efficient. The very high-field systems would also make the ECG
15For example SENSE factor 2 stands for: parallel techniques are on and the reconstruction takes place
in the image space with the acquisition time reduction by a factor 2. SENSE factor 1 means that the
acquisition is performed without any parallel techniques.
16A mapping of activated brain centers using the so-called Blood-Oxygen-Level Dependence effect
(BOLD), see [86], [9].
17The system of additional shim coils is used to improve the homogeneity of B0. It is a part of each MR
system. To guarantee a good B0 homogeneity at very high fields, we often need to perform a non-automatic
(manual) shimming procedure, which is difficult and time demanding.
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triggering difficult. First, the ECG measurement is always deteriorated by any strong
magnetic field (it is sometimes difficult to obtain an ECG signal suitable for the triggering
at 3 T, and sometimes even in 1.5 T systems). Secondly, an electrical activity in the
heart tissue is influenced by the strong magnetic field by means of the so-called magneto-
hydrodynamic effect (MHD, see [62], [43]) that would have to be taken into account.
Finally, we list some properties of 3 T MR systems in comparison with 1.5 T systems:
• Longer T1 relaxation: It may be an advantage e.g. in cardiac MR tagged images (see
Section 3.10.1), where the grid fading depends on the T1 relaxation rate. However,
the slow T1 relaxation can be a disadvantage in some other applications (for example,
we need to increase the repetition time TR in order to obtain a T2 weighted image).
• Stronger susceptibility artifacts (described in Section 3.9.1) due to a bad B0 homo-
geneity: Although higher susceptibility effects may be positive in diagnosis of some
pathologies (e.g. an old hemorrhage), it is usually not the case for Cardiac MRI.
• The RF energy increases due to a higher Larmor frequency of the RF pulses. We can
easily reach the level of maximum specific absorption rate for human (SAR). In such
a case we have to re-adjust the parameters of the sequence, which often leads to a
lower quality of the resulting image.
• Higher noise of the gradient system at 3 T fields.
• Higher price of 3 T systems.
Nowadays, 1.5 T MR systems seem to be optimal for most clinical applications in the
field of Cardiac MRI. With 3 T systems, we could benefit from the higher signal in the
diagnosis of some pathologies of the myocardial wall (possibly for some cardiomyopathies,
e.g. ARVD, see Section 2.4.3), or we could obtain tagged MR images covering the whole
cardiac cycle thanks to a longer T1 relaxation time. However in most cases, we would be
fighting with stronger image artifacts and finally, we would not gain much from the higher
signal.
Gradient coils
In order to use fast MR sequences, we need a powerful system of gradient coils that will
be able to create a strong gradient of the magnetic field and will be able to switch on / off
the gradient coils quickly. The gradient system is given by the following main parameters:
• Maximum amplitude – which gives the spatial resolution of the images. The usual
values are 20–35mT/m and the best systems are equipped with gradients with a
maximum amplitude of ∼45mT/m.
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• Slew rate – which gives the measurement time by means of the shortest possi-
ble TR and TE. The usual values are 80–120mT/m/ms, the best systems have
∼ 200mT/m/ms.
• Duty cycle – continuous switching on of the gradient system (nowadays usually 100%
for any MR system).
Transmitting coil
The transmitting coil in Cardiac MRI is usually represented by the basic body coil.
Receiving coil
Dedicated receiving coils are used for Cardiac MRI. The closer they fit the geometry (the
thorax, in this case) the less noise they detect. Receiving coils usually consist of more
elements used for parallel imaging (6–32), see Section 3.7.
3.9 Image artifacts
In the following section, we will focus on some typical artifacts in MR imaging. Thanks to a
technical progress in MR systems on the one hand, many artifacts have almost disappeared
– especially when considering ‘classical sequences’ that have been used for decades. On the
other hand, by using faster sequences, higher magnetic fields, stronger and faster gradients
we are obtaining new imaging possibilities but some ‘old’ artifacts may re-appear or some
new ones can arise (see e.g. [66]). This section mainly aims at introducing some typical
artifacts that may appear especially in Cardiac MRI, so that we would be aware of them
and possibly, we would be able to avoid some of them.
3.9.1 Artifacts coming from the MR system
Many artifacts are due to an imperfection of various parts of the MR system. Usually, the
user of the MR system does not have any possibility to correct them. The most common
artifacts come from:
• RF instabilities – bad adjustment of RF pulses. In some multiple 2D acquisitions
(M2D), the level of signal may vary in between the slices (e.g. in some cardiac Cine
MR sequences).
• Gradient system
– Nonlinear gradient can cause geometrical distortion, especially if a large Field
Of View (FOV) is used.
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– Eddy currents induced by switching on and off the gradients causing an image
distortion, see Figure 3.12(a).
– Non-symmetry of the gradients (+G vs. -G) typically causes ghost artifacts, see
Figure 3.12(b).
– Time instability of the gradients.
• B0 inhomogeneities
– the higher the static magnetic field, the more difficult it is to make it perfectly
homogenous. A system of correction shimming coils is used. A bad shimming
causes shorter FID and MR echos and therefore there is a lower level of signal
in the resulting image.
– susceptibility artifacts cause local B0 inhomogeneities and result in bright areas
(misregistered signals) and dark areas (signal voids) nearby the tissue (material)
with a high susceptibility. They can be caused e.g. by metal objects (such
as orthopedic prosthesis, vascular stents or surgical clips) or intrinsic tissue
components especially in sequences sensitive to the B0 inhomogeneities, see
Figure 3.13.
A B0 inhomogeneity causes the gradients in coherent (balanced) GE sequences not to be
perfectly symmetric, which leads to periodic bands of signal void and signal augmentation
with a period ∼ 1 / TR (see Figure 3.18). A short TR available with current MR systems
(as for example in the sequence bSSFP – trueFISP) decreases the periodicity of the artifacts
and we are able to move them out of the field of view by adjusting a frequency offset (‘delta
offset frequency’).
3.9.2 Artifacts caused by the examined subject
Typical artifacts are due to motion (either of the patient or of the imaging organ), due to
blood flow, and to the so-called chemical shift.
• The motion causes an image blurring in the direction of phase encoding gradient, see
Figure 3.14. It can be corrected by shortening the acquisition (using fast sequences),
averaging over several measurements18 (which leads to a long acquisition time), syn-
chronization of the data acquisition with the organ motion (e.g. by ECG triggering in
cardiac MRI), acquisition in a breath-hold period or synchronization with breathing
motion (navigator echo technique). These possibilities will be discussed in cardiac
imaging in Section 3.10.1.
18Number of acquisitions is usually denoted by NEX.
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(a) Image distortion caused by the




ghost artifact caused by gradi-
ent non-symmetry.
Figure 3.12: Artifacts caused by the gradient system.
(a) Metal objects in a brain (a
vessel clip) causes a signal void in
the right temporal lobe. Part of
the frontal lobe with missing sig-
nal due to an interface between
brain tissue and air in the frontal
bone sinuses.
(b) A limited spatial resolution and sus-
ceptibility artifacts in bSSFP sequence
caused by local field inhomogeneities at
myocardium–fat interface make the thin
wall of the right ventricle difficult to dis-
tinguish.
Figure 3.13: Susceptibility artifacts induced by local field inhomogeneities.
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(a) Motion artifact (in the vertical direction – the phase en-
coding direction).
(b) Chemical shift artifact.
Figure 3.14: Motion and chemical shift artifacts.
• The in-plane flow causes an image blurring in the phase encoding direction (same
principle as in the case of the motion of the patient). The through plane motion can
amplify or suppress the signal of flowing blood – which can be productive in some
angiographic sequences or counter-productive e.g. in some gradient echo kinematical
images of the heart. Additional saturation pulses next to the imaging plane can solve
the problem.
• The resonance frequency of 1H in free water and in fat tissue slightly differs due
to molecular structures, as was discussed in Section 3.5. The shift of the resonance
frequency (chemical shift) may interact with the frequency encoding step (see Section
3.4.2). The reconstruction algorithm cannot distinguish if the change of the resonance
frequency is caused by the location of the tissue (frequency encoding) or by the
chemical shift19 and the tissue is shifted in the direction of the frequency encoding
gradient. The chemical shift artifacts are stronger at higher fields. We can decrease
the chemical shift by increasing the RF bandwidth (which on the other hand decreases
SNR). See Figure 3.14 for a typical chemical shift artifact.
19For example, chemical shift between the water and fat at 1.5 T field is: ∆f = 3.5 ppm = 220 Hz. If the
bandwidth of the RF pulse is 60Hz / pixel, the actual shift is 3 pixels in the frequency encoding direction
(ppm = particle per million).
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(a) Undersampling in the phase en-
coding direction
(b) Correct acquisition.
(c) Phase encoding in the vertical di-
rection. Note the thorax is mirrored
below the inferior wall of the heart.
(d) Phase encoding in the hori-
zontal direction without the wrap
around artifact.
Figure 3.15: Wrap around artifact due to undersampling of data acquisition in the phase
encoding direction.
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3.9.3 Intrinsic MR artifacts
We mention two artifacts entirely specific to the MRI spatial encoding process: the partial
volume effect and the wrap around artifact.
• Partial volume effect is caused by signal averaging in a voxel that contains different
types of tissues. A solution can be to decrease the voxel size, which would on the
other hand lead to a lower SNR.
• Wrap around artifact is caused by undersampling of the k-space. As we saw in Section
3.4.2, a 2D image is encoded using the phase encoding and the frequency encoding
(readout) gradient. All the frequency encoding steps corresponding to one phase
encoding gradient are acquired during one shot of the MR sequence. By oversampling
in the frequency encoding direction, we nearly do not lengthen the measurement.
However, each phase encoding step needs a single shot of the MR sequence that
lasts one TR period (repetition time). To shorten the image acquisition time, we
often decrease the number of phase encoding steps. At the same time, such an
undersampling can create typical wrap around artifacts as shown in Figure 3.15. We
can avoid them by:
– Increasing the number of phase encoding steps (larger FOV), which however
increases the acquisition time an the acquisition time is limited by a breath-
hold period in Cardiac MRI.
– Increasing the voxel size (at least in the phase encoding direction), which leads
to a lower spatial resolution and an non-isometric voxel in directions x and y.
– Using a rectangular acquisition matrix with shorter edge corresponding to the
phase encoding direction. The rectangular FOV must correspond to the actual
geometry of the scanned organ. The lower number of phase encoding steps
reduces SNR but the acquisition time shortening is non-negligible (e.g. the rect-
angular FOV with a ratio 1:2 reduces the acquisition time by a factor 2).
3.10 Some special sequences used in cardiovascular MRI
3.10.1 Cardiac MRI
Cardiac MRI (CMR) is a highly specialized imaging technique to examine the heart. It can
provide high quality images used to assess heart functional indicators or e.g. to diagnose
some pathologies of the heart wall. See Figure 3.16 with the basic anatomy of the heart
in a typical MR image. Compared to MR imaging of other organs, the following aspects
need to be taken into account in Cardiac MRI: the motion of the heart, breathing motion
and the blood flow in the heart cavities.
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Figure 3.16: Basic heart anatomy in cardiac MRI. A 4-chamber view (on the left side) and
short-axis projections (on the right side).
Heart motion
We use fast imaging sequences to deal with heart motion. The images are usually acquired
over several heartbeats triggered by the patient’s ECG.20 There exist two main triggering
strategies: prospective and retrospective gating.
In prospective triggering, the imaging sequence is always launched when the R wave of
the QRS complex21 is detected. Then, the image data are acquired over the cardiac cycle
at precisely defined time points. The acquired time frames are perfectly synchronized,
assuming that the heart rhythm is regular. A difficulty may arise when the cardiac cycle
becomes shorter than the imaging sequence. If such a situation occurs we have to re-launch
the acquisition after shortening the sequence (e.g. by reducing the number of acquired time
frame images, in case we are performing a dynamic imaging of the heart function).
Retrospective triggering is used only in the acquisition of dynamic sequences of images
20Some other types of triggering are also possible, e.g. using the peripheral pulse or acoustic signals from
the heart. Nevertheless, the ECG is by far the most usual.
21The sequence itself can be delayed by a constant time period TD (time delay) which is measured starting
from the detected QRS complex. For instance if we aim at obtaining a single diastolic image (e.g. a T1 or
T2 weighted image), we need to apply an appropriate TD.
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(Cine MRI, see later). The image data are acquired in a continuous way while the ECG
signal is recorded. Both types of data are post-processed and each image data sample is
assigned and interpolated to the proper time frame. This approach allows to cover the whole
cardiac cycle – including the atrial contraction – however, interpolated images might be
to some extent blurred. Thanks to non-intermittent data acquisition, tissue magnetization
reaches steady state in the very beginning.
Using strategies that accelerate the image acquisition even further (e.g. a high parallel
acquisition factor), we can acquire data in real time instead of over several cardiac cycles
as in the previous triggering approaches. However, we will obtain a lower SNR and a
worse spatial and temporal resolution. While the resolution of the cardiac gated sequence
is22 ∼ 2 x 2 x 8 mm x 30 ms, in real-time imaging we can obtain a resolution of ∼
5 x 5 x 10 mm x 100 ms with a parallel acquisition factor often above 2.
Breathing motion
Breathing motion is dealt with either by acquisition in a breath-hold period (with strongest
limitations in dyspneic patients), or by monitoring breath motion e.g. using a respiratory
belt (that detects the movement of the thorax and abdomen) or by tracking the diaphragm
using the MR navigator echo technique, see [76] and Figure 3.17. During acquisition in
free breathing, image data are acquired only in a certain position of the diaphragm. The
measurement is highly dependent on co-operation of the examined subject. The acquisition
takes longer – especially if the breathing pattern is not regular – and the image obtained
can sometimes be of low quality. Free breathing techniques are not suitable for continu-
ous measurements, in particular for heart kinematics. However, using the free-breathing
strategy with a well co-operating subject we can obtain truly 3D-morphological images (by
means of Section 3.4.3) with a very good spatial resolution (e.g. 1 x 1 x 1 mm).
Blood flow
Several strategies are used for blood flow deletion in the heart cavities. In general, the
signal in the cavity can be enhanced (the bright blood technique) or suppressed (the dark
blood technique).
Bright blood can be obtained by several procedures, a first instance being a GE
sequence with a short TR. Due to the short TR, the signal is suppressed in the imaging
slice (magnetic saturation effect). On the other hand, the blood flowing into the imaging
slice is not saturated and gives a strong signal (GE inflow effect). If the blood flow is not
perpendicular to the imaging slice (e.g. due to some turbulence), this effect does not occur
homogeneously and some signal drops may appear in the cavity. A typical example of this
22A usually acquired (non-interpolated) resolution at 1.5 T.
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(a) Positioning of the navigator to
track the diaphragm
(b) Motion of the diaphragm dur-
ing free breathing
(c) The green box stands for
the acceptable position of the di-
aphragm
Figure 3.17: Cardiac MRI in free breathing using breath navigator. Cardiac data are
acquired if the position of the diaphragm is in the predefined location.
sequence is FLASH triggered by the ECG (the so-called segmented FLASH23). A second
MR sequence type used for bright blood imaging is a balanced sequence with a very short
TR (TR ∼ 1–3 ms, the balanced steady-state free precession – bSSFP, trueFISP, FIESTA),
see Section 3.3.4. Balanced sequences are flow-independent but extremely sensitive to the
homogeneity of the magnetic field B0. Typical artifacts (signal voids) discussed in Section
3.9.1 arise especially in higher fields (3 T), see Figure 3.18. These artifacts may be avoided
by adjusting a frequency offset (the so-called delta offset frequency). However, in some
subjects the frequency offset needs to be re-adjusted – perhaps even several times – during
examination, depending on the position of the imaging slice. It extends the examination
and makes the usage of the bSSFP sequence in 3 T systems sometimes difficult.
The suppression of the blood signal in the cavity is achieved in the dark blood tech-
nique either by gradient moment rephasing (GMR, also called gradient moment nulling)
or by double-suppression pre-pulse (see Figure 3.19). In principle, we obtain just a static
2D image of the heart either in diastole or in systole with a very good spatial resolution
(∼1.5 x 1.5 x 8 mm).
In the following sections we give some details about the Cardiac MRI sequences used
in clinical practice. A detailed presentation is given for example in [13].
23Fast Low Angle SHot is a non-coherent GE sequence (see Section 3.3.4). ‘Segmented’ means that the
image acquisition is divided into several cardiac cycles.
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Figure 3.18: Left: Blurred LV lateral wall in the end-systole caused by the motion of the
tissue and the blood flow in the segmented FLASH sequence. Right: A signal void in the
LV inferior wall caused by the off-resonance frequency in the bSSFP sequence.
(a) Double inversion pulse (b) T2 weighted image
Figure 3.19: Dark blood technique – double inversion pulse. If the blood changes in the
imaging slice between a couple of 180 ◦ pulses, there will be a zero signal in the cavity (the
dark blood). The static tissue will not be affected.
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Cine MRI
Cine MRI refers to an examination of the heart kinematics. The heart is covered by 2D
planes (M2D series) and the image data are usually acquired with a temporal resolution of
30–60ms. By a technique of echo sharing24 the data may be reconstructed with a temporal
resolution of about 20–40ms. The acquired spatial resolution is about 2 x 2 x 10 mm25.
The ventricles can therefore be entirely covered by 10–15 slices, if no gap between the slices
is imposed.
In Cine MRI we use bright blood techniques and the heart cavities are white whereas
the myocardium is dark in the acquired images. The resolution for the myocardial wall is
limited, but the cavity volumes can be measured very accurately. Typical sequences used
for Cine MRI are balanced steady state free precession (bSSFP, trueFISP) and segmented
FLASH.
The acquisition is performed in breath-hold periods. Each slice can be acquired in a
single breath-hold, or we can perform the acquisition of multiple slices during one breath-
hold. The latter approach is faster but it provides a lower spatial or temporal resolution.
Since the breath-hold is not completely reproducible (especially if it is performed in an
inspiration), we often have to deal with a spatial realignment of the slices acquired during
different breath-holds. Retrospective triggering is preferred in clinical practice.
Tagged Cine MRI
Tagged Cine MRI is an example of magnetization-prepared GE sequences (see Section
3.3.4). An additional saturating pulse is applied before the standard Cine MRI sequence is
launched. The pre-pulse saturates a part of the tissue, usually in the form of lines arranged
e.g. in a parallel or radial pattern (the so-called SPAMM technique, SPAtial Modulation
of Magnetization, [117], [5], [4]). The lines can form a rectangular grid as shown at the
bottom of Figures 3.20 and 3.21. Since the saturation lines are imprinted in the tissue,
they deform with the heart motion. The processed tagged images could directly provide
a motion description in the Lagrangian formulation. However, the processing of tagged
images is still very challenging and is not a part of standard cardiac packages available in
MR systems.
The saturation pulse is strictly dependent on the triggering pulse and must be applied
before each repetition of the MR sequence with exactly the same timing with respect to
the cardiac cycle. This is why we have to use prospective triggering and therefore we do
not usually observe atrial contraction in the acquired data. In order to avoid strong image
artifacts, SPAMM is commonly used in combination with segmented FLASH.
The tissue magnetization becomes gradually less saturated during the cardiac cycle,
24The neighbouring time frame images share several lines of the k-space, which leads to some kind of
interpolation along the time axis.
25Which is often automatically interpolated to a smaller voxel, e.g. 1.5 x 1.5 x 10 mm.
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(a) end-diastolic image (b) end-systolic image
(c) end-diastolic image (d) end-systolic image
Figure 3.20: Short axis projection of the Cine MRI and tagged Cine MRI of a healthy
subject.
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(a) end-diastolic image (b) end-systolic image
(c) end-diastolic image (d) end-systolic image
Figure 3.21: Short axis projection of the Cine MRI and tagged Cine MRI of a heart with
an acute myocardial infarction in the LV antero-septal segment.
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(a) Myxom in right atrium (b) Sarcom in right atrium (c) Thrombus in left ventricle
(‘pseudotumor’)
Figure 3.22: Heart tumors in dark blood technique.
which makes the tags fade. The desaturation is given by the T1 relaxation. In 1.5 T
systems, the tags can usually only be clearly distinguished during the systolic part of the
cardiac cycle. Longer T1 relaxation at higher fields provides longer lasting tags. Therefore,
3 T systems are more suitable for tagged Cine MRI data acquisition.
Dark blood technique
The dark blood technique (a suppression of blood in the heart cavity) is used for detailed
studies of the heart wall morphology. We acquire T1 or T2 weighted images in short and
long axis projections (usually 2D or M2D acquisition). We can combine blood suppression
with some other pre-pulses, for instance in order to cancel the signal of fat (see Section 3.5).
Myocardial tissue suppression by the IR pre-pulse is used in the so-called late enhancement
technique (LE). T1 images with TI∼220 ms are acquired approximately 10 minutes after
administering an extracellular contrast agent. The myocardial signal is suppressed and the
regions with the entrapped contrast agent are clearly visible.
Dark blood images can be used to diagnose for instance the following pathologies and
symptoms:
• Certain conditions of the pericardium (e.g. pericardial fibrosis, deposits, effusion,
etc.).
• Fat deposits in the arrhythmogenic right ventricle dysplasia (ARVD, see Figure 3.10).
• Heart tumors or thrombi (see Figure 3.22).
• Nonviable myocardium (see [111]): the extracellular contrast agent will enter the
hypoperfused part of the myocardium with a certain delay, which can be used to
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Figure 3.23: Fast perfusion and wash-out of the contrast agent in a healthy tissue (solid
line). A non-viable tissue (dashed line) has a delayed perfusion and the contrast agent
stays in the tissue for a long time period (late enhancement, LE). From presentation of
J. Froehlich at ESMRMB School of MRI 2008 in Advanced Cardiac MRI.
assess the perfusion defects during the first pass of the contrast agent. Then, the
contrast agent will remain in the non-viable myocardium for a long time due to
an altered wash-in / wash-out mechanism which creates the LE effect. Figure 3.23
illustrates the contrast agent pharmacokinetics.
Using the LE technique, we can distinguish even small subendocardial post-infarcted
scars, see Figure 3.24(b). The typical post-ischemic scar is located either in the
subendocardial region or it propagates from the subendocardial region to the epicar-
dial part. The entire wall thickness may be affected in a transmural infarction.
• Cardiomyopathies26 (HCM, some DCMs, non-compaction of the LV, ARVD), my-
ocarditis, enzymatic diseases (e.g. Fabry’s disease), infiltration of the myocardium
(e.g. by amyloid, sarcoidosis) can cause LE which is usually not as intensive as in
the case of infarction. Therefore we need LE images with a good spatial resolution
and a high SNR. LE may be present in any part of the myocardium (e.g. only in the
mid-myocardium or in the subepicardial layer), compared to the ischemic LE, which
is always initiated in the subendocarial region. For examples of the non-ischemic LE,
see Figure 3.25, LE in HCM is shown in Figure 2.12(b).
• Haemochromatosis – shortens the T2* relaxation (magnetic susceptibility effect).
26See Section 2.4.3.
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(a) Scheme of ischemic LE
(b) LE in the subendocardial region of the LV anterior wall (an infarct scar). Magnitude image (left)
and phase sensitive (right) image reconstruction.
Figure 3.24: Ischemic late enhancement.
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(a) Sarcoidosis (b) Myocarditis
Figure 3.25: Examples of non-ischemic late enhancement.
3D acquisition
When using a breath navigator, a fully 3D approach is available (see Section 3.4.3). The
resulting spatial resolution is as good as 1 x 1 x 1 mm. The acquisition time is about 15
minutes. 3D sequences can for instance be used for the examination of coronary arteries
without any contrast agent (a native image, see [44]) or to obtain a 3D image of the
infarcted scar using the late enhancement technique, see Figure 3.26. The 3D LE images
with such a good spatial resolution are not routinely used in clinical practice, because of the
long acquisition time and since the 2D LE images are suitable for estimating myocardial
viability.
3.10.2 Phase contrast MRI
Applying a bipolar gradient causes a phase change of the moving spins, which can be used
to measure the velocity of the flow by phase contrast imaging (PCI). The phase change Φ
depends linearly on the component of velocity parallel to the applied gradient:
Φ = γTGv, (3.13)
where T represents the duration of the gradient and G the gradient strength, see Figure
3.27. The variable γ stands for a gyromagnetic ratio of the nuclei concerned, and v is
the velocity in the direction given by the gradient G. The signal phase Φ lies in the
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(a) 2D acquisition (segmented FLASH, phase
sensitive reconstruction) in breath-holds,
voxel size 2 x 2 x 10 mm.
(b) 3D acquisition (bSSFP, trueFISP) with breath navi-
gator, voxel size 1 x 1 x 1 mm.
Figure 3.26: Late enhancement in the LV atero-septal segments and in the apex due to
myocardial infarction.
(a)
Figure 3.27: A bipolar gradient applied in phase contrast imaging causes phase shift of the
moving spins.
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(a) Acquisition planning. (b) Amplitude image. (c) Phase image encoding the
velocity information. Tones of
white color encodes the veloc-
ity towards the LV.
Figure 3.28: Measurement of the velocity component perpendicular to the mitral valve
using PCI.
range [−pi, pi] and is zero for the static spins. Before performing PCI, we need to adjust
the multiplication factor of the velocity v in Equation (3.13) – given by the strength and
duration of the gradient – according to the expected maximum velocity. An aliasing of the
phase shift may occur when the factor γTG is large. On the other hand, a low factor γTG
would reduce the accuracy of the velocity measurement.
In PCI, the acquired data consist of the signal amplitude (as in standard MRI), and in
addition of the signal phase. We can reconstruct both types of images: the amplitude image
(see Figures 3.28(b) and 3.29(a)) and the phase image (see Figures 3.28(c) and 3.29(b)).
By post-processing the 2D phase contrast images, we can for example visualize the velocity
profile through the imaging plane (see Figure 3.29(c)). Figure 3.30 shows a computed flow
through the mitral and aortic valves during a cardiac cycle.
The PCI sequence as described above produces a single velocity component in a 2D
imaging slice. The acquisition is performed in a breath-hold period. Such a type of sequence
is implemented in any clinical MR system and can be routinely used for instance to evaluate
the function of heart valves (stenosis, regurgitation) or to diagnose septal defects. To obtain
the full velocity vector using this type of sequence, we need to perform three measurements
with three perpendicular bipolar gradients representing the components of the velocity. The
spatial registration is necessary since the images representing each velocity component are
acquired in other breath-holds.
Nowadays, measurements of the full 3D vector in a 3D volume are becoming available,
when using a breath-navigator (see [109], [85]). It is a long acquisition which is still
difficult to perform on patients. By using a tripolar gradient, we can encode and visualize
the acceleration of the flow (see [34], [105], [19], [6]).
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(a) Amplitude image. (b) Phase image encoding the
velocity information. Tones of
black color encode the velocity
outwards from the LV.
(c) Visualization of the aortic
flow profile.
Figure 3.29: Measurement of the velocity component perpendicular to the aortic valve
using PCI.



















(a) Flow through left ventricle outflow tract.



















(b) Flow through mitral valve.
Figure 3.30: Plots of outflow and inflow of the LV obtained by post-processing phase
contrast images. Note that the opposing directions of the flows through the mitral and
aortic valve are respectively represented by different signs of the flow.
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3.10.3 MR angiography
Using MRI, we are able to examine and obtain data of a vascular system (the so-called
MR angiography, MRA). The vascular system may be visualized when using a contrast
agent, but there exist also completely non-invasive methods without any contrast agent
administered in the patient (a native MRA). In the following paragraphs, we briefly list
the main principles of MRA. A detailed description can be found e.g. in [93].
Signal void in SE
The first method – although it is not strictly speaking an angiographic method – can
provide information about the vessels using a simple principle of the spin echo sequence
(SE, see Section 3.3.1). The spins in the blood flowing in the direction perpendicular to the
imaging slice are first excited by the 90 ◦ RF pulse. If the spins flow out from the imaging
slice before the 180 ◦ refocusing pulse is applied, there will be no signal at this location
(the new inflowing spins – although influenced by the 180 ◦ pulse – were not excited by the
90 ◦ pulse beforehand). The phenomenon is called flow void, see Figure 3.31(b).
Time of flight
Time of flight (TOF) is based on the GE inflow effect (GE signal enhancement), which was
discussed in Section 3.10.1 (a part related to the bright blood techniques in Cardiac MRI).
In principle, when using a GE sequence with a short TR, the static tissue in the imaging
slice will become saturated and will not give a sufficient MR signal (magnetic saturation
effect). Nevertheless, the inflowing blood – not influenced by the previous excitations –
will give a strong signal.
A short27 TR (TR = 20–50 ms) can be used in coherent GE sequences (FISP), as
described in Section 3.3.4. According to the principle of TOF, the imaging slices need
to be perpendicular to the blood flow. TOF is suitable also for 3D acquisition with a
reasonable acquisition time. See Figure 3.31(a) for an example of 3D TOF.
Phase contrast angiography
Phase contract MR angiography (PC-MRA) is based on phase contrast imaging as de-
scribed in Section 3.10.2. We need to perform measurements of 3 components of the
velocity vector, together with the so-called gradient moment nulling measurement (GMN),






z − GMN we
eliminate the static tissue and obtain an MRA image that is independent of the flow direc-
tion with respect to the measurement slice. Using the PC-MRA we can obtain 3D images
27An appropriate TR depends on many factors, e.g. on the velocity of the flow. Although a very short
TR could even better suppress the static tissue, it may also saturate to some extent blood if the flow is not
fast enough.
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of high quality but the measurement time is rather long. See Figure 3.31(c) for an example
of 3D PC-MRA.
Contrast agent angiography
A bolus of contrast agent in the blood shortens the T1 relaxation time and the vessels give
a strong signal in T1 weighted images. The static tissue is subtracted using a measure-
ment performed beforehand without the contrast agent. We need to adjust the timing of
acquisition to the period when the bolus is present in the part of the vascular system of
interest. See Figure 3.31(e) where the arterial part only is well visualized. Intravascular
contrast agent (‘vasovist’, see Section 3.6) can recirculate through the circulatory systems
several times and therefore this is suitable for some MRA applications. However, we have
to distinguish between the arterial and venous component of the system, when using this
type of contrast agent (see Figure 3.31(d)).
Advantages of the contrast agent MRA is are high image quality and a fast acquisition
time. Some disadvantages are mainly related to the application of the contrast agent
(contraindications e.g. in patients with kidney failure, price of the contrast agent).
3.11 Appendix: Diffusion Tensor Imaging (DTI)
The measurement of diffusion by magnetic resonance was described by Stejskal et Tanner
already in 1965 (see [102]). When applying a strong bipolar gradient, the signal will be
dependent on the spin diffusion. The first gradient will dephase all the spins and the
second gradient will refocus the static ones. The spins that changed the position will not
be refocused and therefore they will not give any signal. The signal decay can be described
by the following equation:
S = S0e
−bD, (3.14)
with b = γ2δ2(∆ − δ3)|g|2 being the so-called diffusion weighting factor b (see [65]). The
value of b is given by the parameters of the sequence (timing and strength of the diffusion
gradients, see Figure 3.32). The variable D represents a tissue diffusivity. Diffusion in
biological tissues with a fiber structure (for example in a brain white matter or a muscle
tissue) is highly anisotropic. Therefore, the diffusivity D is represented by a tensor.
The tensor D is antisymmetric and is characterized by 6 values. To assess D by means
of Equation (3.14) using MRI we need to perform measurements with 6 different gradient
directions, and in addition a measurement without diffusion weighting usually denoted as
B0 image. The principal eigenvalue of tensor D gives the preferential diffusion direction,
which occurs in the direction of fibers. The reconstruction of the fibers using the principal
eigenvalues of D is called Diffusion Tensor Imaging (DTI, see [83]).
DTI has become a valuable examination in the brain. It used in neurosciences in order to
assess neural connections between brain centers, or in clinical practice in order to visualize
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(a) Time Of Flight (in the brain). (b) Flow void in the vessels per-
pendicular to the imaging slice
in SE sequence (black dots in the
brain).
(c) Phase contrast MRA (PC-MRA, in
the brain).
(d) Intravascular contrast agent
(vasovist) – the contrast agent
is present both in arteries and
veins of crus.
(e) Contrast agent MRA – arterial part (using extracellular contrast agent
and bolus timing).
Figure 3.31: Examples of MRA images.
89
Figure 3.32: Diffusion weighted sequence with a couple of strong gradients. The gradients
have either opposite polarity or a 180 ◦ RF pulse is placed between them (as in this case).
e.g. the relation of neural tracts with an epileptic focus or a brain tumor, see Figure 3.33.
However, if performing DTI in the muscle tissue (and in particular in myocardium), some
additional issues need to be taken into account:
• Homogeneity of B0 – it is more difficult to obtain a homogeneous field in the thorax
than in the brain.
• Due to shorter T2 relaxation time in muscle than in brain (see Table 3.3) we would
like to shorten TE in the case of muscle imaging. For technical limitations, we are
usually not able to shorten TE to the optimal value.
• Possibly a lower anisotropy in the muscle than in the white matter of the brain.
• In the case of the in vivo DTI of myocardium, the most challenging issue arises from
the heart motion.
DTI of the myocardium can provide information about the distribution of myocardial
fiber directions for the heart model. This will be discussed in Section 4.4.1.
3.12 Remarks about the experimental protocol
A detailed experimental protocol suggested for the animal experiments performed during
the thesis is in Appendix 10. Here we sum up some basic requirements on the type of data.
Cine MRI
We used the Cine MRI data to build anatomical models. To avoid the bSSFP offset-
frequency artifacts, we decided to use a segmented FLASH sequence. In order to get the
best spatial and temporal resolution, each slice was acquired in a single breath-hold period.
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Figure 3.33: Reconstruction of the neural fibers in the white matter of brain using DTI.
The acquisition was performed in the expiration of animal, controlled by a respirator. The
breath-holds were perfectly reproducible and we did not need to solve the problem of
slice realignment. By using retrospective ECG triggering we covered the whole cardiac
cycle, including the atrial contraction. See Figure 3.20 for the Cine MR images of a
healthy subject and Figure 3.21 with a hypokinetic part of the left ventricle caused by the
myocardial infarction created during the experiment.
Thanks to the small size of the animal, we were able to use adequately small acquisition
matrices and we obtained a better temporal resolution. The radial or spiral k-space tra-
jectory was considered but at the time of the experiments, the sequence was not available
in the MR system. We did not use parallel techniques in order not to decrease SNR.
Tagged Cine MRI
We used a standard segmented FLASH sequence with SPAMM. The geometry (and acqui-
sition matrices) were given by the Cine MR acquisitions. We decreased the RF bandwidth
to the minimum value (equivalently, we increased the water-fat shift to the maximum value)
in order to increase SNR. The temporal resolution was still acceptable and the noise in the
images decreased significantly. In Figures 3.20 and 3.21 we can also see the tagged images
of the healthy and of the diseased animal.
A good quality of the tagged images was the main objective for performing the image
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acquisition in a 3 T MR system.
Dark blood technique
We used the STIR technique to acquire the T2 weighted images with a fat suppression.
The spectroscopic fat saturation (CHESS) was not effective enough due an inadequate
shimming of the static magnetic field B0.
Late enhancement images
We acquired 2D LE images with both types of reconstructions – the magnitude and the
phase sensitive. We did not perform acquisition of 3D data in free breathing because of
the time limitations in the experiment.
Phase contrast imaging
We acquired a single component of the velocity vector parallel to the heart valves. Since
we did not perform any particular calibration of the MR system, the quantitative values
could not be taken as the ‘ground truth’. However, the post-processed data provided at
least an exact timing for each part of the cardiac cycle (opening and closure of the valves,
period of fast ventricle filling, atrial contraction).
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Chapter 4
Biomechanical model of the heart
4.1 Introduction
The biomechanical model of the heart developed at INRIA is based on physiological consid-
erations and is consistent with essential thermomechanical requirements (energy balances
in particular). The model is described in detail in [95] and [25]. We aim at performing
clinical simulations using real medical data and a model inversion by means of estimat-
ing some of the parameters of the model. In this chapter, we will first summarize the
main ingredients of the model. Then, we will deal with the problem of model setup and
calibration, using medical data of healthy and pathological hearts.
In principle, we could model the whole 4-chamber organ (with 2 atria and 2 ventricles).
However, it is quite difficult to obtain reasonable anatomical models of the atria and our
main interest is in modeling the behavior of the ventricles. Therefore, the geometrical
models used for the simulations consist only of 2 ventricles.
4.2 Multiscale modeling for the heart model
The heart is modeled as a visco-elastic material with an active component that enables
the contraction. The blood flow pattern plays an important role in some pathologies as
for instance in valve diseases or some congenital heart defects. In such cases, simulating
possible treatment strategies could help in the therapy planning. However the patients
included in the work related to the thesis suffered from other types of diseases, in which
a detailed description of the flow would not change any clinical decisions. This is why,
although it would be possible to perform a full fluid-structure interaction as presented
e.g. in [38], we model just the solid part and the internal pressure in each ventricle is
represented by a single lumped value1 PV .
1All pressure variables used in the model are vectors of a size given by the number of cavities. In our
case for instance PV = (PVLV , PVRV ), with PVLV and PVRV being the LV and RV pressures.
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The heart is coupled with systemic and pulmonary circulations, that are represented
by Windkessel models (see [74], [103]). Hence, the main unknowns of the problem are the
displacements of the myocardium (y), the ventricle pressures (PV ) and the pressures in large
arteries just behind the semilunar valves (the aortic and the pulmonary artery pressures,
denoted by Par). The atrial pressures (Pat) are considered as measured values (the input
data). Internal variables2 related to the active part of the model (namely the strain, active
stress and active stiffness in a sarcomere denoted by ec, τc, kc) will be discussed in the
following section.
4.2.1 The active part (Bestel–Cle´ment–Sorine model)
The active part of the model is based on the modeling of interaction of contractile proteins
– the actin and myosin molecules – in a sarcomere, the functional unit of the muscle cells






= (1− n(ξ, t))f(ξ, t) + n(ξ, t)g(ξ, t),
n(ξ, 0) = n0(ξ) ∀ξ, (4.1)
where n(ξ, t) represents the number of actin-myosin cross-bridges with extension ξ at time
t and ec is the active strain of the sarcomere. The functions f(ξ, t) and g(ξ, t) represent
the rates of creation and destruction of the cross-bridges, respectively. A new cross-bridge
may be formed if the myosin head is near the actin binding site and if the binding site is
not covered by troponin-tropomyosin complex. The second assumption is satisfied in the
in vivo conditions if the intracellular Ca2+ concentration reaches a certain threshold C.
On the other hand, the cross-bridge may be released if the Ca2+ concentration falls below
the threshold C or if the bridge extension or the contraction rate are excessive. A detailed
analysis of the problem was introduced by Bestel, Cle´ment and Sorine in [12], where the
following prescriptions for functions f and g are proposed:
f(ξ, t) = kATP1ξ∈[0,1]1Ca2+≥C ,
g(ξ, t) = α|e˙c|+ kSR1Ca2+<C + kATP1Ca2+≥C1ξ /∈[0,1], (4.2)
with kATP being the rate of the myosin ATPase activity (the contraction rate), kSR being
the rate of sarcoplasmic reticulum calcium re-uptake mechanisms and α is a constant
related to the cross-bridge release due to a high contraction rate.
We can introduce the unique control variable u:
u = kATP1Ca2+≥C − kSR1Ca2+<C , (4.3)
2By internal variables, we mean the unknown variables with no spatial derivatives present in the resulting
system of equations. These variables are governed just by ordinary differential equations.
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the electrical activation u being positive during contraction and non-positive during relax-
ation. The function u can be regularized in order to avoid numerical difficulties. A typical
profile used in the simulations is depicted in Figure 7.5.
Using moment scaling techniques (see [116] and [25]), we can obtain the following
constitutive equations for the active part (the Bestel–Cle´ment–Sorine model):
k˙c = −(|u|+ α|e˙c|)kc + k0|u|+,
τ˙c = −(|u|+ α|e˙c|)τc + e˙ckc + σ0|u|+,
σc = d(ec)τc + µce˙c,
(4.4)
where τc represents the active stress that can be developed in the tissue and kc the active
tissue stiffness. If the Frank–Starling mechanism is taken into account (see Section 2.3.5),
the final active stress σc will also depend on the actual strain ec of the sarcomere by means
of the function d in the last equation of (4.4) which will be discussed in Section 4.3. The
parameter µc represents a viscosity in the active element.
4.2.2 Electrical activation
Electrical activation is considered as a model input and it is given by the function u
prescribed by (4.3) at each part of the myocardium. It represents a concentration of the
cytosolic TroponinC–Ca2+ complexes (TnC–Ca), which trigger the fiber contraction as
discussed in Section 2.3.2. In general, the electrical activation should be modeled on a
cellular level by means of modeling the transmembrane potential and intracellular TnC–
Ca dynamics, and on an organ level by modeling the propagation wave of the activation
in 3D anatomical models. In this section we will briefly sum up several possibilities for
modeling these phenomena. The electrical activation modeling is worked up in monographs
[94], [90], [104].
The cytosolic TnC–Ca concentration in cardiac muscle cells depends on Ca2+ ionic
flows between the extracellular space, the sarcoplasmic reticulum and the sarcoplasm. The
inflow of the Ca2+ ions into the sarcoplasm is induced by the opening of the cellular
membrane L-Ca2+ channels triggered by the action potential generated on the membrane,
and by Ca2+ channels in the membrane of the sarcoplasmic reticulum being opened thanks
to an increased sarcoplasmic Ca2+ concentration (‘Ca2+ dependent release of Ca2+ ions’).
Therefore we would ideally like the 0D cellular model to be able to represent the resting
membrane potential, the ionic flows (Iion) during an action potential that cause an increase
of the intracellular Ca2+ concentration, and the creation of TnC–Ca complexes. The
following electrophysiological models of various levels of complexity can be considered:
1. A fully biophysical approach that models the transmembrane potential using systems
of ordinary differential equations (ODEs), taking into account various types of ionic
channels and ionic flows. Some examples of these models are: Beeler–Reuter 1977
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([8]), Luo–Rudy LR1 1991 ([72]), Luo–Rudy LR2 1994 ([73]), ten Tusscher 2004
([106]). Then, the intracellular Ca2+ dynamics can be modeled e.g. according to [32].
2. Simplified models analogous to 1. that can typically represent the transmembrane po-
tential but do not take into account the full complexity of the membrane. Some exam-
ples of these so-called phenomenological models are: FitzHugh–Nagumo 1961 ([37]),
Aliev–Panfilov 1996 ([3]), Fenton–Karma 1998 ([36]), Bernus 2002 ([11]), Mitchell–
Schaffer 2003 ([77]). Due to similar profile of the propagating waves of the trans-
membrane potential and the cytosolic TnC–Ca concentration as obtained with the
more complex model of [32], we can directly rescale the transmembrane potential to
obtain the activation function u of the biomechanical heart model. This approach
was used in [23].
3. An ad-hoc prescription of the function u with a profile corresponding to the physio-
logical models.
The phenomenological models can capture important physiological features. The full
biophysical cellular models should in theory improve the results. Unfortunately, these
complex models are rather computationally intensive and difficult to tune, hence we often
do not obtain such encouraging results as with the phenomenological ones.
Although the approach 3. is the simplest one, it can represent the heart contraction
correctly if the timing of the activation onset in each part of the myocardium is well pre-
scribed.3 However, if we have no information about the tissue repolarization, the activation
based on the uniform function u cannot accurately represent heart relaxation.
Now, we will discuss the following possibilities of modeling the activation propagation





ad 1. At the 3D tissue and organ level, the propagation wave is modeled using reaction-
diffusion systems of partial differential equations (PDEs), that are coupled with ODEs
modeling the ionic currents Iion flowing through the membrane (as described above). The
so-called bidomain models (see [104], [16], [35]) consider the intracellular and extracellular
compartments, each of them characterized by its electrical potential ui and ue, with the
transmembrane potential given by v = ui − ue. The ion concentration is denoted by c.
A gating variable w represents the state of the ionic channels (either ‘opened’ or ‘closed’,
3The activation is given by depolarization times that offset the function u.
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and in some types of channels may in addition also feature an ‘inactivated’ state). The




∂t − div(Di∇ui) + ρIion(v, w, c) = Iiapp in Ω× (0, T ),
−ρCm∂(ui−ue)∂t − div(De∇ue)− ρIion(v, w, c) = Ieapp in Ω× (0, T ),
∂w
∂t = R(v, w) in Ω× (0, T ),
∂c
∂t = S(v, w, c) in Ω× (0, T ),
(4.5)
with ρ being the ratio of membrane area to tissue volume, Cm the membrane capacitance,
Iiapp and I
e
app are applied currents. The tensors Di and De represent the intracellular and
extracellular conductivities.
ad 2. The main difficulty in using the bidomain equation (4.5) is that we need a
very fine spatial discretization in order to capture the phenomena that occur between the
extracellular and intracellular compartments. Using some additional assumptions, as for
instance an equal anisotropy ratio of the conductivity tensors De = λDi (see [104]), we
can simplify (4.5) and obtain a single reaction-diffusion equation for the transmembrane




∂t − div(D∇v) + ρIion(v, w, c) = Iapp in Ω× (0, T ),
∂w
∂t = R(v, w) in Ω× (0, T ),
∂c
∂t = S(v, w, c) in Ω× (0, T ).
(4.6)
The phenomenological model proposed by Mitchell and Schaffer ([77]) coupled either with
the bi– or monodomain reaction-diffusion equation is used e.g. in [14] and [15]. The same
electrophysiological model is used in [23] for a weak electromechanical coupling with our
biomechanical model.
ad 3. The Eikonal equation is a static non-linear partial differential equation derived
from more complex models of the electrical activation discussed above (see [60], [30]). The
following form of the Eikonal equation can be used:
c0
√
∇T Td D∇Td − div(D∇Td) = τ in Ω× (0, T ), (4.7)
where c0 is a dimensionless constant related to the cell membrane, τ is the cell membrane
time constant, D is a tensor related to the myocardial fiber directions. The unknown
variable Td represents depolarization times of the myocardial tissue.
ad 4. An analytical prescription of the depolarization times Td can be given by a
traveling planar or spherical wave which in a physiological activation propagates from the
heart apex to the base (as shown in Figures 6.2 and 7.7). We may adjust the propagation
velocity, so that the activation period corresponds to the physiological timing, or the period
of activation may be given by the measured data (QRS duration in ECG that will be
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denoted by QRSd). We can apply a more complex yet still analytical prescription by
giving a fast propagation velocity for the activation of the endocardial part and a slow
transmural propagation, as depicted in Figure 8.18. In Section 8.7 we show that both types
of analytical prescriptions give almost identical results including in a joint state-parameter
estimation, supposing that the propagation velocities are well adjusted.
In most of the simulations performed in the thesis, we use a simple analytical pre-
scription of the electrical activation – with the timing of propagation corresponding to the
measured QRSd. In Chapter 7 we use in addition a prescription of the depolarization times
based on the Eikonal equation (4.7) and measured electro-physiological data.
4.2.3 The rheological model
The myocardial tissue is modeled as a material of Hill–Maxwell type (see [52]) with two
branches, depicted in Figure 4.1: the active series branch and the passive parallel branch.
The active part is modeled by the Bestel-Cle´ment-Sorine component. It creates the active
contraction in the privileged direction given by the direction of myocardial fibers n. The
parallel passive branch is 3-dimensional and is modeled as a viscoelastic material, with a
Mooney–Rivlin based hyperelastic potential (Ciarlet–Geymonat material, see [27])
W e = κ1(J1 − 3) + κ2(J2 − 3) + κ(J3 − 1) + κ(ln J3), (4.8)
with κ1, κ2, κ being the material parameters (the passive tissue stiffness) and J1, J2, J3
being the reduced invariants of the Cauchy–Green tensor C = F T · F with F = 1 + ∇y





where the parameter η represents a viscosity in the passive branch.
The variable e1D stands for the strain in the active branch and it combines ec (the
strain in the Bestel–Cle´ment–Sorine unit) and es (the strain related to the passive elastic
element Es, see Figure 4.1), and σ1D is the corresponding stress. The strain in the passive
branch coincides with the Green–Lagrange strain in the Hill–Maxwell unit denoted by e.








+ σ1D(e1D, ec)n⊗ n. (4.10)
4.2.4 Coupling with systemic and pulmonary circulations
A cardiac cycle can be divided into 2 non-isovolumetric phases (ventricle filling and ejection)
and 2 isovolumetric phases (isovolumetric contraction and relaxation). Let V (t) denote the
ventricle volume at time t. Then the blood flow leaving the ventricle is given by Q = −V˙ (t).
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Figure 4.1: Rheological model of Hill–Maxwell type with 1D-active branch (Bestel–
Cle´ment–Sorine model) and 3D passive branch. From [25].
During the isovolumetric phases, the tissue displacements need to satisfy the constraint
Q = 0. The value of the ventricle pressure PV then corresponds to the Lagrange multiplier
of this constraint. In the non-isovolumetric phases, we have either a condition PV = Pat
in the filling phase, or PV = Par during the ejection. The former equation says that the
ventricle pressure is prescribed during the filling phase (Pat is a part of the given data) and
the latter equation couples the heart with the circulatory systems.
The systemic and pulmonary circulations are represented by Windkessel models with
resistances and capacitances Rp and Cp in the proximal part of the system (just behind
the ventricle outflow tracts), and Cd and Rd in the distal part of the circulation. The










where the variable Pd represents the blood pressure in the distal part of the circulation
and Psv stands for the venous pressure.
4.2.5 Boundary conditions
In order to complete the system of equations governing the biomechanical model, we need
to prescribe boundary conditions. We would like the boundary conditions to reflect the
following constraints that can be observed in the image data:
• The base of the heart (the valves) will follow the movement along the long axis
according to the image data.
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Figure 4.2: Scheme of the Windkessel model. From [78].
• The heart apex will be nearly fixed.
• The boundary conditions will represent a contact of the myocardium with surround-
ing structures – in particular with the thoracic cage and diaphragm.
The simplest would be to fix (or prescribe displacements on) a part of the heart surface B
using the Dirichlet boundary conditions:
y = 0 on B. (4.12)
We can apply Dirichlet boundary conditions on the base of the heart (areas around the
valves, see Figure 4.3(a)) and as a post-processing of the results we can subtract the
simulated displacement of the apex from the modeled displacement vector y. Although
we can obtain a good model even with such a simple approach (see Figure 4.4), we rather
consider the following more physiological types of boundary conditions.
We replace the Dirichlet boundary condition by visco-elastic boundary conditions pre-
scribed on the heart base and on the area around the heart apex. The force associated





(a(x)y + b(x)y˙) · δvdS ∀δv ∈ V, (4.13)
where the functions a(x) and b(x) represent elastic and viscous moduli. They are adjusted
so as to preserve the motion of the base of the heart, as seen in the long axis projections of
Cine MRI, and to prevent the apex from displacing. Therefore the stiffness of the boundary
conditions applied on the apex needs to be higher than for the boundary conditions applied
on the base.
A contact between the heart and the surrounding structures – as for instance the
thoracic cage or diaphragm (see Figures 4.3(b), 4.3(c) and 4.5) – can be represented by ad-
ditional visco-elastic boundary conditions with stiffnesses approximately of the same order
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(a) View of the heart base:
Light and dark blue, pink and
purple areas around the valves
designated for the boundary
conditions.
(b) Inferior-wall view: Purple
area for a contact with the di-
aphragm; orange and brown re-
gions for fixation of apex.
(c) Anterior-wall view: Red area
for a contact with the thoracic
cage.
Figure 4.3: Prescription of the boundary conditions on the base of the heart, the apex and
the epicaridal surface adjacent to the thoracic cage and diaphragm.
as for the apex. Such boundary conditions prevent the ventricle wall from the movements
that are constrained by the surrounding anatomical structures but to some extent also pre-
vent the myocardial wall from contracting because of the partial fixation of the adjacent
epicardium.
To avoid this drawback, we can use another type of boundary conditions that directly
represent the contact between the heart wall and the surrounding structures by penalizing
the distance between them. A representation of the distances between the surfaces uses
the same approach as in [81], where distances of surfaces of the model from observations
(the reference surfaces) were computed in order to correct the model. The variational form




| dist(x, Sref)|−ν · δvdS, (4.14)
where Sref is the pericardial surface designated for the sliding boundary condition,
dist(x, Sref) stands for the signed distance of x to the surface Sref and
|dist(x, Sref)|− =
{
dist(x, Sref) if x is inside Sref ,
0, otherwise.
(4.15)
The variable ν stands for an outward unit normal vector to B and K is a large penalization
coefficient. By using the boundary conditions given by (4.14), we can observe more physi-
ological wall thickening and the epicardial surface may slide on the pericardium, as in the
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(a) Diastole, blue color represents non-activated model
(b) Systole, red color represents activated model



















Location End-systole End-diastole Mean pressure
(mmHg / Pa) (mmHg / Pa) (mmHg / Pa)
LV 115 / 15200 14 / 1850 40 / 5400
aorta 115 / 15200 70 / 9400 95 / 12700
Measured pressure values
Figure 4.4: Example of the resulting model of healthy heart: The anatomical model is based
on Cardiac CT data. Dirichlet boundary conditions are applied on the heart base and the
simulated displacement of the apex is subtracted from y. Comparison of the simulation
(long axis projection of the mesh or synthetic tagged images in short axis) with measured
MR images. The simulated pressures are comparable with the measured values.
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Figure 4.5: Surfaces designated for the contact boundary conditions are obtained using
Cine MRI (or tagged Cine MRI, as in this case).
real situation. In practice, we need to create the complementary – pericardial – surface Sref
and both surfaces involved in the sliding boundary conditions need to be smooth without
large surface irregularities.
Most of the models in the thesis are calibrated using the visco-elastic boundary con-
ditions (4.13) applied on the base, apex and on the epicardial surfaces adjacent to the
thoracic cage and the diaphragm. In Chapter 8, some preliminary simulations are per-
formed with the sliding boundary conditions (4.14). Direct comparisons between the two
types of the boundary conditions are shown in Figures 8.21 and 8.22.
4.2.6 The full heart model
The variational formulation of the model taking into account the equations (4.3), (4.4),
(4.8) – (4.11) and the boundary conditions presented above can be written according to
the principal of virtual work (PVW, [7]):∫
Ω0
ρy¨ · δvdΩ0 +
∫
Ω0
Σ : δedΩ0 +
∫
Γ
PV ν · F−1 · δvJdΓ = 0 ∀δv ∈ V. (4.16)
We recall that y and PV are the main unknowns of the problem – the displacement field,
and the left and right ventricle pressures. The symbol Ω0 denotes the reference domain
corresponding to the cardiac tissue, and Γ represents the left and right ventricle endocardial
surfaces with outward unit normal vector ν.
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The model given by Equation (4.16) is discretized in space using P1-Lagrange finite ele-
ments and in time using a mid-point Newmark scheme, see [95] and [25]. We introduce the
following matrix-form notation according to [78]. Let y
h
∈ Vh denote the discretized dis-
placement vector y and y˙
h
is the associated velocity. The degrees of freedom (DOFs) of our
problem consist of 3 components of the displacement y
h
for each node of the computational
mesh which is not fixed by the Dirichlet boundary condition. Let Y , Y˙ are displacement
and velocity vectors associated with the DOFs stored in columns. The problem of linear
elasticity would be to find Y such that
MY¨ + CY˙ +KY + ΣPS(t) = F
e(t),
Y (0) = Y0,
Y˙ (0) = Y˙0,
(4.17)
with M , C, K being the mass, damping and stiffness matrices of the linear problem. The
variable ΣPS(t) represents an imposed active stress in time t (the prestress) and F
e is an
external force.
We can re-write equation (4.17) for a non-linear case, still with the prescribed prestress:
MY¨ + C(Y˙ ) +K(Y, t) + ΣPS(t) = F
e(t),
Y (0) = Y0,
Y˙ (0) = Y˙0.
(4.18)
The active stress in our heart model is not imposed from the ‘outside’ as in systems
(4.17) and (4.18), but it is created by the tissue itself thanks to the actin-myosin interactions
in sarcomeres with an activation given be the function u. Hence, the full model can be
written in the following form:
MY¨ + C(Y˙ ) +K(Y, u(t)) = F e(t),
Y (0) = Y0,
Y˙ (0) = Y˙0.
(4.19)
The time discretization for the mid-point between the time steps n and n + 1 has the
























Figure 4.6: Maximum active stress depending on the sarcomere length in an experiment
(left) with relative positions of the actin and myosin filaments depicted at the upper right
corner (from [46]), and function d representing the same phenomenon in the model (right).
4.3 Functional modulations in the model
Basic physiological mechanisms of the regulation of heart function were discussed in Section
2.3.5. These mechanisms are included in the model and can be modulated in the following
ways.
The contractility level of the model is given by the product of the parameters kATP
(the maximum value of the electrical activation function u) and σ0 (the tissue active con-
tractility) in Equations (4.3) and (4.4). By increasing (decreasing) either of them, we
will achieve the positive (negative) inotropic stimulation. The lusitropic activation (the
relaxation rate level) is given by the parameter kSR (the minimum value of the electrical
activation function u) in (4.3). The dromotopic stimulation (an increased conductivity in
the heart conduction system) can be modulated directly by the propagation velocity of the
electrical activation wave, if some simple analytically prescribed activation pattern is used.
The heterotropic regulation (the Frank–Starling mechanism) is modeled by means of
the function d in (4.4). It modifies the active stress τc according to the actual strain of the
sarcomere (ec). The function d ∈ [0, 1], and d = 1 for the optimum sarcomere length and
decreases to 0 for either an overextension of the sarcomere or if the sarcomere shortens
below a certain threshold, see Figure 4.6.
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4.4 Model calibration
In this section, we will describe a basic strategy in setting up the subject-specific4 heart
models. The clinical data used in creating the models consist of image data and pressure
data measured in the heart cavities and large vessels. The calibrated models need to
correctly represent both the motion pattern according to the image data and the pressure
values according to the measured pressure curves.
4.4.1 Anatomical model
Image modalities
The subject-specific anatomical models are created by segmenting image data acquired by
Cardiac MRI or Cardiac CT.
Cardiac MRI was discussed in detail in Section 3.10.1. It can provide a static 3D image
with a spatial resolution as good as 2 x 2 x 2 mm or kinematical Cine images with a spatial
resolution of about 2 x 2 x 10 mm and with a temporal resolution of about 30 ms.
The 3D static images are acquired in free-breathing. Due to a long data acquisition5
and a non-uniform data quality, they are often not available. The Cine MRI data are
acquired during several breath-hold periods of the examined subject. Since the breath-
holds are not exactly reproducible (especially in patients in whom the data are acquired
usually during inspiration), we often need to re-align the 2D image data to obtain the
correct 3D geometry. In subjects with a myocardial infarction, Cardiac MRI can visualize
the infarct scar by means of the late-enhancement technique. The scar can be directly
projected in the mesh without any major registration issues6. As for the morphological
images, the late-enhancement data can be either acquired in breath-hold periods with a
non-isotropic voxel of about 2 x 2 x 10 mm – a quite limited resolution for an accurate
3D definition of the scar in the anatomical model – or using the true 3D approach in free-
breathing with a spatial resolution of around 2 x 2 x 2 mm but with all the difficulties of
the 3D morphological data (i.e. long acquisition time and unpredictable image quality).
A disadvantage of Cardiac MRI data is that current commonly available image segmen-
tation software is not efficient enough to create anatomical models automatically from pa-
tients’ data of usual resolution and quality, and we need to use either some semi-automatic
or fully manual approaches.
Cardiac CT can provide data of a better spatial resolution compared to MR images and
4By subject, we mean either a human healthy volunteer, patient or animal during an animal experiment.
5It is an additional approximately 15-mins acquisition after an usual 30–60 min Cardiac MRI exami-
nation. The resulting image is usually not crucial for patient’s diagnosis (except if we aim for instance at
native MR coronarography).
6Supposing that the subject did not move between the acquisition of the morphological and the late-
enhancement data.
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Figure 4.7: A 4-chamber projection using 2D echocardiography can give an approximate
value of the LV ejection fraction (left: end-diastole, right: end-systole).
of better image quality.7 It is easier to create accurate anatomical models thanks to already
existing robust algorithms for image segmentation. As drawbacks of Cardiac CT we should
mention a lower temporal resolution (we acquire either just a static image or a dynamic
sequence with a temporal resolution of about 100 ms), registration issues if we aim at
using also some other imaging modalities (e.g. Cine MRI with a better temporal resolution,
tagged MRI, late-enhancement MR images or FDG–PET8). Significant radiational doses
prevent us from performing cardiac CT on purpose only for creating the models (e.g. in
healthy volunteers). In fact, only one of the anatomical models used in the thesis was
created from the Cardiac CT data – the model presented in Figure 4.4. All other subject-
specific anatomies were created using the Cine MRI data.
Finally, we can discuss the role of echocardiography9 in setting up the models. Current
3D-echocardiography can provide a reasonable geometry but the data quality depends on
many additional non-cardiac factors (e.g. patient’s level of obesity). Creating anatomical
models is a long procedure, which is the reason why we prefer using data of a quality as high
as possible. Therefore we use Cardiac MRI or CT data. Nevertheless, echocardiographic
data can be used e.g. in measuring some functional indicators, as for instance the LV
ejection fraction (see Figure 4.7) or a flow through the valves using the Doppler technique
(see Figure 4.8). This can serve as complementary information to set up the biomechanical
7The acquisition is limited to the time period when the bolus of the contrast agent is present in the heart
(period of 10–20 secs). Then, depending on many factors such as the number of detectors or the energy of
X–rays, we may obtain a spatial resolution of about 0.5 x 0.5 x 0.5 mm.
8Positron Emission Tomography using 18fluor-deoxy-glucose is in some countries considered as a gold
standard for assessing the myocardial viability. See [114] for a review of non-invasive imaging of the viability.
9Echocardiography is an ultrasound examination of the heart and is described e.g. in [87].
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Figure 4.8: Analysis of flow through mitral valve using pulse Doppler measurement.
model. Some easily measured indicators could be used in follow-ups of patients in order to
develop models representing some long-term processes (e.g. tissue remodeling).
Segmentation
The LV and RV endocardial and the epicardial surfaces are segmented manually using
the software CardioViz3D, see [107]. We exclude the atria from the geometrical models
due to difficulties in their segmentation. Therefore we truncate the models slightly above
the atrio-ventricular and semilunar valves. We cannot obtain a very accurate geometry of
the myocardium in the vicinity of the valves because of the low image spatial resolution
and anatomical complexity. Nevertheless, we try to obtain reasonable surfaces in this part
of the myocardium as well, in order to preserve the full ventricle volumes. We exclude
papillary muscles and trabeculae from the segmentation of endocardia. The segmentation
of each surface has its own specificity.
The ellipsoidal shape of the LV endocardium facilitates the segmentation. The most
difficult task is to exclude the papillary muscles and the trabeculae (see Figure 4.9) because
of inter-subject variability. The complex shape of the RV endocardium and the thin RV
wall – which is often not clearly visible in MR images obtained by the bSSFP (trueFISP)
sequence due to susceptibility artifacts10 – make the RV segmentation rather difficult. The
10The magnetic field inhomogeneities are caused by epicardial fat. The thin RV wall is hidden in the
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Figure 4.9: Surface segmentation using CardioViz3D software. We try to exclude the
papillary muscles and the trabeculae in the LV (blue contour) and RV (yellow contour).
Note also a difficult segmentation of the RV wall (partially invisible due to limited spatial
resolution and susceptibility artifacts), and a complicated segmentation of the inferior wall
epicardium due to close connection with diaphragm and liver.
epicardium of the inferior wall is in a direct contact with the diaphragm and hepatic tissue.
In some cases, the epicardial contour is undistinguishable in a single time frame image. If
this occurs we have to carefully watch the whole Cine loop, to reconstruct the epicardial
surface adequately. Some difficulties in segmenting the RV and the epicardium can also be
seen in Figure 4.9.
Mesh creation
The surfaces exported from CardioViz3D usually need to be regularized in the valve regions,
where the geometry is the most complex. For this task, we can use for instance the
commercial software 3-Matic11. Then, we create computational tetrahedral meshes using
the Yams and GHS3D meshing tools developed by Team-project Gamma at INRIA, see
[41].
In subjects with post-infarcted scars, the regions of non-viable tissue are segmented
from the late-enhancement MR images and projected into the computational meshes (see
Figure 6.3). The volumic meshes of the LV are subdivided into 17 segments according to




Figure 4.10: A 17-segment subdivision of the LV proposed by AHA in [21] (the AHA
segments).
the American Heart Association (AHA) recommendations (see [21], Section 2.2 and Figure
4.10).
Myocardial fibers
The direction of the active contraction in the model is given by the myocardial fiber di-
rections. Their prescription may be performed using an ex-vivo MR-DTI study12 (see
e.g. [113] where an analysis of a postinfarct porcine ex-vivo myocardium is perfomed, or
[88] where an atlas of ex-vivo canine hearts is used to prescribe the fibers). There are some
promising results in the in vivo MR-DTI measurements on the beating heart (see e.g. [115]
and [108]) but these methods are still at the research stage.
In our models, we use an analytical prescription of the fibers based on anatomical
knowledge (see e.g. [101]). The procedure is fully described in [78] and it was also used in
[23]. The angles between the fibers and the short axis plane are prescribed on the epicardial
and endocardial surfaces (both for the LV and RV). Inside the myocardium, the fibers are
linearly interpolated. The directions corresponding the best with [88] are -60/60 degrees
in the LV and -50/50 degrees in the RV, from the epicardium to the endocardium (see
[78]). Thanks to the automatic analytical prescription, we can guarantee that we use the
same approach for all subjects involved, either in validation studies (see [22]) or in clinical
12For an explanation of Magnetic Resonance Diffusion Tensor Imaging (MR-DTI), see Section 3.11.
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Figure 4.11: Analytical prescription of myocardial fibers in porcine geometry (left) com-
pared with ex-vivo MR-DTI study of the same heart (right). This is the heart model
that was used for the simulation presented in Figure 4.4. Visualization using MedINRIA
software developed by Team-project Asclepios at INRIA.
applications (see [97]). See Figures 4.11 and 6.1 for examples of myocardial fibers created
in this manner. The epicardial and endocardial fiber directions are considered as additional
parameters of the model, as was used in [112].
4.4.2 Calibration of the model parameters
By adjusting the boundary conditions, the passive material properties (passive tissue stiff-
ness) and the active properties (tissue contractility), we would like the motion pattern and
the simulated pressures to correspond to the measured data. The simulated pressure values
in the ventricles and in the large arteries are modulated by the contractility of the ventricles
and by the Windkessel models. In a calibration of the tissue mechanical parameters, first
we will be using constant values over the whole myocardium. Later on, we can take into
account local variations of these values, e.g. in between the AHA segments. Indeed, this
is necessary especially for pathological hearts in which the values may vary significantly
throughout the myocardium. The model calibration is usually performed using a simple
electrical activation, e.g. an analytical prescription of the depolarization wave starting in
the apex and propagating along the long axis. The calibration consists of the following
steps.
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First we would like to adjust the fiber directions for both ventricles. We fix the base
of the heart by applying Dirichlet boundary conditions. At this stage, we do not aim
at a precise adjustment of the mechanical parameters of the passive tissue stiffness and
contractility. Yet, we need to use some meaningful values of these parameters, so that the
simulation can be in agreement with the measured data (e.g. by means of an approximate
value of the LV ejection fraction). We test several combinations of the fiber directions. We
usually start with the values -60/60 degrees in the LV and -50/50 degrees in the RV, from
the epicardium to the endocardium. Then we can try to make the fibers more horizontal
or vertical by 10–15 degrees. Excessively horizontal fibers make the contraction mainly
circumferential without any longitudinal shortening. Even more, a longitudinal extension
could appear. The other extreme would be just a longitudinal contraction with a low
circumferential component. A choice of fiber directions in a compromise between these two
extreme positions leads to reasonable resulting simulations.
In the second step, we adjust the visco-elastic boundary conditions applied on the heart
base and apex. The concerned surfaces around the valves can be created automatically
using the borders between the LV and RV endocardial and epicardial surfaces. The apex
reference surface is registered from the image data. We adjust the stiffnesses of the bound-
ary conditions applied on the base so that the longitudinal movement of the base of the
heart is preserved. To that purpose we usually compare with the motion of aortic and
mitral valves in the long axis projections of Cine MRI. Unlike the base of the heart, we
would like the apex to be nearly fixed. This is why the boundary conditions applied on
the apex are stiffer than the ones applied on the base (by a factor 10–50).
In some cases, the model may tend to bulge – especially in thin parts of the myocardium
if there is a high pressure in the ventricle (see the orange contour of the model in Figure
4.12). The bulging of the real heart is to some extent prevented by a contact with the
surrounding structures such as the thoracic cage, diaphragm or a stiff pericardial sac. We
represent such a contact in the model by applying additional boundary conditions on parts
of the epicardial surfaces designated using the image data (the green surface in Figure
4.12). Then, the stiffness of these boundary conditions – usually of the same order as in
the case of the boundary condition applied on the apex – has to be adjusted (see the blue
contour in Figure 4.12 with not adequately stiff boundary condition and the red contour
with the stiffness high enough).
The third step consists of an adjustment of the passive tissue properties. Supposing that
the passive tissue stiffness is uniform throughout each ventricle and assuming we have accu-
rately measured atrial pressure and ventricle volume changes, we can calibrate the passive
tissue stiffness using the part of the cardiac cycle corresponding to the atrial contraction.
The atrial pressures can be replaced by measured flows through the atrioventricular valves.
Next, using information about the ejection fraction we can adjust the tissue contrac-
tility. For this task, we fix the arterial pressure to the measured end-systolic value. In
non-pathological hearts, we can obtain an adequate local motion pattern just by using a
uniform contractility value. In pathological hearts, we often need to modify the contrac-
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Figure 4.12: Visco-elastic boundary conditions (BCs) applied on the part of epicardium
in contact with the thoracic cage (the green surface). The myocardium of this particular
subject is very thin at this location due to post-infarction LV apical aneurysm formation.
An extreme wall bulging occurs if no BC is applied (the orange contour). The blue color
represents the model with unsufficiently stiff BC and the red color represents properly
calibrated BC.
tility values locally. A manual approach of the contractility adjustment is used in Chapter
7, while an automatic approach by means of data assimilation techniques is applied in
Chapter 8.
The adjustment of the Windkessel models is the last calibration step. The Windkessel
models given by (4.11) consist of two components: The proximal part representing the
beginning of the large arteries (aorta and pulmonary artery) is characterized by a resistance
Rp and a capacitance Cp. The distal part has a resistance Rd and a capacitance Cd, see
Figure 4.2. The values of resistance and capacitance in the distal part are larger than in the
proximal part: Rd > Rp, Cd > Cp. The adjustment of the parameters of the Windkessel
models follows the scheme:
1. Adjusting of Rd according to the systolic increase of the distal pressure Pd (given
measured data).
2. Adjusting of Cd so that the arterial pressure can be periodic between the cardiac
cycles (time constant τd = RdCd ∼ 1 s).
3. Adjusting of Rp according to the systolic increase of the arterial pressure Pa and of
the ventricle pressure PV (given measured data).
4. Adjusting of Cp so that the time constant or the proximal part of the Windkessel
model would be τp = RpCp ∼ 1 ms.
A high increase of the resistance in the Windkessel models would prevent the ventricles
from ejecting an appropriate volume. For this reason, we perform the fine adjustment of
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Figure 4.13: Example of simulated pressure curves for the left ventricle using a well cali-
brated Windkessel model (4.11).
the contractility values and of the Windkessel models simultaneously. Finally we obtain
both accurate ejection volumes and correct pressure characteristics. An example of the
simulated pressures with a well calibrated Windkessel model is shown in Figure 4.13.
Difficulties
• The visco-elastic boundary conditions (4.13) representing the contact of the my-
ocardium with the surrounding structures prevent the wall from an adequate systolic
thickening. The sliding boundary conditions given by (4.14) have better properties
in this respect but their adjustment is more difficult. We need to designate comple-
mentary epicardial and pericardial surfaces which should be smooth without large
irregularities, so that they do not prevent the surfaces from sliding freely on each
other.
• The calibration of the passive properties is a very difficult part for the following
reasons:
– In a fast heart action, the atrial contraction cannot be completely separated
from the other parts of ventricle filling. Therefore, it is not possible to accu-
rately assess the pressure and volume increases that correspond to the atrial
contraction.
– In practice, it is difficult to measure atrial pressures since the absolute values and
also the variations during a cardiac cycle are very low. In fact, a direct measure-
ment of the left atrial (LA) pressure during the catheterization is difficult.13 We
13Typically, we would have to enter the left atrium from the right atrium by crossing the atrial septum.
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usually replace the LA pressure by measuring the pulmonary capillary wedged
pressure (PCWP, see chapter 19 in [70]), which more likely mirrors the mean LA
pressure over the cardiac cycle and can give information about the global LA
pressure rather than the accurate pressure variations. This is why we cannot
easily apply the adjustment procedure of the tissue properties according to the
atrial pressure and ventricle volume changes during the atrial contraction.
– Although we may substitute measured atrial pressures by measured AV flows, we
would still need an absolute value of the initial pressure. Moreover, the Doppler
measurement provides velocities and not flows and the accuracy of Doppler
echocardiography and of phase contrast MRI14 measurements is a difficult issue.
– The LV wall thickness may vary significantly in between the LV regions, es-
pecially in pathological hearts. The passive properties may vary from less stiff
values in a normal tissue to very stiff in thin remodeled parts of the myocardium
(due to an increased tissue fibrosis).
• Some missing data (e.g. the measured aortic pressure) especially in patient-specific
models make the adjustment of the Windkessel models more difficult.








A 1D implementation of the cardiac model described in Chapter 4 will be used for the model
validation using experimental data coming from the contraction of individual muscle fibers.
The aim of this chapter is to show that the 1D model is able to represent the myocardial
fiber contraction for several preload and afterload values according to the experiment.
Thanks to the experimental data, we will be able to study in detail some aspects of the
model, as for example material laws, some model parameters, or the implementation of the
Frank–Starling mechanism.
5.1.1 Basic physiological considerations of the muscle contraction
We refer to Section 2.3.2 for the physiological basis of muscle contraction. The heterotropic
regulation (the Frank–Starling mechanism) was discussed in Section 2.3.5. Here we sum
up some basic physiological facts.
Muscle contraction is based on an interaction of thick and thin filaments in a sarcomere
– the functional unit of the muscle cell (see Figure 2.5). The thin filaments consist of actin
fibers and regulatory proteins such as tropomyosin and troponin. The main component of
the thick filaments is a myosin protein.
The preload is defined as the tension in the fiber before contraction occurs. In a typical
physiological experiment (as depicted in Figure 5.1(a)), the preload is given by the load
that is attached to the fiber before the fiber is activated. Since the preload causes a passive
extension of the fiber, it is often related to the degree of passive extension.
By afterload we mean the tension generated by the fiber during contraction. In the
physiological experiment, it is given by the weight of the load which is fixed to the fiber
and that the fiber must overcome. If we apply such an afterload value that the fiber is
not able to shorten (or raise the load) despite the active stress, we talk about isometric
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contraction. By fixing the generated stress during the fiber contraction we obtain isotonic
contraction.
An increased preload causes an increased force of the contraction according to the
Frank–Starling mechanism. One possible explanation of this phenomenon is due to a better
overlap between the actin and myosin molecules when the fiber is stretched. This leads to a
higher number of actin–myosin cross-bridge formation and to the subsequent increase of the
active stress in the fiber. If the applied preload exceeds the maximum in the Frank–Starling
curve (the point D in Figure 2.9, left), the contraction force will drop. It is a reversible
effect in the case of skeletal fiber – by decreasing the preload we would get again onto the
increasing part of the Frank–Starling curve. However, for the cardiac fiber the effect is
irreversible. Getting to the decreasing part of the curve would damage the cardiac fiber




In the experiment settings, the papillary muscle from a laboratory rat with acromegaly was
used as a cardiac fiber1. The animal was of an excessive growth but the heart was almost
of a normal size. The initial length of the papillary muscle was approximately 4–4.5 mm
and the cross-section area approximately 1.2 mm2. The fiber was stretched passively by
applying a preload. Then, the muscle was stimulated electrically to induce contraction
against an afterload, see Figure 5.1(a). In the isotonic case, the expected shortening was
of an order of 20–25% with respect to the configuration of the extended fiber.
The following two preload values were used: a high value – corresponding to the preload
supposedly giving the optimal properties with respect to the Frank–Starling mechanism –
and a lower value. The initial passive extension of the fiber after applying the preload was
not measured. The expected value for the high preload was of the order of 20%–30%.
During the experiment, the displacement of the lower end of the muscle and the force
created by the fiber were measured simultaneously with the sampling rate of 0.5 ms. For
an easy comparison between the experiments and the corresponding simulations, the data
were postprocessed, so that we could use the following indicators independent of the fiber
geometry:
• The fiber extension defined as the measured displacement divided by the length of
the unloaded fiber, which is taken as a reference configuration. By fiber shortening
we mean the negative extension.
1Experimental data were provided by Prof. Yves Lecarpentier, Department of Physiology, University
Paris-Sud XI, Hospital Biceˆtre.
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• The stress indicator defined as the measured force divided by the cross-section area
of the unloaded fiber.
• The strain rate as a difference of the subsequent extensions:
(extensioni−extensioni−1)/time step. We used basic filtering techniques to decrease
noise in the strain rate data.
Both the experimental data and the simulated results will be rescaled accordingly to these
indicators. The loads applied on the fiber (the preload and the afterload) will also be
transformed in the stress formulation by dividing the force by the cross-section area. See
Figure 5.1 for the measured experimental data.
5.2.2 Biomechanical model
The myocardial fiber is modeled as a viscoelastic material with an active component rep-
resenting the contraction as described in Chapter 4. Here, we will recall the main model
ingredients that will be used in the 1D simulation setup.
The activation of the contraction is given by the electrical activation function u
representing the cytosolic TroponinC–Ca2+ concentration:
u = kATP1Ca2+≥C − kSR1Ca2+<C . (5.1)
The electrical activation function u is positive during contraction and non-positive during
relaxation. The maximum and minimum values of u are given by the parameters kATP
and kSR respectively. These parameters represent the contraction and relaxation rates.
The active part of the model is governed by the constitutive equations in the following
form (Bestel–Cle´ment–Sorine model, [12]):
k˙c = −(|u|+ α|e˙c|)kc + k0|u|+,
τ˙c = −(|u|+ α|e˙c|)τc + e˙ckc + σ0|u|+,
σc = d(ec)τc + µce˙c,
(5.2)
where τc represents the active stress that can be developed by the tissue and kc the active
tissue stiffness. If the Frank–Starling mechanism is taken into account, the final active
stress σc will also depend on the actual strain ec of the sarcomere by means of the function
d. A typical example of the function d is depicted in Figure 4.6. The parameter µc
represents a viscosity in the active element.
By analyzing equations (5.1) and (5.2), we can see that during the fiber activation the
active fiber stress rises to the limit value given by σ0 with the time constant 1/kATP . The
time constant for the relaxation is given by 1/kSR. By varying the parameter σ0 we can
modulate the inotropic state of the fiber (an increase or decrease of the fiber contractility)
and by varying kATP we can vary the contraction rate. The parameter kSR controls the








(a) Experiment settings. Reference configuration
(1), passive extension by preload m1 (2), activation
of contraction against afterload m1+m2 (3), con-
tracted fiber (4).















(b) Stress vs. time plots. Maxima of the stresses
characterize afterload values. The purple color rep-
resents the isometric contraction and the dark blue
color the contraction against the preload alone.


















(c) Relative extension vs. time plots.
















(d) Strain rate vs. time plots.
Figure 5.1: Example of the measured and scaled data. Solid lines represent experiments
with the high preload value (optimal fiber extension with respect to the Frank–Starling
mechanism), dashed lines represent experiments where the lower preload was applied.
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The myocardial tissue is modeled as a material of Hill–Maxwell type with two branches,
depicted in Figure 4.1: the active series branch and the passive parallel branch. The active
part is modeled by the Bestel–Cle´ment–Sorine component and the parallel part is modeled
as a viscoelastic material. The type of hyperelastic potential used in the simulation will be





where the parameter η represents a viscosity in the passive branch.
5.2.3 Various parameters in the model
In the following section, we will study some model parameters. We will be using the
high preload value and the corresponding afterload values – the solid lines in the plots in
Figure 5.1. In these preliminary tests, the Frank–Starling mechanism will not influence the
simulations – the function d in (5.2) will be set to the constant value d = 1.
Viscosity
There are two viscosity elements included in the model: one in the passive branch (η)
and one in the active branch (µc). The active viscosity is larger than the passive one. A
high viscosity in the model causes a phenomenon of delayed relaxation – especially for low
afterload values. Since we do not observe it in the experimental data (see Figure 5.1(b)),
we need to decrease the viscosity.
Figure 5.2 shows a few tests when modifying the viscosity values. By decreasing the
active viscosity, we obtain stress curves more similar to the experimental data. The passive
viscosity is already low and even when decreasing it the simulation does not change (see
Figure 5.2(e)). Figures 5.2(c) and 5.2(f) show nearly the same behavior and the stress
curves are comparable with the shape of the experimental data. In the following parts, we
will be using the viscosity values according to Figure 5.2(c).
Time constant of the Bestel–Cle´ment–Sorine model
The whole contraction–relaxation cycle in the experiment lasts less than 400 ms and we
assume that in the period ∼200 ms the fiber reaches its asymptotic shortening value.
Indeed, in the experimental data in Figure 5.1(c) the shortening does not seem to be
limited by the duration of the activation. By decreasing the viscosity in the model we
already shortened to some extent the period of activation necessary to reach this asymptotic
value. However, we will have to control this period directly by the time constant of the
Bestel–Cle´ment–Sorine active component, which is given by 1/kATP .
Figure 5.3 shows simulations with three values of kATP , either with a very long ac-
tivation (action potential duration APD = 1000 ms) – in order to obtain the value of
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(a) Original values η0 = 68 Pa.s,
µ0c = 2700 Pa.s















(b) η = η0, µc = µ
0
c/5















(c) η = η0, µc = µ
0
c/10
















(d) η = η0 ∗ 10, µc = µ0c
















(e) η = η0/100, µc = µ
0
c















(f) η = η0 ∗ 5, µc = µ0c/10
Figure 5.2: Simulated stresses using various viscosity values. Note that if the fiber contracts
against a low load and the viscosity is set to a high value, the relaxation is delayed. This
effect is not present in the experimental data in Figure 5.1(c). Note the ‘overshoot’ and
‘undershoot’ in the curves shortly after the onset of contraction and relaxation, caused
by the inertia effects, and the oscillations during the relaxation due to the 1D model
implementation of contact conditions. We mention these issues in the discussion.
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asymptotic shortening – and with APD corresponding to the experiment (APD = 200 ms).
We can see that when using the value kATP = 40, the timing of the contraction–relaxation
cycle is close to the experiment.
Material laws
For the parallel passive branch of the model we tested the following hyperelastic potentials.
• A polynomial potential (the Mooney-Rivlin material):
W e = κ1(J1 − 3) + κ2(J2 − 3), (5.4)
• An exponential material:
W e = κ1(J1 − 3) + κ2(J2 − 3) + c0ec1(J1−3)2 , (5.5)
with κ1, κ2, c0, c1 being the material parameters and J1, J2, J3 being the reduced invariants
of the Cauchy–Green strain tensor C. For an implementation of the material laws in the
1D model see Appendix 5.6.
In Figure 5.4, we plotted several stress–strain laws using either the Mooney–Rivlin
material (5.4) or the exponential material (5.5), with material parameters listed in Table
5.1. All of them were calibrated for an initial extension of 28% after application of the high
preload. As we can see in the experimental data, when using the high preload the fiber is
extended 28% above the initial (reference) length and during the contraction against the
lowest afterload the shortening level is around 8% – namely a difference of 36% (see solid
lines in Figure 5.1(c)). For this reason, we need our stress–strain law to be rather soft in
the contraction part.
The exponential material is more flexible and we can adjust it, so that it is flatter in the
contraction part (material denoted by ‘epx1c’ in Figure 5.4). It means that for low stress
variations (afterload values), we can obtain larger variations of the shortening. However,
when the shortening gets above 25% of the initial length, the stress increases very steeply
– especially in the exponential material – no matter what material parameters are used.
Moreover, the exponential material is quite symmetric in the contraction and the passive
extension parts. If we adjust the material law to be flat in the contraction part (in order to
reproduce the experiment), the passive part will become flat as well. In fact, we would need
a material law in which the contractile and the passive extension parts could be adjusted
more independently. For these reasons, we finally used the simpler Mooney–Rivlin material
(5.4), which seems to be a good compromise both for the contraction and for the passive
extension parts.
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(a) kATP = 10




















































(b) kATP = 20




















































(c) kATP = 40
Figure 5.3: Relative extension for various values of kATP . Left column represents the
simulations with long activation (APD = 1000 ms), in which the asymptotic shortening
level can be estimated. Timing in the middle column is according to the experiment (APD
= 200 ms). Note that maximum contraction strain rate increases with increasing kATP
(right column).
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Figure 5.4: Examples of stress–strain curves for several material laws. Note, that the
exponential material has a softer response for small strains. The parameters of the materials
are in Table 5.1.
label κ1 (Pa) κ2 (Pa) c0 (Pa) c1
MRa 5000*0.96 80*0.96 0 0
MRb 5000*0.55 5000*0.55 0 0
MRc 80*1.22 5000*1.22 0 0
exp1a 5000*0.95 80*0.95 10 10
exp1b 5000*0.875 80*0.875 100 10
exp1c 5000*0.13 80*0.13 1000 10
exp2a 5000*0.88 80*0.88 10 100
Table 5.1: Parameters of materials plotted in Figure 5.4. ’MR’ stands for the material of
the Mooney–Rivlin type, ’exp’ for the exponential material.
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5.2.4 Calibration for the high preload value
For the model calibration, we used the experimental data of the isometric and isotonic
contraction when the high preload was applied with the following constraints:
1. The passive elongation of the fiber is of an order 25–30%.
2. When applying the maximum afterload value used in the experiment together with
the high preload, we will obtain an isometric contraction.
3. The duration of the contraction corresponds to the experiment and the fiber will
reach the asymptotic shortening during this period. The maximum simulated strain
rate in the isotonic contraction with the lowest afterload corresponds to the measured
value.
4. When applying the minimum afterload value used in the experiment together with
the high preload, we will obtain the isotonic contraction with the level of shortening
corresponding to the data.
The condition 1. gives us information about the passive tissue stiffness. Thanks to the
assumption 2. we are able to calibrate the active tissue contractility. The time constant of
the simulated contraction is governed by the condition 3., which was discussed in Section
5.2.3. To obtain the level of shortening in the isotonic case according to the experiment
– condition 4. – we will have to use the right material law.
5.2.5 Adjustment of the Frank–Starling mechanism
In order to adjust the Frank–Starling mechanism by means of the dependence of the max-
imum generated stress on the length of the fiber, we will be using the experimental data
from the isometric contractions both with the high and the low preload. The function
d(ec) in equation (5.2) needs to be adjusted so that the simulations with the adequate
combinations of preload and afterload values lead to the isometric contractions.
The high preload gives maximum properties with respect to the Frank–Starling mech-
anism. Therefore, d(ec) = 1 for ec = 0.28 (the extension using the high preload). When
using the lower preload, the fiber extension is around 7% and the maximum generated stress
corresponds approximately to half of the stress values generated using the high preload.
Therefore, d(ec) ∼ 0.5 for ec = 0.07.
In fact, the function d of a shape in agreement with the curve in Figure 2.9 (left) and
with the quantitative properties listed above would be very steep for negative values of ec,
hence the fiber would hardly shorten below the initial length. We decided not to modify
the implementation of the Frank–Starling mechanism at the moment and rather make the
function d constant when the fiber length is below the value obtained with the low preload
passive extension, as is illustrated in Figure 5.5.
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Figure 5.5: Frank–Starling curve applied in the model.
5.3 Results
We performed the model calibration according to Sections 5.2.4 and 5.2.5. The model
parameters were adjusted so that we obtain isometric contractions for both the high and
the low preload values and the corresponding afterloads, and the isotonic contraction with
a given shortening level for the high preload.
To simulate all the remaining curves to be compared with the measured data, we fixed
the model parameters and input the combinations of the preload / afterload values as used
in the experiment. The measured data and the simulations are plotted in Figure 5.6.
As we can see, the simulated extension curves are directly comparable with the experi-
mental values for the high preload. We managed to adjust the Frank–Starling mechanism
so that the shortening with the low preload is also quite accurate, except for the case in
which the fiber is contracting against the preload itself.
5.4 Discussion
During the experiment, the level of initial fiber extension was not measured. It is probably
due to the fact that the error in measuring the non-extended fiber would be very high. In
the simulation setup, we used the unstretched fiber as a reference configuration and we
assumed that the fiber extension was 28% for the high preload value. In a more detailed
study, we should explore the possibilities of measurement of this value.
We adjusted the material viscosity so that the fiber would not stay in the contracted
state after the end of activation. This phenomenon is pronounced for low values of after-
loads, if the viscosity is high. We set up the parameter kATP so that the timing of the
simulated contraction–relaxation cycle corresponds to the experiment. By this approach,
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(a) Relative extension vs. time plots.






























(b) Stress vs. time plots. Maxima of the stresses characterize afterload values.
































(c) Strain rate vs. time plots.
Figure 5.6: Experimental data (left column) and simulations (right column). The con-
tractions with the high preload are plotted with solid lines, the contractions with the low
preload with dashed lines. 128
we obtained the correct duration of the activation. The maximum simulated strain rate
was higher in the simulation than in the experiment. To treat this issue, we would need to
perform further – more detailed – analyses taking into account both the viscous elements
and the time constant of the active part.
The exponential law is more suitable for adjustments of the stress–strain law in the
contraction part. Unfortunately, we would need the relation to be quite flat in the con-
traction part and steeper in the relaxation part. This is not possible using the standard
exponential law, since the behavior is quite symmetric. We would need a law in which the
two parts can be adjusted separately.
The contraction with the low preload is prevented by the Frank–Starling mechanism.
Our implementation of the Frank–Starling mechanism is based on the modification of
the active stress according to the actual strain. We managed to obtain the isometric
contraction for adequate afterload values for both preloads. However, Figure 5.5 shows
that the Frank–Starling curve used in the model – although it gives reasonable levels
of shortening compared with our experimental data – does not correspond to the typical
Frank–Starling curve for low strain levels (see Figure 2.9). We may consider the mechanism
not to be dependent only on the actual strain level but also on the stress in the fiber, as
was shown in [20].
The simulated shortening levels corresponded to the experimental data except for the
contraction against the low preload. When the low preload was applied and the fiber
was contracting against the preload alone, the measured shortening was ∼30% while the
simulated only ∼20%. To improve this aspect, we should investigate some other material
laws and also revise the implementation of the Frank–Starling property. We should also
consider that there could have been a measurement error for this particular combination
of the loads and try to reproduce some other data sets.
The shape of the simulated stress curves is deteriorated by the mass effect (the ‘over-
shoot’ in the beginning of the contraction and ‘undershoot’ in the beginning of the relax-
ation. We think that it is possible that this effect is present also in the experiment but
filtered in the measured stress curves. Secondly, oscillations in simulations during relax-
ation are caused by the 1D model implementation (contact problem between the fiber and
the surface on which the fiber tip with the load lands). We can consider some damping
property in this contact boundary condition in order to prevent these oscillations.
5.5 Conclusions and perspectives
In this Chapter, we showed that the model is able to represent the physiologic contraction of
the myocardial fiber – and we can obtain shortening levels corresponding to the simulations.
We observed some non-physiological phenomena related to the parameters used in the
model and we were able to avoid them to some extent by adjusting parameter values
directly related to these effects. We can further explore the passive properties of the model
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in order to obtain results even closer to the simulations. For the Frank–Starling mechanism
implementations, we would like to use data sets with more preload values in order to obtain
more reference points of the curve given by the function d.
The 1D model is a fast way to test some model situations, new implementations or
effect of some regulations on the local level. In the future, we may keep using the 1D setup
for validating certain properties of the model which would be difficult to observe in the full
3D case.
5.6 Appendix: Implementation of exponential law in 1D
model
The right Cauchy–Green tensor C = F TF , where deformation gradient is given by F =
1 +∇
ξ
y (gradient with respect to the reference configuration) is given by:
C =




The strain tensor C represents deformation in the longitudinal direction with incom-
pressibility assumption taken into account (detC = 1).
The invariants of the tensor C are:





((trC)2 − trC2) = 2C1/2 + C−1,
I3 = detC = 1. (5.6)
We introduce reduced invariants defined by the following formulas: J1 = I1I
−1/3
3 , J2 =
I2I
−2/3
3 , J3 = I
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W is a hyperelastic potential characterizing the type of material against the Green–
Lagrange strain tensor E = 12(C − 1). The second term is associated with the incom-
pressibility condition. We assume that the radial stress is zero since there is no loading


























The hyperelastic potential is given by the following formula:
W = κ1(J1 − 3) + κ2(J2 − 3), (5.8)





















































(2(1− C−3/2)− C−3/2(1− C3/2)) + 2κ2
3
(2(C−1/2 − C−2))− C−3/2(C−1/2 − C))
= 2(1− C−3/2)(κ1 + C−1/2κ2).
Since C = (1 + yx)




= 2(κ1 + κ2(1 + yx)
−1)(1− (1 + yx)−3κ2).
Consequently, the derivative with respect to yx is
∂Σxx
∂yx
= 2(κ1 + κ2(1 + yx)
−1(−3(1 + yx)−4)) + 2κ2(−1)(1 + yx)−2(1− (1 + yx)−3).
5.6.2 Exponential law
The hyperelastic potential include the same terms as the the Mooney–Rivlin material and
additionally the exponential term:
W = WMR +Wexp = κ1(J1 − 3) + κ2(J2 − 3) + c0ec1(J1−3)2 . (5.9)
The 2nd Piola-Kirchhoff stress along longitudinal direction is given by (5.7) and can
be split into the part corresponding to Mooney–Rivlin terms and to the part given by the








































where J1 = I1I
−1/3
3 = I1 = C + 2C
−1/2, since I3 = 1 is an incompressibility assumption.
Finally,













= ΣMR + 4c0c1e
c1(I1−3)2(I1 − 3)(1− C−3/2).























2C1/2(1− C3/2)2 (2c1(J1− 3)2 + 1)+ 3C−2(J1− 3)) .
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Chapter 6
Validation of the model using
animal experiments
This chapter is adapted from [22].
6.1 Introduction
Personalized – or patient-specific – biomechanical modeling of the heart represents a
tremendous challenge for clinical applications [99]. In such endeavors, the predictive capa-
bilities of the model – namely, its ability to adequately simulate the various phenomena of
concern in a given clinical application once the relevant parameters have been calibrated
– is crucial, not only to represent normal behavior, but also pathologies, since personalized
modeling aims at diagnosis and prognosis assistance.
The present work pertains to the clinical assessment of a biomechanical heart model
used to represent the effect of acute myocardial infarction, with animal data providing
a controlled infarct condition with a follow-up over several weeks. First, we set up the
personalized model using data coming from the healthy animal. We will show that the
model simulations compare quite accurately with the measured data, both for the tissue
motion and for the blood pressures. The second part deals with the modeling of an acute
myocardial infarction using the same biomechanical model with locally modified material
properties, with a detailed assessment of the simulated indicators.
6.2 Experimental data
The experimental data1 consisted of animal data obtained with a farm pig of 25kg. The
in vivo study was approved by the Institutional Animal Care and Use Committee of ‘Fac-
1For the Experimental protocol proposed during the planning of the animal experiments, see Appendix
10.
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ulte´ de Cre´teil’, France. The animal was housed and cared according to European Union
Standards. Before each data acquisition, the subject was premedicated with intramuscu-
lar Ketamin (15 mg/kg), anesthetized with Propofol (0.35 mg/kg intravenous bolus and
0.05 mg/kg/min continuous infusion), intubated and ventilated, see [42] for the details.
The subject was examined and data acquired once in a baseline condition (physiological
heartbeat).
Then, antero-septal myocardial infarction was induced by a 120-min occlusion of the
mid-left anterior descending coronary artery, using a balloon catheter, followed by reflow.
Such an occlusion led to an extended myocardial infarction, as was proven in the follow-up
by the late-enhancement MR images. The animal was re-examined 10 and 38 days after the
infarct creation. The corresponding stages are referred to as baseline, T0+10 and T0+38
in the sequel. The T0+10 data acquisition corresponds to the acute stage (edematous
necrotic tissue with only slightly diminished wall thickness), while at T0+38 we could
already expect – and indeed observed – thinning of the LV wall (caused by resorption of
the necrosis and tissue remodeling).
In each of the studied stages (baseline, T0+10 and T0+38), non-invasive MR image
data were acquired and pressures in the heart cavities and large vessels were measured.
The image data were acquired using a Philips Achieva 3 T MR system (200 mT/m/ms
slew rate, maximal gradient strength 80 mT/m, 32-channel phased-array cardiac coil). The
following types of MR data were were obtained:
• kinematics of the heart in the short and long axis views
– Cine in retrospective ECG gating (segmented FLASH, flip angle 15 ◦, TR∼6 ms,
TE∼3.5 ms, turbo factor 5, SENSE 1, acq. matrix 210 x 160, voxel size
1.5 x 1.7 x 8 mm, 40 time frames / cardiac cycle)
– tagged Cine data in prospective ECG gating (segmented FLASH with SPAMM,
flip angle 10 ◦, TR∼8 ms, TE∼4.5 ms, turbo factor 4, SENSE 1, acquisition
matrix 200 x 150, voxel size 1.3 x 1.4 x 7 mm, tag spacing 7 mm, 19 time frames
/ cardiac cycle without echo sharing)
• visualization of the infarct by means of the late-enhancement technique (gadolin-
ium chelate contrast agent – gadoterate dimeglumine, Dotarem, 0.2 mmol/kg, T1
weighted gradient echo, 3D acquisition, flip angle 15 ◦, TR∼5.0 ms, TE∼2.4 ms, TI
∼ 220 ms, turbo factor 32, SENSE 2, acquisition matrix 175 x 175 x 15, voxel size
1.5 x 1.5 x 5 mm, magnitude and phase sensitive reconstructions)
• visualization of the infarct and the tissue edema using T2-weighted images with an
inversion recovery to suppress the fat (TR∼1700 ms, TE∼60 ms, TI∼180 ms, turbo
factor 20, acq. matrix 200 x 160, voxel size 1.8 x 1.8 x 8 mm)
• 2D flow through the aortic and mitral valve (phase contrast imaging in retrospective
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ECG gating, flip angle 10 ◦, TR∼6.0 ms, TE∼3.5 ms, turbo factor 2, SENSE 1, acq.
matrix 160 x 160, voxel size 2 x 2 x 8 mm, 40 time frames / cardiac cycle)
The pressures were measured invasively by means of retrograde catheterization (aortic
and left ventricle pressure) and by antegrade catheterization (right atrium, right ventricle,
pulmonary artery and pulmonary capillary wedged pressure).
6.3 Biomechanical model
6.3.1 Model formulation
The biomechanical model used here – described in Chapter 4 and detailed in [95] – is
based on physiological considerations and is consistent with essential thermomechanical
requirements (energy balances in particular), preserved from the continuous dynamical
equations to the discrete versions used for numerical simulations. We also refer to [23] for
another example of some physiological simulations performed within the same modeling
framework.
The heart tissue is modeled as an active 3D viscoelastic material. It contains a 1D
active component in the direction of the myocardial fibers, modeled according to [12]. The
external blood circulations are represented by Windkessel models [74].
6.3.2 Anatomical model
The cardiac anatomy was obtained by segmenting a diastolic time frame of the Cine MR
images preceding the atrial contraction, a state considered as a reference (stress-free) con-
figuration of the heart. Segmentation of the left and right heart ventricles in this particular
time frame image was performed manually using the CardioViz3D software [107]. Thanks
to the anesthesia of animal, the position of each slice of Cine MRI was very reproducible
and we did not need to perform any spatial registration.
Then a computational mesh was built in the segmented geometry using the Yams and
GHS3D meshing tools [41], see the resulting mesh in Fig. 6.1.
Fiber directions – needed in the biomechanical model as privileged directions of con-
traction – were prescribed in the same anatomical model based on general anatomical
knowledge [101]: -60/60 degrees in LV, -50/50 degrees in RV, from epicardium to endo-
cardium, see Fig. 6.1.
6.3.3 Electrical activation of the model
In all simulations we used a simple electrical activation pattern in which the depolarization
times were prescribed analytically by a planar wave propagating from the apex to the base
of the heart along the long axis, see Figure 6.2. The propagation velocity was adjusted
so that the whole myocardium would be activated in a time period corresponding to the
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Figure 6.1: Computational mesh for baseline (left) and generic fibers prescribed in the
mesh (right).
measured QRS duration (QRSd). The action potential duration in the simulation was kept
constant over the whole myocardium, and was adjusted according to the Cine MRI data.
6.3.4 Calibration of mechanical parameters of the model
The model parameters were calibrated for the baseline condition, namely, in the healthy
heart. Tissue contractility and passive tissue stiffness were calibrated to obtain good ad-
equacy of the ventricular pressures and global motion compared to the measured data,
including the LV pressure time derivative dp/dt and the ejection fractions. Correct peak
ventricular pressure and the pressures in large arteries (aorta and pulmonary artery) were
obtained by calibrating capacitances and resistances of the Windkessel models.
6.3.5 Modeling of the infarct
For each of the post-infarct stages, a new anatomical model was created by segmenting
MR images in the same way as for the baseline condition. Additionally, we segmented the
infarcted tissue using late enhancement images and projected it in the mesh (see Fig. 6.3).
The initial aortic pressure and values of atrial pressures were taken from the measurements.
The heart rate and duration of the heart contraction were adjusted to the MR image data.
In order to represent the impact of the infarct on the tissue, we decreased the contractility
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(a) 0 ms – end-diastole (b) 40 ms (c) 50 ms (d) 60 ms (e) 70 ms
(f) 80 ms (g) 90 ms (h) 100 ms (i) 110 ms (j) 310 ms – end-
systole
Figure 6.2: Analytical prescription of the electrical activation at the baseline stage: the
red activation planar wave propagates from the apex to the base. The activation offset
between the apex and the base corresponds to the measured QRSd.
Parameter Baseline T0+10 T0+38
contractility σ0 σ0/5 (infarcted region) σ0/5 (infarcted region)
stiffness κ1 κ1 ∗ 10 (infarcted region) κ1 ∗ 10 (infarcted region)
minimum aortic pressure 73 mmHg 53 mmHg 89 mmHg
activation duration 220 ms 275 ms 246 ms
left atrial pressure 12 mmHg 12 mmHg 20 mmHg
Table 6.1: Parameter values modified in infarction model.
and increased the passive stiffness in the regions concerned, as segmented from the late-
enhancement MR images. All other parameters of the model were kept exactly as in the
baseline simulation. We summarize the parameter variations in Table 6.1.
6.3.6 Results
In Figure 6.4 we compare the simulated and measured pressures and volumes in the main
compartments, for each of the three stages.
The heart motion is more accurately confronted with experimental data by plotting the
model contours within MR images, see Figs. 6.5, 6.6 and 6.7. We also produced synthetic
tagged images from the model simulations, which are compared with experimental ones in
Fig. 6.8.
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Figure 6.3: Infarct at T0+38: in the mesh (left, in red) as segmented from the late en-
hancement MR images (right, yellow arrows).
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Figure 6.4: Volumes and pressures: baseline (left), T0+10 (in the middle), T0+38 (right).
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Figure 6.5: Baseline: Initial configuration (top) and end-systolic time frame (bottom), with
model contours in purple.
Figure 6.6: T0+10: Initial configuration (top) and end-systolic time frame (bottom), with
model contours in purple.
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Figure 6.7: T0+38: Initial configuration (top) and end-systolic time frame (bottom), with
model contours in purple.
Figure 6.8: Comparison of MR and synthetic tagged images for baseline (left four images)
and T0+10 stage (right four images). End-diastolic time frames are displayed in the upper
row, end-systolic time frames in the lower row.
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6.4 Discussion
There were no signs of dyssynchrony of the heart contraction in the Cine MRI at any stage
of the experiment and the width of the QRS complex was physiological as well. Therefore
we used the same electrical activation pattern – analytically prescribed representing the
physiological activation – for all the stages.
Left ventricular volumes plotted in Fig. 6.4 are not directly accurate. This is mainly
due to the fact that simulated and measured volumes are not computed based on the same
regions. Simulated volumes take into account the model cavities approximately up to the
valve plane, whereas measured volumes are taken in a truncated anatomy between two fixed
sections in the image space. Hence, in Figure 6.4 we also show a shifted simulated volume to
account for this difference. Nevertheless, these curves are mainly to be considered to assess
the timings of the cardiac cycle, as detailed motions are directly assessed by comparing
images and model contours.
The simulated and measured pressure values are found to be in very good overall
agreement at the three stages. We note that the systolic pressure increase rate (dp/dt)
is somewhat underestimated in the simulations at the infarcted stages. This may be due
to an increase in the contractility resulting from growth combined with an adaptation
mechanism of the cardiovascular system. In a larger study a mini-pig should be used
(instead of a young subject) to avoid the influence of growth and young age specificities in
the post-infarct follow-up.
The comparison of model contours with image also demonstrates a very good adequacy
of the simulated motion. The main discrepancy is to be observed near the base, which is
due to artificial boundary conditions which must be imposed in this region to account for
the truncated part of the anatomy. The akinetic region (in the anterior and antero-septal
apical and mid-cavity segments) is clearly visible – both in the images and in the model
– and is even more pronounced at T0+38.
The synthetic tagged images in the baseline clearly show that the simulation of the
healthy heart is very accurate in all segments of the left ventricle. The akinetic region seen
in the T0+10 clinical tagged images is also well captured in the synthetic tagged images,
although the anterior segment shows some slight thickening in the simulation. This is likely
to be due to the difficulty of accurately assessing the extension of the infarcted region in
the acute stage with the late enhancement images.
Therefore, according to the various indicators considered, by changing just a few rel-
evant physiological parameters we obtain a very good adequacy between simulations and
experimental data.
6.5 Further perspectives
This infarct model was considered in a case without any other co-morbidity factor. For a
real patient, other factors (e.g. electrical activation pathologies) should be taken into ac-
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count in the model. In addition, other artificial infarct protocols may be used, in particular
since reversible occlusion may have a limited impact (tissue stunning, see [63]). From the
follow-up of the animal in the present case, we can see that the tissue was really massively
infarcted. Furthermore, we prefer reversible occlusion since it is more usual in patients in
today’s treatments of the myocardial infarction.
We emphasize that other physical variables can be obtained from the model simulations,
such as stresses which may be essential to better understand some physiological phenomena
involved in tissue remodeling, in particular.
A detailed study of the influence of the key physical parameters – namely, contractility
and tissue stiffness – should be undertaken. This may be automatized by performing
estimation of these parameters [99]. The experimental data can also be used in a global
estimation procedure to correct the various model variables, hence to obtain improved
motion fields and pressures, see [80]. This is in fact necessary to obtain a correct estimation
of the parameters.
6.6 Conclusions
We showed that our biomechanical model of the heart can be personalized and calibrated to
accurately reproduce the pressures and motion measured in a healthy animal subject. Then,
we demonstrated that we can also adequately represent the behavior of the acutely infarcted
heart by changing only the parameters directly related to the pathology (contractility and
stiffness in the infarcted area) and to the physiological state of the subject during the exam
(atrial and aortic blood pressure, heart rythm).
Of course, a more extensive validation – with numerous animal and human data-sets
– is required to show that this personalized modeling strategy can be valuable in clinical
applications. Further perspectives include automated estimation of the relevant physiolog-






7.1 Cardiac Resynchronization Therapy (CRT)
Cardiac Resynchronization Therapy (CRT), also called biventricular pacing, is a non-
pharmacological therapy for patients with an advanced heart failure. Such patients very
often have an abnormal electrical conduction in the heart, such as an atrio–ventricular
block or an intraventricular conduction delay. The latter is often manifested as a left bun-
dle branch block (LBBB). In an LBBB, the lateral wall of the left ventricle (LV) may start
to contract with a delay of as much as 100 ms with respect to the initiation of the septum
contraction. The physiological offset between the activation of the septum and of the LV
lateral wall is less than 40ms1, see Figure 7.1 on the left.
The period of depolarization of the ventricles is directly mirrored by the QRS complex
of the electrocardiogram (ECG). A typical ECG sign of prolonged ventricle activation is
an extended QRS complex with a modified configuration of each wave. A QRS duration
(QRSd) greater than 120 ms is considered to be non-physiological but it is a non-specific
sign. Indeed, we cannot distinguish e.g. between an inter–ventricular conduction delay (a
delay between the LV and RV activation) or an intraventricular delay (in which a conduction
block is localized in the LV) just from the QRSd. Some typical QRS complex deformations
and diagnostic criteria for LBBB and RBBB are depicted on the right side of Figure 7.1
and can be summarized as follows ([70, Chap. 12]):
LBBB
• QRSd ≥ 120ms
1The whole endocardial portion of the myocardium is activated in about 30 ms thanks to the fast
conduction system of Purkinje fibers, see Section 2.3.3 and [46].
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Figure 7.1: Left: Isochrones of activation times (in ms) for the heart ventricles in physio-
logical case. Right: Typical ECG signs of RBBB and LBBB. From [70].
• Broad R waves in lateral precordial leads (V5 and V6) and usually also in leads I,
avL
• Small or absent initial r waves in right precordial leads (V1 and V2) followed by deep
S waves
RBBB
• QRSd ≥ 120ms
• Broad R waves (rsr’, rsR’, or rSR’ patterns) in right precordial leads (V1 and V2)
• Wide and deep S waves in left precordial leads (V5 and V6)
The echocardiographic or Cine MR image of the LBBB often includes the so-called
septal flash. It consists of a rapid septal movement towards the LV cavity at the very
beginning of the systole when the septum is being activated. As soon as the LV lateral
wall becomes activated and contracts, the resulting pressure increase pushes the septum
back towards the right ventricle. The time period of the septal flash can serve as an
indicator of the offset between the activation of the septum and LV lateral wall.
CRT is based on cardiac pacing in the right and in the left ventricle. Therefore it
may decrease the dyssynchrony of the ventricle contraction. The pacing leads are usually
placed in the right atrium (RA), right ventricle (as in the usual DDD pacing2), and an
additional lead is placed in a lateral branch of the coronary sinus3. While the RV lead
2The first ’D’ stands for a dual pacing (RA and RV), the second ’D’ – dual sensing (RA and RV), the
third ’D’ – the sensed event can both inhibit or activate the stimulation.
3For the coronary vein anatomy we refer to Figure 2.2.
145


















































Figure 7.2: Left: Physiological LV pressure curve (in blue) and its time derivative dp/dt
(in green). Right: LV pressure and LV dp/dt in LBBB. Note that the maximum value
of the LV dp/dt in the physiological activation is ∼ 1500 mmHg/s, while it is less than
1000 mmHg/s in this particular example of the LBBB.
paces in the RV endocardium, the coronary sinus lead stimulates the epicardial part of the
LV. Combinations of more than 3 pacing leads may be used, and the offset between each
of them can be adjusted.
A long term pacing on the LV endocardium surface is technically more complicated.
The lead needs to cross the inter-atrial septum from the RA to the LA and eventually reach
the endocardial part of the LV via the mitral valve. The implantation issue is definitely not
invincible and for example mathematical modeling could give some objective motivations
for launching a large study comparing LV epicardial / LV endocardial pacing strategies.
Several clinical studies have shown that patients may profit from the CRT. Among them
for instance the MIRACLE study (started in 1998, [1]), COMPANION study (started
in 2000, [18]) or CARE–HF study (started in 2001, [28]). Nevertheless, up to 30% of
the indicated patients turn out to be non-responders ([57]). All those facts raise many
questions about CRT optimization, as for example: ’What would be the best number of
the pacing leads, which position would be optimal and what would be the optimal offset
for each pacing lead?’ The final goal of any modeling effort would be to determine whether
a particular patient could benefit from the CRT and what would be the best set up of the
CRT in his (her) case.
An immediate effect of the CRT can be assessed by measuring the left ventricle pressure
and its time derivative (LV dp/dt). The maximum value of LV dp/dt quantifies the ability
of the ventricle to build up the pressure. While the normal value of the max LV dp/dt is
1500–2500 mmHg/s, the value can be even lower than 500 mmHg/s in a dyssynchronous
heart contraction, see Figure 7.2. The value of max LV dp/dt may also be decreased in a
synchronous contraction due to decreased contractility.
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In this study4, we would like to set up patient-specific biomechanical models that would
be able to represent the baseline situation (LBBB) by means of the motion pattern and
of the simulated and measured LV pressures and LV dp/dt. Once the model is adjusted
properly, we will fix all the model parameters. By varying the electrical activation according
to the CRT pacing patterns, we would like to show that the model is able to predict the
changes of the LV dp/dt according to the measurements.
In the first part, analytical prescriptions of the electrical activation will be used. The
objective will be to show that by using relatively simple activation patterns calibrated
according to some typical motion signs visible in the Cine MRI, we can represent the
baseline stage. Then, by making the artificial electrical activation more synchronous, we
would like the value of the max LV dp/dt to increase.
In the second part, we will be using patient-specific electrical activation patterns ob-
tained by post-processing data from an electrophysiological (EP) study, both for the base-
line stage and for all the pacing modes. We will directly compare the results of the simulated
values of max LV dp/dt with the measured values. The aim of this study is to assess the
model predictivity with respect to this particular indicator of the LV function.
7.2 Methods
7.2.1 Patient selection
The patients included in this study suffered from an advanced heart failure (NYHA5 III-
IV) and a dyssynchronous heart contraction with the LBBB pattern and were indicated
for the CRT. The etiology of the heart failure (HF) was either an ischemic heart disease
(IHD) or a dilated cardiomyopathy (DCM). The patients are listed in Table 7.1.
7.2.2 Measured data
The measured data consist of the non-invasive cardiac magnetic resonance imaging data
(CMR) acquired in the baseline condition and of the invasively measured electrophysiolog-
ical data and LV pressures in the baseline and for each CRT pacing pattern.
Cardiac MRI
Cardiac MR (CMR) data were acquired in the baseline condition using the MR system
Philips Achieva 1.5 T. The CMR consisted of the standard Cine MRI sequences (to ob-
4The work was performed in co-operation with King’s College London, St. Thomas’ Hospital in London
(where also all clinical data were acquired) and Team-Project Asclepios of INRIA, Sophia Antipolis. People
involved in the project are listed in [97].
5NYHA classes stand for the stages of heart failure according to the New York Heart Association, see
Table 2.1 in Section 2.4.1. Patients with NYHA III are comfortable at rest but any other activity causes
fatigue, palpitation, or dyspnea. Class IV patients may suffer from these symptoms even at rest.
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Patient Etiology Simulations with simulations with
of HF analytical act. patterns patient-specific act. patterns
KCL003 DCM baseline no
KCL006 DCM baseline no
KCL008 DCM baseline no
KCL009 DCM / IHD yes yes
KCL010 DCM baseline no
KCL011 IHD baseline no
(LE not segmented yet)
KCL012 DCM yes yes
KCL014 IHD yes no
Table 7.1: Patients included in the study. Note: Only electrophysiological data of KCL009
and KCL012 were processed at KCL. In other cases, analytical prescriptions of electrical
activation were used and usually only preliminary calibration of the baseline activation
(the LBBB pattern) was performed. KCL009 is a patient with DCM and some not very
extended nonviable postischemic regions.
tain the heart morphology and kinematics) and of late-enhancement images (acquired 10
minutes after administering an extracellular paramagnetic contrast agent – a gadolinium
chelate). The late-enhancement images were used to assess the non-viable myocardial tissue
and possibly to visualize a non-specific late-enhancement in some dilated cardiomyopahies.
Additional 3D morphological sequences in free breathing (using the breath-navigator) were
performed to obtain 3D diastolic images with high spatial resolution. The sequence pa-
rameters are as follows:
• Cine MRI in retrospective ECG gating (bSSFP, flip angle 60 ◦, TR ∼ 3.3 ms, TE ∼
1.6 ms, turbo factor 14, acq. matrix 224 x 168, voxel size 1.8 x 2.4 x 10 mm, 30–40
time frames / cardiac cycle)
• LE images – bSSFP with IR pre-pulse, flip angle 15 ◦, TR ∼ 4.9 ms, TE ∼ 1.9 ms,
TI ∼ 220 ms, turbo factor 30, acq. matrix 300 x 280, voxel size 1.45 x 1.45 x 10 mm
• 3D morphology in free breathing – bSSFP, 3D acquisition, flip angle 90 ◦, TR
∼ 4.7 ms, TE ∼ 2.4 ms, turbo factor 20, acq. matrix 230 x 230 x 230, voxel size
1.4 x 1.4 x 1.5 mm
Electrophysiological data
A non-contact mapping study was performed using an Ensite 3000 multi-electrode array
catheter system (St Jude, Sylmar, CA). The electrophysiological (EP) potentials were
measured by electrodes mounted on an 8 mm balloon. They were automatically projected
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Figure 7.3: Left: Measured isochrones on the LV endocardium. Right: Estimated
isochrones in the whole myocardium according to Section 7.6.
on the LV endocardial surface, where both isopotential and isochronal maps were recon-
structed (see Figure 7.3). Such non-contact multi-electrode approach can provide the EP
potentials from the whole LV endocardium surface taken during a single cardiac cycle.
Hence the measurement of the EP potentials is fast and can be performed for each electri-
cal activation pattern.
The EP data were registered to the MR data by XMR fusion (see [91]). For the
registered 3D geometries see Figure 7.4.
LV pressure data
In addition to measuring the EP potentials on the LV surface, the LV pressure was measured
using a high fidelity pressure sensor for each electrical activation pattern. The pressure
data were automatically processed and the time derivative of the LV pressure (LV dp/dt)
was obtained. Both curves – the LV pressure and the LV dp/dt – were recorded over several
cardiac cycles.
7.3 Creation of geometrical models
For each patient, the short axis Cine MRI (multiple 2D series, M2D) covering the whole
ventricle volumes were available with a spatial resolution of (2 x 2 x 10) mm. Some
patients had also 3D morphological data taken in diastole with a spatial resolution of
∼ (1.5 x 1.5 x 1.5) mm. M2D Cine data are not the best option for creating the geometrical
models because of the misalignment between the slices acquired in the different breath-
hold periods and a limited resolution in the slice-selection direction. Unfortunately, the 3D
morphological data were of limited quality. That is why we built the geometrical models
of all patients from the Cine MRI data.
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Figure 7.4: Fusion of late-enhancement derived scars (red surfaces), anatomical MR (vol-
ume rendering) and Ensite isochronal map (colored surface). From [98].
The models of the left and right ventricles6 were obtained by manually segmenting the
diastolic time frame image of the Cine MRI preceding the atrial contraction, using the
CardioViz3D software, see [107]. Computational tetrahedral meshes were created using
Yams and GHS3D, see [41]. The volumic mesh of the LV was subdivided into 17 segments
according to the American Heart Association (AHA) recommendations, see [21]. In patients
with an IHD and post-infarcted scars, the infarcted tissue was visualized by means of the
MR late-enhancement, and it was projected into the computational mesh.
The direction of the active contraction in the model is given by the myocardial fiber
directions. This is a reason why the prescription of fiber directions in the geometrical
model is important. We tested two possibilities:
• Myocardial fibers coming from an atlas of ex vivo canine hearts (see [88]), registered
into the actual geometry.
• Geometrical fiber prescription according to anatomical knowledge, see e.g. [101].
Although the fibers coming from the analysis of group of a animal hearts is a interesting
approach, the resulting fibers turned out to be very horizontal and there was no longitu-
dinal shortening observed in the full 3D heart model. Instead, we saw some longitudinal
elongation. On the other hand, the geometrically prescribed fibers with usual orientation
on the endocardial and epicardial surfaces and the fibers linearly interpolated inside the
myocardium gave very good results.
6The atria were excluded from the geometrical models due to the difficulty of their segmentation, and
since we are primarily interested in the modeling of the heart ventricles. Therefore, the models were trun-
cated slightly above the atrio-ventricular and semilunar valves, and full ventricle volumes were preserved.
150
Parameter of function u Value
Minimum of u -5
Maximum of u 10
tfastDepol 40 ms
trepol 150 ms
Table 7.2: Parameters of the electrical activation function u used for each patient.
7.4 Biomechanical model
The biomechanical heart model was described in Chapter 4. The objective of this study
is to apply several electrical activation patterns, representing either the baseline case (the
LBBB) or the CRT pacing modes. The electrical activation pattern will therefore serve as
an important input of the model. In the following paragraphs we will give some details
about the model activation, and about the calibration strategy.
7.4.1 Electrical activation of the model
The electrical activation of each node of the model is given by the function u, see (4.3) in
Section 4.2. The electrical activation u consists of the fast depolarization part (u increases
from umin to umax during a very short period tfastDepol), of the plateau (u = umax during a
time period tplateau) and of the repolarization phase (u drops back to umin during a period
trepol). We used a function u of the same profile for each part of the heart muscle
7, which
means that we did not vary neither umin, umax, nor the duration of fast depolarization,
plateau or of the repolarization phase over the model geometry. The plateau duration was
adapted to the duration of the systole observed in the Cine MR image data. See Figure
7.5 with a profile of the electrical activation u used in the model of a patient denoted as
KCL009 and Table 7.2 with the actual values of the parameters of the function u.
The offset of the function u between each node of the computational mesh is given
by depolarization times Td. They are either prescribed analytically or obtained by post-
processing the electrophysiological data. The two approaches will be discussed in Sections
7.5 and 7.6.
7.4.2 Calibration strategy
The calibration was performed using the MR image data and the LV pressure and LV
dp/dt measurements at the baseline. In the first steps, we did not apply the patient-
specific electrical activation patterns yet. Instead, we used the analytical prescription
7Except if the duration of the plateau or repolarization times were estimated from the EP data.
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Figure 7.5: KCL009, electrical activation function u with parameters according to Table
7.2 and with plateau duration of 250 ms.
of the activation discussed in detail in Section 7.5. At this stage, we adjusted the visco-
elastic boundary conditions and the approximate values of the main mechanical parameters
of the model – in particular of the passive tissue stiffness and of the tissue contractility –
according to the measured global functional indicators, e.g. the LV ejection fraction. These
parameters were kept constant over the whole myocardial tissue, at the moment.
In the second step, we modified the contractility and the passive tissue stiffness in the
infarcted region (for the patients after the myocardial infarction), according to the strategy
of Chapter 6 – the contractility in the infarcted region was decreased by a factor 5 and the
passive tissue stiffness was increased by a factor 10.
To personalize the model at the local level we analyzed in detail the Cine MRI data.
We focused in particular on the wall thickening during the contraction and on the end-
diastolic wall thickness in each AHA segment. Then, we adjusted the contractility values
according to the observed hypokinetic zones. Assuming that the pathologically thin parts
of the myocardial wall have undergone fibrous remodeling would justify increasing the
passive tissue stiffness in the concerned AHA segments. In fact, the thinned region is not
necessarily fibrous and may also be hibernating or stunned (see [63]), but by increasing
the passive tissue stiffness by a factor 1.5–2.0 we prevent to some extent the thin wall
from bulging – which is normally achieved by the surrounding tissues. The handling of
the boundary conditions setup is a very difficult modeling issue – see Section 4.2.5) –
and by increasing the tissue stiffness in the thin-wall zones we obtained a reasonable model
behavior compared with the image data. Some detailed information on the local parameter
values will be given in Section 7.6, which deals with the patient-specific activation patterns.
The adjustment of the Windkessel models was the last step in the model calibration.
Since the aortic, pulmonary artery and RV pressures were not measured, we had to adjust
the diastolic arterial pressures to meaningful values with respect to the measured LV end-
152
(a) time t = 150ms (b) time t = 200ms
(c) time t = 250ms (d) time t = 300ms
Figure 7.6: KCL014 using the analytical prescription of the LBBB-like pattern. The blue
part of the mesh represents the non-activated tissue, the red is the activated myocardium.
systolic pressure and according to the type of pathology.
When applying the patient-specific activation patterns, there was usually no need for
further corrections of the model. As soon as the simulated motion pattern was close enough
to the measured image data, and the simulated LV pressure and LV dp/dt corresponded
to the baseline activation, we fixed all the parameters of the model. The model was said
to be calibrated at the baseline conditions.
7.5 Analytical activation patterns
The initiation Td of the electrical activation (the depolarization time) for each node of the
computational domain is given by an analytical prescription of a planar traveling wave
starting either in the LV apex or in the septum. The propagation velocity is denoted by
v and the propagation direction is given by the vector w, which points either from the
septum to the lateral ventricle wall (simulating the LBBB-like pattern, see Figure 7.6) or
w is directly given by the LV long axis, see Figure 7.7.
We analyzed in detail 3 patients with the following sets of data: KCL009 and
KCL012 with the known QRSd8 and the measured LV pressures in the baseline and in
8Therefore the duration of the period during which the whole ventricle myocardium is activated is a
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(a) time t = 90ms (b) time t = 140ms
(c) time t = 190ms (d) time t = 240ms
Figure 7.7: KCL014 using the analytical prescription of the synchronous activation pattern.
The blue part of the mesh represents the non-activated tissue, the red is the activated
myocardium.
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activation velocity of V simulated QRSd simulated LV dp/dt
pattern propagation (m/s) (ms) (mmHg/s)
LBBB-like 0.55 170 950
LBBB-like 0.7 140 1080
apex–base 1.5 100 1540
Table 7.3: Analytical activation patterns for patient KCL009. The measured max LV dp/dt
at baseline was 890 mmHg/s with QRSd∼170 ms and the measured max LV dp/dt in
the most synchronous case (’p1TRIV pattern’) was 1450 mmHg/s with QRSd∼120ms. The
analytical activation corresponding best to the measured patterns are in boldface and in
italics.
re-synchronized stages; the third patient was KCL014 for whom only the baseline pressure
values were available.
Each patient has an LBBB pattern with a septal flash visible in the Cine MRI. This
is why we used the LBBB-like analytical pattern. The propagation velocity of the acti-
vation wave along the direction septum–lateral wall was adjusted, so that the timing of
the activation in the model would induce the septal flash corresponding to the measured
data. We observed that such a propagation velocity will also activate the whole ventricle
myocardium in the time period comparable to the measured QRSd. We calibrated the
mechanical parameters of the models according to Section 7.4.2. The resulting max LV
dp/dt of the simulations, when applying the propagation velocities adjusted with respect
to the septal flash timing, correspond to boldface lines in Tables 7.3, 7.4 and 7.5.
After obtaining satisfactory results for the LBBB-like patterns, we set out make the
analytical prescription of the electrical activation more synchronous. We either increased
the propagation velocity of the activation wave or we varied its direction and onset. Typi-
cally, we used the activation wave starting in the apex and propagating along the long axis,
instead of the LBBB-like pattern. The more synchronous the activation was, the higher
increase of the simulated max LV dp/dt was obtained. When the period of activation in
the model corresponded approximately to the QRSd of the CRT re-synchronized case, the
increase of the maximum of LV dp/dt was close to the measured data (see the lines in
italics in Tables 7.3, 7.4 and 7.5).
At this stage, we showed that the model can represent the LBBB pattern using a
very simple prescription of the electrical activation and that the simulated max LV dp/dt
is comparable to the measured value. The model is able to capture the phenomenon of
the increase of max LV dp/dt when the electrical activation becomes more synchronous,
see Figure 7.8. If the propagation direction and velocity are adjusted according to the
measured QRSd of the re-synchronzed activation pattern, the change of the max LV dp/dt
known value.
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activation velocity of V simulated QRSd simulated LV dp/dt
pattern propagation (m/s) (ms) (mmHg/s)
LBBB-like 0.5 200 585
LBBB-like 0.75 130 750
LBBB-like 1.0 100 910
LBBB-like 1.4 70 1000
LBBB-like 3.0 50 1130
apex–base 1.0 135 840
apex–base 1.4 100 960
apex–base 1.5 90 990
apex–base 3.0 65 1200
Table 7.4: Analytical activation patterns for patients KCL012. The measured max LV
dp/dt at baseline was 640 mmHg/s with QRSd∼205 ms and the measured max LV dp/dt
in the most synchronous case (’p2DDDLV pattern’) was 960 mmHg/s with QRSd∼115ms.
The analytical activation corresponding best to the measured patterns are in boldface
and in italics.
activation velocity of V simulated QRSd simulated LV dp/dt
pattern propagation (m/s) (ms) (mmHg/s)
LBBB-like 0.5 180 750
apex–base 1.0 105 940
apex–base 3.0 65 1200
Table 7.5: Analytical activation patterns for patients KCL014. The measured max LV
dp/dt at baseline was 720 mmHg/s with QRSd∼180ms.
156




















data, cardiac cycle #6
simulation




















data, cardiac cycle #6
simulation
Figure 7.8: KCL014 using the analytical prescription of LBBB-like pattern. The red
solid curve represents the measured LV dp/dt in the baseline, the blue dashed curve is
the simulated dp/dt using the LBBB-like activation (left, electrical activation according to
Figure 7.6), or the synchronous activation with the apex–base propagation (right, electrical
activation according to Figure 7.7).
in the model is acceptable with respect to the measurements. In the following section, we
will be dealing with detailed patient-specific electrical activation patterns.
7.6 Ensite based patterns
7.6.1 Modeling of the patient-specific electrical activation based on the
electrophysiological Ensite data
The electrical activation was obtained by EP measurements of the LV endocardial poten-
tials by means of the Ensite system, see Section 7.2.2. The Eikonal model given by equation
(4.7) was used to estimate the depolarization times in the whole myocardium. The Eikonal
model was adjusted by researchers at King’s College London (KCL) according to [26] and
the depolarization times for each part of the myocardium Td were estimated. It is more
difficult to obtain the action potential duration (APD) from the Ensite data, because of
a problematic identification of the repolarization T wave. Nevertheless, the repolarization
times were estimated in some of the activation patterns of patient KCL009. In all other
cases we used the constant APD corresponding to the duration of contraction in the Cine
MR images and in the measured LV pressure curves. Thanks to the long repolarization
phase – the time period when the electrical activation function u decreases from the max-
imum back to the minimum value – the differences in real APDs were to some extent
smoothed.
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Figure 7.9: KCL009, inferior view on the computational mesh with two infarcted regions
(in red and green colors).
7.6.2 KCL009
Baseline (LBBB)
KCL009 is a sixty year old woman with heart failure of class NYHA III. The etiology of the
heart failure is a non-ischemic DCM with no flow-limiting disease on coronary angiography
although cardiac MRI showed two post-ischemic scars of moderate sizes (in the apical
infero-lateral and in the basal infero-lateral segments), see Figure 7.9. The LV ejection
fraction was approximately 25%. The surface ECG demonstrated significant conduction
disease with a left bundle branch block (LBBB) and a QRS duration of 154 ms.
The model calibration strategy was described in detail in Section 7.4.2. Here, we add
a few particular details of the patient-specific set up:
• Duration of plateau of the electrical activation function u: 250 ms for the baseline
(see Figure 7.5) and 200 ms for the paced modes9.
• Contractility is decreased by a factor 2 in AHA 2, 3, 8, 9 (basal and mid-cavity septal
segments).
• Passive tissue stiffness is increased by a factor 1.5 in AHA 12, 13, 15, 16 (the thinnest
parts of the LV wall).
9We identify the action potential duration (APD) with duration of the plateau of u. The cardiac tissue
is activated for a longer time period due to a long repolarization phase.
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Figure 7.10: KCL009, baseline simulation. Reference segmented image (diastole, on the
left) and the end-systolic image as an output of the direct simulation (on the right). Orange
color represents contours of the biomechanical model.








Table 7.6: KCL009: Measured and simulated values of max LV dp/dt.
In Figure 7.10 we superposed the simulated mesh contours in the Cine MRI data. The
simulated pressure and volume indicators are depicted in Figure 7.11.
Pacing modes
All the model parameters were kept exactly as they had been calibrated in the baseline.
For each pacing pattern, we input in the model the electrical activation estimated from
the Ensite data. In Figures 7.12, 7.13, 7.14 and 7.15 we compared LV pressure and dp/dt
curves predicted by the simulation vs. measured during the EP-procedure. Numerical
values of maximum values of the LV dp/dt are listed in Table 7.6.2 and plotted in Figure
7.16.
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(b) Simulated Pressure–Volume curves














































data, cardiac cycle #3
simulation
(c) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #3
simulation
(d) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.11: KCL009: baseline simulation.
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data, cardiac cycle #13
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #13
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.12: KCL009: AAI pacing pattern (1 pacing lead placed in the RA).
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data, cardiac cycle #5
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #5
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.13: KCL009: DDDRV (pacing leads placed in the RA and in the RV).
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data, cardiac cycle #16
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #16
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.14: KCL009: DDDLV pacing pattern (pacing leads placed in the RA and LV
endocardium).
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data, cardiac cycle #5
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #5
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.15: KCL009: P1TRIV pacing (pacing leads placed in the RA, RV, LV endo-
cardium and a lateral branch of the coronary sinus).
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The patient KCL012 is a seventy seven year old woman with a developed dilated cardiomy-
opathy (DCM). She was in NYHA class III heart failure with an LV ejection fraction of
15% and a left bundle branch block (LBBB) with a QRS duration of 200 ms. There was
no post-infarct scar in the late-enhancement images but a functional block was observed
in the electrophysiological mapping.
In the set up of the patient-specific model we modified in particular the following
mechanical parameters of the model:
• Contractility was decreased by a factor 1.5 in the septum since it was visibly less
contractile than the LV lateral wall.
• In agreement with [70, Chap. 64], we supposed that the DCM is usually accompanied
by interstitial fibrosis. Therefore we increased the passive tissue stiffness by a factor
1.5 in the whole myocardium.
As we can see in Figures 7.17 and 7.18 the simulated local motion and LV pressure
correspond well to the measured data (Cine MRI, pressure in the LV cavity). The simulated
LV dp/dt slightly overestimates the measured value. All other simulated pressures (the
aortic, RV and pulmonary artery pressures) are meaningful with respect to the measured
LV pressure and to the known pathology.
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Figure 7.17: KCL012, baseline simulation. Reference segmented image (diastole, on the
left) and the end-systolic image as an output of the direct simulation (on the right). The
red color represents contours of the biomechanical model.






Table 7.7: KCL012: Measured and simulated values of max LV dp/dt.
Pacing modes
As in patient KCL009, we kept all the parameters of the model exactly as they had been
calibrated in the baseline. For each pacing pattern, we used the electrical activation esti-
mated from the Ensite data as a model input. In Figures 7.19, 7.20 and 7.21 we compared
simulated (predicted) LV dp/dt curves with the measured ones. The values of max LV
dp/dt are listed in Table 7.6.3 and plotted in Figure 7.22.
7.7 Discussion
7.7.1 Measured pressure values
For each activation pattern, the LV pressure was measured during 7–15 cardiac cycles. In
all patients, the maximum pressure value oscillated within the respiratory cycle. Although
the max LV dp/dt was more stable comparing with the LV pressure variations in between
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(b) Simulated Pressure–Volume curves














































data, cardiac cycle #7
simulation
(c) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #7
simulation
(d) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.18: KCL012: baseline simulation.
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data, cardiac cycle #2
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #2
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.19: KCL012: AAI pacing pattern (1 pacing lead placed in the RA).
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data, cardiac cycle #10
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #10
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.20: KCL012: Biventricular pacing (pacing leads placed in the RV endocardium
and a lateral branch of the coronary sinus).
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data, cardiac cycle #2
simulation
(a) LV pressure in measurement (red line) and in simulation (blue dashed line)










































data, cardiac cycle #2
simulation
(b) LV dp/dt in measurement (red line) and in simulation (blue dashed line)
Figure 7.21: KCL012: p2dddlv pacing (pacing leads placed in the LV endocardium and a
lateral branch of the coronary sinus).
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Figure 7.22: KCL012: Comparison of measured and estimated values of max LV dp/dt for
all activation patterns.
the cardiac cycles, in some patterns the values varied quite significantly as well. Usually,
there were some extrasystoles present in the data. Although they were directly visible in
the measurement record, we did not try to detect them automatically. If we wanted to
create an average cardiac cycle over several heartbeats, we would have to automatically
find the cycles in the expiration and exclude those initiated by the extrasystole. We decided
to compare the simulated results with one particular cardiac cycle taken in the expiration
phase, that was not initialized by the extrasystole. Then, to see variations in the maximum
LV pressure and dp/dt values, we superimposed the simulated curves in the pressure record
with all measured cardiac cycles.
The aortic and the RV pressures were not measured during the study. Nevertheless,
when adjusting the model we were careful to obtain consistent values for those pressures
with respect to the measured LV pressures and to the patient’s pathology. It is very likely
that for instance the RV pressure may to some extent influence the LV dp/dt and modify
the septal flash pattern. An increased RV pressure prevents the septum from returning
back into the RV and the septal flash is getting less pronounced. Adjusting the Windkessel
models without the measured aortic pressure is also problematic. As we saw in examples
of three patients (KCL009, KCL012 and KCL014), the end-systolic LV pressure may vary
significantly between two subjects, e.g. according to the level of the heart failure. By
increasing the resistance in the Windkessel model, we would increase the end-systolic LV
pressure but the LV ejection fraction would decrease. The measured aortic pressure would
facilitate the Windkessel model calibration. These are some reasons why we would like to
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have the RV and aortic pressures measured in future patients.
7.7.2 Personalization of the biomechanical model
The main mechanical parameters of the model were calibrated manually. Although we
projected the nonviable infarcted scar in the computational meshes of the patients with
the IHD, the variation of the parameters just between the non-infarcted vs. infarcted part
of the heart would not be sufficient. It is caused by the fact that the progression of the
IHD over the LV is not uniform and therefore some viable regions may be more kinetic
than the others. In the calibration of the passive tissue properties, we assumed that the
thin parts of the ventricle had undergone some fibrous remodeling (especially in the DCM
patients), therefore we increased the passive tissue stiffness there.
Manual adjustment of the mechanical parameters is a time-demanding process and is
subjected to errors in performing the model adjustments. Automatic procedures based on
data assimilation techniques (parameter estimation) would be very helpful in this respect.
In Chapter 8 we performed an estimation of the contractility parameter in a ‘controlled
infarct’ – the infarct created during an animal experiment. The infarct was special in a
sense that it was very extended and the rest of the tissue was completely healthy. Hence,
we obtained just two different regions: the infarcted part of the heart and the healthy
normokinetic part. The electrical activation was not affected in this case. Although we
obtained very encouraging results using those animal data, a direct application of the
algorithm on real patients is difficult. The first reason is that the non-infarcted tissue
does not have a uniform contractility level. Secondly, the pathological electrical activation
needs to be very accurately represented in the model. In the Appendix we will show
some promising preliminary results in the estimation of contractility parameters in patient
KCL014.
7.7.3 Repolarization times
Estimating the repolarization times from the Ensite data is difficult due to a complicated
identification of the repolarization T wave. We used a constant value of APD over the
whole myocardium in cases in which the repolarization times could not be extracted from
the data. It is known that there are physiological variations of the APD through the wall
thickness and also in between segments of the ventricles. If the APD was strictly constant
in a LBBB patient with a large offset between the activation of the septum and lateral
LV wall, we should see an ‘inverse septal flash’ in the late systole. The septum should
be pushed heavily in the direction of the RV in the time period when the septum is not
activated anymore but the LV lateral wall still contracts.
Although we imposed a constant APD we did not observe a pronounced ‘inverse septal
flash’, thanks to the long repolarization phase. In the future, we would like to estimate the
repolarization times directly from the Cine MRI using some filtering techniques.
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The distribution of repolarization times is important, in order for the model to produce
the correct ventricle ejection fraction. This indicator was not measured except for the
baseline case (the Cine MRI). Having the estimated repolarization times together with some
measurements of the LV ejection fraction at each pacing pattern (e.g. by echocardiography),
we could assess the model predictivity also with respect to this global indicator of the heart
function.
7.7.4 Analytical activation patterns
The analytical activation patterns did not take into account any local decrease of the con-
ductivity. We only adjusted the direction and velocity of the activation wave propagation,
so that the electrical activation would induce the septal flash in the model comparable with
the one in the image data. Then, the activation time corresponded approximately to the
measured QRSd as well.
We were able to adjust the model so that it represented the baseline activations in
patients KCL009, KCL012 and KCL014. When we made the analytical activation more
synchronous – by imposing the activation direction along the long axis and increasing the
velocity of the propagation – the indicator of max LV dp/dt increased. Moreover, when
the timing of the activation in patients KCL009 and KCL012 corresponded to the timing
of the re-synchronized patterns, the resulting simulated and measured max LV dp/dt were
close to each other. We could have made the analytical patterns even more physiological,
e.g. by using two types of propagation velocities – the fast propagation along the given axis
and much slower propagation through the ventricle walls. Nevertheless, even with quite
simple patterns we were able to set up the patient-specific models accurately.
7.7.5 Patient-specific activation patterns
Simulations with the patient-specific activation patterns obtained by processing the Ensite
data were performed for patients KCL009 and KCL012. The predictivity of the model
for patient KCL009 was excellent. Therefore we will mainly discuss the results of patient
KCL012.
Although the results in patient KCL012 show an increase of the max LV dp/dt in the re-
synchronized cases, the simulated max LV dp/dt did not increase sufficiently with respect to
the measurements. KCL012 was a patient with an extremely extended DCM (with the LV
inner diameter ∼80 mm and the wall thickness in the LV mid-cavity ∼ 8–10 mm) and with
a very low LV ejection fraction (∼ 15%). The baseline max LV dp/dt was 680 mmHg/s,
which is a very low value. The late-enhancement images did not show any ischemic heart
damage, by means of the macroscopic infarctions. Since the function of the LV was severely
affected everywhere, it was difficult to distinguish which parts are hypokinetic and which
are completely akinetic. Based on our visual observations, we decreased the contractility
in the septum.
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We saw that the analytical activation patterns represent quite accurately the real ac-
tivation and the simulated values of max LV dp/dt are very close to the measured ones.
In the activation patterns based on the EP mapping, the problem of insufficient max LV
dp/dt increase may have arisen from the fact that the estimation of the electrophysiological
data was not optimal. The whole pipe-line of the EP data processing consists of several
steps and each of them is subjected to some errors, as for example:
• The error in the projection of the measured potentials from the Ensite leads onto
the LV endocardium will be larger in more dilated ventricles. The DCM in patient
KCL012 was much more developed than in KCL009.
• An error in the XMR registration.
• Modeling errors caused by using a simple EP model (the Eikonal equation).
Finally, we have to point out that the Ensite data themselves include a high level of noise.
7.7.6 Remark: Treppe (Bowditch) effect
The model was calibrated manually for the baseline electrical activation. The heart-rate in the
baseline was usually around 60–70/min, while the pacing was performed with the rate of 100/min. It
is known that in the healthy heart, the faster stimulation rate increases the myocardium contractility
(the so-called Bowditch staircase phenomenon or treppe effect [17], see Figure 7.23). It is probably
caused by an accumulation of Ca2+ in the sarcoplasm of the cardiomyocytes when the heart-rate
increases. We did not take the phenomenon into account, since all our patients had a chronic heart
failure. Therefore, for the simulations of the paced activation patterns we we kept all the model
parameters as in the baseline – including the tissue contractility – and we only changed the electrical
activation.
7.8 Conclusions and perspectives
In this part of the thesis, we showed predictivity of the model with respect to the indicator
of max LV dp/dt in patients undergoing cardiac resynchronization therapy (CRT). We
were able to set up patient-specific models in the baseline conditions for 8 patients using
the analytical activation patterns representing the pathological electrical activation of each
patient (the LBBB-like pattern). The models represent the measured Cine MRI data
including the timing of the septal flash that was used for calibration of the analytical
activation pattern. The simulated LV pressures and LV dp/dt are close to the measured
ones.
For two patients, we applied complete patient-specific electrical activation patterns
coming from the post-processing of the electrophysiological Ensite data. In the first case,
the predictivity of the model was excellent. Although results in the second case were not
as accurate, the sensitivity of the predicted LV dp/dt with respect to the pacing patterns
was correct.
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Figure 7.23: An increased heart-rate causes an increase of the force of contraction
(Bowditch or treppe effect). From [70].
In the future, we would like to continue in the study and apply the Ensite-based activa-
tion patterns on other patients, so that we would fulfill the pre-clinical study. Afterwards,
we would like to try to use the model for planning of the CRT before the intervention itself.
For each pacing pattern, we would like to evaluate the sensitivity of the LV dp/dt when
varying slightly the position of the leads. The modeling of a long-term effect of the CRT
would be another challenging step.
The value of max LV dp/dt is established as a clinical indicator of the global LV syn-
chronicity and contractility. It is often used to assess the immediate effect of the CRT
mainly since it is easily measured during the CRT implementation. However, it is not
certain that the LV dp/dt is the best parameter for assessing neither the short-term, nor
the long-term effect of the CRT. The model can provide other mechanical indicators, as for
instance the strains and stresses. It is possible that in studying the long-term CRT effects,
such quantities – in particular indicators representing local loading of the myocardium –
will play an even more important role than the LV dp/dt, and modeling will be crucial in
estimating those quantities.
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Figure 7.24: Inferior wall view (on the left) and anterior wall view (on the right) of the
mesh of KCL014 used for the estimation. The red region corresponds to the transmural
infarction, the green to the subendocardial infarction, the yellow to the infarcted apex and
the light blue to the hypokinetic septum.
Appendix: Estimation of contractility parameter in KCL014
The case KCL014 is a patient with an IHD with several extended myocardial infarction
scars. We projected the non-viable tissue registered from the late-enhancement MR images
in the computational mesh and split it into 3 parts: the transmural infarct (TM), the
subendocardial infarct (SE) and the infarcted apex. We added a special reference for the
septum, which was visibly less kinetic than the rest of the non-infarcted myocardium, see
Figure 7.24. We performed an estimation of the contractility parameter with the same set
up as in Chapter 8, where all details can be found. As we can see in Figure 7.25, we were
successful if the observation surfaces were produced by the direct model itself (synthetic
observations). However, when using the segmented real MR images as the observations, the
results were inconclusive. The electrical activation pattern could be the main issue, since
we used only the simplified analytical prescription of the LBBB-like pattern as in Section
7.5 and we know that the parameter estimation using the real observations (coming from
the MR images) is very sensitive to the correct electrical activation pattern.
176





































































Estimation of Tissue Contractility
from Cardiac Cine MRI Using the
Biomechanical Heart Model
An important part of setting up any biomechanical model is its proper calibration according
to the measured data. In order for the model to represent the reality as accurately as
possible, the right model parameter values have to be chosen. Some parameter values can
be directly connected with the functional state of the modeled system and their abnormal
values may be associated with certain diseases. The estimation of such parameters could
therefore be used as a diagnostic tool.
In this chapter, we will be using a biomechanical model of the heartbeat described in
Chapter 4. This model, even when calibrated manually, can give an important clinical out-
put as shown in Chapter 7. Nevertheless, the goal of this work is to perform an automatic
adjustment of a key mechanical property of the model, namely the active tissue contractil-
ity. First, the estimated contractility values can improve the model itself. Moreover, they
can serve as an indicator of the local heart function, by means of a detection of hypokinetic
or akinetic regions in the myocardial tissue as typically arises after a myocardial infarction.
To achieve these objectives, we will be using Cine MR image data1 and data assimilation
techniques.
Special data assimilation techniques for parameter estimation in the cardiovascular
system were developed in [80], [81] and [79]. For the first application of the algorithms in
estimating the contractility parameters using real image data as observations, we would
like to use a data set with a pronounced and extended hypokinetic or akinetic region caused
by an acute myocardial infarction. At the same time, we would like to test the estimator
1Cine MRI stands for a sequence used in cardiac magnetic resonance imaging, that produces 2-
dimensional time series images. Usually, the whole ventricle volumes are covered by short axis planes
and a few standard long axis projections are acquired as well.
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on a healthy data set where the contractility parameters should be quite homogeneous
throughout the left ventricle (LV) myocardium. To ensure that the studied pathology (the
myocardial infarct) is the only difference between the healthy and the diseased data sets,
we decided to design an animal experiment in which a controlled infarction was created.
Thanks to this approach, first we obtained all data sets from the same subject. And
secondly, we were able to perform some invasive measurements also at the healthy stage,
which would be unacceptable for human volunteers.
The animal experiment, including the data acquisition was described in Chapter 6 and
Appendix 10 contains the detailed experimental protocol. We also refer to Chapter 6 for
the setup and validation of the model in the healthy conditions and after the myocardial
infarction. A presentation of Cardiac MRI is given in Section 3.10.1. In the following
section we will summarize the experimental data acquisition and the calibration strategy
for the healthy and the infarcted hearts.
8.1 Experimental Data and Direct Modeling
8.1.1 Experimental data
The experimental data consist of animal data obtained with a farm pig of 25 kg. The subject
was examined and data acquired once in a baseline condition (physiological heartbeat),
and 10 and 38 days after the antero-septal infarct creation. The corresponding stages are
referred to as baseline, T0+10 and T0+38 in the sequel. The T0+10 data acquisition
corresponds to the acute stage of the infarct (edematous necrotic tissue with only slightly
diminished wall thickness), while at T0+38 we could already expect – and indeed observed
– thinning of the LV wall (caused by resorption of the necrosis and tissue remodeling).
In each of the studied stages (baseline, T0+10 and T0+38), non-invasive MR image
data were acquired and pressures in the heart cavities and large vessels were measured.
The cardiac MR data consist of Cine MRI, tagged Cine MRI, late enhancement images
and phase contrast images. The pressures were measured invasively by means of retrograde
catheterization (aortic and left ventricle pressure) and by antegrade catheterization (right
atrium, right ventricle, pulmonary artery and pulmonary capillary wedged pressure).
8.1.2 Anatomical model
Anatomical models for each stage were created from the end-diastolic time frames of the
Cardiac MR images, according to Section 4.4.1. Fiber directions were prescribed using
the values of angles between the short axis plane and the fibers on the epicardium and
endocardium -60/60 degrees in LV, and -50/50 degrees in RV. The non-viable tissue in the
infarcted stages was segmented from the late enhancement images and projected in the
volumic meshes. The left ventricle of each stage was also subdivided into 6 volume regions
– which correspond in their upper third to the basal segments of the standard 17-segment
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(a) 0 ms – end-diastole (b) 40 ms (c) 50 ms (d) 60 ms (e) 70 ms
(f) 80 ms (g) 90 ms (h) 100 ms (i) 110 ms (j) 310 ms – end-
systole
Figure 8.1: Analytical prescription of the electrical activation at the baseline stage: the
red activation planar wave propagates from the apex to the base. The activation offset
between the apex and the base corresponds to the measured QRSd.
subdivision of the left ventricle proposed by the American Heart Association (AHA) in
[21]. The details about this subdivision is given in Section 8.5.1. The 2-region mesh (with
the infarcted and the non-infarcted part) and the subdivision of the LV into 6 regions will
be used to estimate the contractility parameters in these regions.
8.1.3 Direct modeling
Manual calibration of the healthy heart (baseline stage)
A direct model of the healthy heart was set up by a manual adjustment of the main me-
chanical parameters of the model, e.g. the active properties (represented by tissue contrac-
tility), the passive properties (tissue stiffness). These parameters were kept constant over
the whole myocardium. The boundary conditions of the model were prescribed according
to Section 4.2.5. We used visco-elastic boundary conditions given by form (4.13) applied
on the base of the ventricles (area around the valves) and on the area around the heart
apex. The boundary conditions stiffnesses were adjusted so that we preserved the motion
of the base of the heart, as seen in the long axis projections of the Cine MR images, and
we prevented the apex from displacing. Therefore the stiffness of the boundary condition
applied on the apex was higher than for the the boundary condition applied on the base.
An additional visco-elastic boundary condition representing a contact between the anterior
heart wall with the thoracic cage was used. This boundary condition stiffness was of the
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same order as for the apex. Finally, the Windkessel models parameters were adjusted so
that the simulated ventricle and arterial pressures would be close to the measured values.
In the direct simulations and also in the estimations we used the following simple
electrical activation pattern: the depolarization times were prescribed analytically by a
planar wave propagating from the apex to the base of the heart along the long axis (see
Figure 8.1). The propagation velocity was adjusted so that the whole myocardium would
be activated in a time period corresponding to the measured QRS duration. The action
potential duration in the simulation was kept constant over the whole myocardium, and
was adjusted according to the Cine MR images and the processed phase contrast data,
which quite accurately reflect the timing of valves opening and closure.
Modeling of the infarct at stages T0+10 and T0+38
An acute myocardial infarction is characterized by a sudden drop of contractility in the
affected part (see [70, Chap. 50]). At stage T0+10 and even more so at stage T0+38, we
can observe in the image data a visibly weaker contraction of the antero-septal part of the
left ventricle. The constant parameter of contractility in the whole myocardium – as was
calibrated for the baseline – applied at the infarcted stages causes the infarcted region to be
much more kinetic in the simulations than in the images and the simulated pressures in the
left ventricle overestimate the measured pressure curves. By decreasing the contractility
in the infarcted region, the direct model gets closer to the measured image and pressure
data.
Conclusion of the direct modeling
The comparison of the direct model v.s. measured data showed that the biomechanical
model is capable of representing both the healthy heartbeat, and the infarcted heart (see
[22]). The infarct can be modeled by modifying the contractility parameter (the parameter
most directly related to the pathology type) and only in the affected region. The model
shows a very good predictivity with respect to the global ventricle volumes and local
kinematics of the wall of the left ventricle, in this particular pathology.2
8.2 Introduction to state and joint state-parameter estima-
tions
Even though we showed in Chapters 6 and 7 that the direct model can be set up manually
with very good results with respect to the measured image and pressure data, the goal
of this part of the thesis is to automatically correct the direct model by means of state
2It is a very particular pathology indeed, since we created a large akinetic region (the infarct) whereas
the non-infarcted tissue remained completely healthy. Moreover, the non-infarcted part may have reacted
by an hypertrophy to compensate for the decreased heart effectivity.
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Figure 8.2: Comparison of output pressures of the direct model (solid lines) and the mea-
sured values (dashed lines) for each stage of the infarction.
estimation and to estimate some crucial mechanical parameters by means of joint state-
parameter estimation. The estimation of the state – or of the state and some parameters
– is also known as data assimilation.
The model used for the estimation process is to some extent a simplification of the
direct model described in Chapter 4. Although we use the same material laws, the ventricle
pressures are not taken as unknowns of the problem anymore. Their prescription is based
on an output pressure value of the direct model. As we can see in Figure 8.2, the measured
and the simulated cavity pressures obtained by the direct modeling are very similar. We
may think of using the simulated pressures as a regularization of the measured ones. By
such an approach we also avoid difficulties with an exact synchronization of the measured
pressures with the timing of the electrical activation in the model, e.g. at changes of the
cardiac cycle phases (openings and closures of the valves).
8.2.1 Formulation of the problem
The discretized problem (4.19) introduced in Section 4.2.6 can be re-written as the following
first order system: 
X˙ = A(X, θ, t),
X(0) = X0 + ζX ,
θ(0) = θ0 + ζθ,
Z(t) = H(X(t)) + χ,
(8.1)
with X = (Y Y˙ )T being the state of the system, where Y and Y˙ represent the unknown
displacement and velocity vectors of degrees of freedom (DOFs). In the dynamical system
given by (8.1), X(0) represents the unknown initial condition with its a-priori knowledge
X0. The θ variables are the unknown parameters in the model with their a-priori knowledge
given by θ0. In our case, the vector θ represents relative contractility values given for each
volume region of the left ventricle. The quantities ζX and ζθ are uncertainties in the initial
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condition (in the state) and in the unknown parameters and both need to be estimated
during the joint state-parameter estimation. The state and the parameters are estimated
using observations Z(t), which are some measurements of the states of the system at time
t. The observation Z(t) is associated with the corresponding state X(t) via an observation
operator H. The variable χ represents a white noise introduced by the measurement
procedure.
In case there is no uncertainty in the parameters θ, the system (8.1) can be written in
the form 
X˙ = A(X, t),
X(0) = X0 + ζX ,
Z(t) = H(X(t)) + χ,
(8.2)
and we only need to perform the state estimation.
8.2.2 Observations and observation operator
The observation operator H is a mapping between the model X(t) and the measured data
Z(t). In practice, the measured data are obtained in discrete time snapshots k with a
sampling rate ∆T . We can define the measurement in the continuous time t for example
by linear interpolation in the following manner:
Z(t) = αk(t)Zk + (1− αk(t))Zk+1, with αk(t) = (k + 1)∆T − t
∆T
, (8.3)
where Zk = Z(k∆T ) and t ∈ [k∆T, (k + 1)∆T ].
The observation operator H can be linear, for example directly given by measured
displacements or velocities of certain points in the computational domain (e.g. when using
post-processed tagged MR images). In general, the observation operator H is a nonlinear
mapping between the model and the measured data. By H ′ we denote the adjoint operator
to H.
8.2.3 Classical assimilation techniques
There are two general approaches for data assimilation – the variational and the sequential
one. We are aiming at estimating the initial condition X(0) = X0 + ζX and the unknown
parameter θ = θ0 + ζθ in the problem given by (8.1) or just the initial condition X(0) =
X0 + ζX in problem (8.2).
Variational estimation
In the variational approach, we need to minimize a functional of the following form:













where the trajectory X(ξX , ξθ, t) satisfies
X˙ = A(X, θ, t),
X(0) = X0 + ξX ,
θ(0) = θ0 + ξθ.
(8.5)
The selection of the norms || · ||W−1 and || · ||P−10,·· in (8.4) is driven by the confidence in
the accuracy of observations (the first term of (8.4)) and by the confidence in the a-priori
knowledge of the initial condition given by X0, and in the parameters given by θ0.
Among the difficulties of the variational approach we should mention the need to com-
pute the adjoint operator and the gradient of (8.4). Each iteration of the assimilation
procedure then implies running the whole direct model in the forward and the backward
sense (the adjoint problem), to finally obtain the gradient dJ(ξX , ξθ) of the system used in
the optimization algorithm. There are heavy associated computational and storage costs.
Sequential estimation (filtering)
In sequential estimation (filtering), the model is corrected using the observations during one
simulated cardiac cycle and the estimated state Xˆ – the so-called observer – is obtained.
The general form for obtaining the corrected state using a filter KX in problem (8.2), in
which we assume no uncertainty in the parameters θ, is as follows:{
˙ˆ
X = A(Xˆ) +KX(Z −H(Xˆ)),
Xˆ(0) = X0.
(8.6)
In the case of the joint state-parameter estimation given by system (8.1), we can intro-





















































and the observer Xˆe has a form analogous to (8.6).
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As a filter KX in (8.6), we could consider the optimal (Kalman) filter (see [58], [59]).
Unfortunately, computing the Kalman filter requires handling a covariance matrix P which
is full and of the same size as the state, which is practically unrealizable.
8.2.4 Physical filters
Considering the difficulties in applying Kalman filtering in large systems, we use alternative
filters that are based on effective feedback control. If the operators A and H are linear, by
substituting the error X˜ = X − Xˆ in (8.6), we obtain{
˙˜X = (A−KXH)X˜ −Kχ,
X˜(0) = ζX .
(8.9)
We aim at X˜ → 0 rapidly. This problem is transformed in the problem of stability of the
operator A −KXH at the critical point 0. According to the theory of stability (see [50],
[33]), we need to choose the filter KX so that the eigenvalues of the operator (A−KXH)
have negative real part. This so-called Luenberger asymptotic observer was introduced in
[71] and the following filters are based on this approach.
Direct velocity feedback (DVF)
Assuming our observations consist of measured velocities, we can apply forces proportional
and opposed to the velocity errors, directly at the measured locations. This standard
technique in the control of mechanical structures is called direct velocity feedback (DVF,
see [89], [29]). To present this method, let us assume that our problem is linear and given
by the following equation:
MY¨ + CY˙ +KY = F, (8.10)
withM , C, K being the mass, damping and stiffness matrices, Y the unknown displacement
vector for DOFs as in (4.17) and we aim at correcting the state using the observations

















Y + (C + γH ′H) ˙ˆY +KYˆ = F + γH ′Z. (8.13)
The positive factor γH ′H on the left hand side of (8.13) ensures the dissipative effect
of the filter. The gain parameter γ governs the effectivity of the state estimator. The
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optimal value of γ for the linear problem (8.10) can be derived by considering the following
quadratic eigenvalue problem (QEP):(
0 K








The parameter γ stabilizes the original problem by shifting the eigenvalues solutions of
(8.14) towards the negative real plane. A detailed analysis of the damping properties of
DVF filter KX is in [80].
In the joint-state parameter estimation in system (8.1), we can combine the approach
of an augmented state formulation as introduced by (8.7) with an application of the DVF








where Xˆ denotes the state observer for a given parameters θ computed by using the ‘cheap’
state filter based on DVF, and the classical Kalman filtering is reduced only on the space
of the parameters θ. A detailed presentation of this extension for the joint state-parameter
estimation is also presented in [80] and an extension for the nonlinear problems by means
of the reduced-order unscented Kalman filtering (UKF) is in [79]. We note that the UKF
approach is highly parallelizable and the final parameter estimation in n regions is obtained
by n+ 1 independent computations, each of them comparable with the direct simulation.
Since our observations do not consist of measured velocities in general, we cannot
directly use the DVF approach. In the following paragraph, we describe a generalized
observation operator based on measuring distances between the surfaces of estimator and
the observations (represented by the surfaces obtained from Cine MRI), and the estimation
procedure using such an observation operator.
Distance discrepancy operator
In our problem, the estimation process is performed only in the left ventricle. We take
the endocardial and epicardial surfaces of the left ventricle obtained by segmenting the
Cine MR images as the observations. Such a choice may be limiting with respect to
the observability of the intra-myocardial parts and also the wall motion tangential to the
surfaces cannot be observed. However, data needed for creating such observations are
available for any examined subject.3 We denote the surfaces segmented from the k-th time
frame image by SLV endok and SLV epik , and Sk = SLV endok ∪ SLV epik . The segmentation of
the contours is difficult in regions around the valves (above AHA segments 1–6) and around
3Typically, we need dynamic MR or CT image data covering the whole volume of the ventricles. These
type of image data are becoming common in clinical practice. In our case, we used multiple 2D acquisitions
of Cine MRI taken in short axis views.
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(a) Computational mesh, view from the anterior
side. The endocardial surface of the LV used for
the estimation ∂ΩˆOBSendo is in orange color. The
red part of the LV endocardium was considered
to be non-observable. Similarly, a part of the LV
epicardial surface was selected (including RV en-
docardium of the septum).
(b) Example of synthetic observations – parts of LV en-
docardial (in red) and epicardial (in blue) surfaces viewed
from top. The surfaces were produced directly by the
model. They were truncated in the same way as the real
MR observations.
Figure 8.3: Computational mesh and examples of synthetic observations.
the apex because of the low resolution of the short axis Cine MR images and the anatomical
complexity at these locations, as discussed in Section 4.4.1. Therefore, we perform the
estimations only in the parts of the left ventricle corresponding to AHA segments 1–16
using the parts of LV endocardial and epicardial surfaces adjacent to those regions, see
Figure 8.3(a). We denote these surfaces of the estimator by ∂ΩˆOBSendo and ∂ΩˆOBSepi
(the observable parts of LV endocardial and epicardial surfaces), ∂ΩˆOBS = ∂ΩˆOBSendo ∪
∂ΩˆOBSepi.
Using the observations as described above, we introduce the discrepancy operator given
by measuring distances between the surfaces of the estimator ∂ΩˆOBS and the observations
Sk. Let the k-th reference surface correspond to time t of the simulation. Then the state
matches the given observation if
dist(xt, Sk) = 0 ∀xt ∈ ∂ΩˆOBS , (8.16)
where dist(xt, Sk) stands for the signed distance of a point xt to surface Sk and
dist(xt, Sk) =
{
dist(xt, SLV endok) if xt ∈ ∂ΩˆOBSendo,
dist(xt, SLV epik) if xt ∈ ∂ΩˆOBSepi.
(8.17)
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Figure 8.4: Projection of simulated contour ∂Ωˆt on segmented surfaces Sk and Sk+1.
We can extend the distance operator on the full finite element model and denote it by
dist(Xˆd, Sk). Then, the condition dist(Xˆ
d, Sk) = 0 can be directly compared with the usual
measurement matching condition, i.e. Z−H(Xˆ) = 0, and the distance operator represents
an extension of the the observation quantity Z −H(Xˆ) that we call discrepancy operator.
By interpolation, we can obtain the discrepancy operator for any simulated time t ([81]):
Wd(Xˆ
d, t) = αk(t) dist(Xˆ
d, Sk)+(1−αk(t)) dist(Xˆd, Sk+1), ∀t ∈ [k∆T, (k+1)∆T ], (8.18)
with αk(t) defined as in (8.3).
Schur displacement feedback (SDF)
Compared to DVF where the observed velocities are used for the model correction, in the
state estimation based on the Schur displacement feedback (SDF) we can directly use the
displacements as observations. We will demonstrate the SDF method on a simple linear
problem given by (8.10). We introduce the notation X = (Xd Xv)T , where Xd and Xv







with a parameter γ > 0, the observer of (8.10) can be written in the following form ([81]):{
K
˙ˆ
Xd = KXˆv + γH ′(Z −HXˆd),
M
˙ˆ
Xv + CXˆv +KXˆd = F.
(8.20)
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By analyzing the QEP, we can find the optimal value of the gain γ (see [81]):
γopt =
√
2ω0 + h.o.t., (8.22)
where ω0 is the lowest eigenfrequency of QEP (8.21).
Considering our type of observations and the discrepancy operator Wd given by (8.18),
System (8.20) turns into ([81]):K
˙ˆ








Xv + CXˆv +KXˆd = F,
(8.23)







dist(x+ y)(νSk · δy)dS, (8.24)
with the notation according to Figure 8.4.
The effective joint state-parameter estimation for the original non-linear problem (8.1)
is based on the application of reduced-order unscented Kalman filtering (UKF) on an
augmented system with the state estimator based on SDF, in the same way as was presented
for DVF.
In the following parts, we will be dealing with the application of the estimation methods
described above, namely the estimation based on the SDF and the measurement of distances
between the contours of the model and observations. The input data were acquired during
the animal experiment and we will be using the pre-calibrated direct model representing
the baseline stage. We emphasize that – by construction of the filtering procedure – the
estimated parameter values plotted in the following sections evolve during the simulation
period – corresponding to a complete heartbeat in our case – and of course the actual
estimation is achieved with the final values.
8.3 State estimation
The data obtained at the baseline stage come from a healthy subject without any cardiac
pathology. We can assume that the contractility parameter will not significantly vary over
the myocardium of the left ventricle. Indeed, we saw in Chapter 6 that a direct model with
constant contractility simulates the healthy stage adequately. We are going to correct the
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direct model representing the baseline stage using the observation surfaces by means of the
state estimation.
As discussed in Section 8.2.4, to perform the state estimation we apply corrections based
on the computed distances between the simulated and measured surfaces, both for the
endocardial and epicardial contours (Schur displacement feedback, SDF). As the efficiency
of the state filter is conditioned by the gain γ, we will test and compare the resulting
corrected simulations when using the following values of γ:
• the optimal value γ0 with respect to the state estimator by means of an analysis of
the eigenvalues and eigenfrequencies of QEP of the linearized problem (8.21), see [81].
• an increased value γ = 8γ0.
• an intermediate value γ = 20γ0.
• a large value γ = 40γ0.
In Figure 8.5, we superposed the contours of the direct (non-corrected) model, the
contours of the corrected models, as well as the observation surfaces in the MR image
data. In Figure 8.6 we plot distance errors between the simulated and segmented surfaces
for LV subdivided into 6 regions according to Section 8.5.1. The resulting distance errors
are summarized in Table 8.1. As we can see, the state estimator becomes effective when
the value of γ is greater than 8γ0. For the lower values, the estimated model is almost
identical to the direct model. The reason why the ‘optimal value’ of γ is not sufficient for
the corrections is that γ0 was computed using the spectral analysis – which pertains to the
linear problem – whereas our problem is highly nonlinear. A second reason may be errors in
the observations (e.g. due to noise in the data or segmentation errors). However, a strong
correction by using a high value of the gain γ can induce some non-physical behaviour,
for example incorrect high stresses. The strong state estimator may also influence the
estimation of parameters in the joint state-parameter estimation, as will be presented
later. Note also in Figure 8.5 that the error in the direct model is rather large in the
beginning of the diastole (time ∼400 ms). One reason comes from the fact that we used
a constant value of the action potential duration. This is why – although the activation
onset corresponds quite well to the Cine MRI data – the onset of the relaxation does not
sufficiently fit the data.
8.4 Adjustment of the joint state-parameter estimator
The joint state-parameter estimator will be set up using the mesh of the stage T0+38 sub-
divided into 2 volumic regions – the infarcted and the non-infarcted parts. The estimations
will be initialized by constant contractility over the whole myocardium (θinit = 1 in each
volume region), using the same contractility value as in the direct model of the baseline
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(a) End-diastole (b) End-systole
Figure 8.5: State estimation at the baseline stage. With increasing values of the state
estimation gain γ, the corrected model is approaching the observations (in green). Colors
correspond to γ values 8γ0 (purple color, almost completely hidden by the red contour of
the direct model), 20γ0 (light blue) and 40γ0 (in yellow).
Region 1 2 3 4 5 6
Direct model 2.2 / 1.2 2.8 / 1.4 1.9 / 3.7 3.1 / 4.1 2.8 / 2.7 2.3 / 2.6
StateEstim γ0 2.5 / 0.9 3.0 / 1.2 1.9 / 3.8 2.6 / 3.7 3.0 / 2.3 2.4 / 2.4
StateEstim 8γ0 1.7 / 0.9 2.5 / 1.2 1.7 / 3.2 2.1 / 3.2 2.7 / 2.3 1.8 / 2.2
StateEstim 20γ0 1.1 / 0.8 1.8 / 1.0 1.7 / 2.2 2.0 / 2.4 2.1 / 2.0 1.7 / 1.8
StateEstim 40γ0 0.9 / 0.7 1.2 / 0.7 0.8 / 1.3 1.4 /1.4 1.4 /1.4 1.3 / 1.2
Table 8.1: Distance errors (in millimeters) for the LV endocardial / epicardial surfaces
at the baseline stage in the direct simulation and in the state estimation. The surfaces
were divided into 6 parts according to the volumic mesh subdivision, and the mean distance
from the observation was computed for each observation step. The values in the table are
maxima of the mean errors for each region over the whole cardiac cycle.
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(a) Direct model, endocardial error






























(b) Direct model, epicardial error






























(c) State estimation, γ = 8γ0, endocardial error






























(d) State estimation, γ = 8γ0, epicardial error






























(e) State estimation, γ = 20γ0, endocardial er-
ror






























(f) State estimation, γ = 20γ0, epicardial error
Figure 8.6: Mean error over the LV endocardial and epicardial surface regions at the
baseline stage during the cardiac cycle. The errors were computed for the direct model
and for the model corrected by the state estimator with increasing the values of gain γ.
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stage. The direct model with the constant contractility cannot represent the hypokinetic
infarcted part of the stage T0+38, as was discussed in Section 8.1.3. This will be corrected
by the joint state-parameter estimator. For preliminary adjustments of the estimator, we
will be using synthetic observations produced by the direct model itself. More detailed
adjustments will be performed using real Cine MR image data.
8.4.1 Estimation using synthetic observations
The synthetic observations were obtained from the direct model of the heartbeat by re-
ducing the contractility in the infarcted part by a factor 4. The endocardial and epicardial
surfaces were exported with a temporal resolution of 26 ms (∆tobs) which corresponds to
that of the Cine MRI at stage T0+38. See Figure 8.3(b) for an example of such surfaces.




||Z(t)−H(X(ξX , t))||2W−1dt, (8.25)





where {tk}nk=0 corresponds to the time discretization of the simulation. The covariance
W−1k depends on the time discretization step ∆t
sim = tk − tk−1 in the following way:
W−1∆tsim = W−1k , hence W = Wk∆t
sim. (8.27)
We assume that the expected spatial errors in the observations given by the covariance
Wobs have white noise characteristics and the covariances corresponding to each observation
time step are independent. Therefore,
W = ∆tobsWobs, (8.28)
where ∆tobs is the time step of the observation snapshots. Then, if we want to define
discrete criteria (8.26) we need to have according to (8.27) and (8.28)
∆tsimWk = ∆t
obsWobs. (8.29)
In our case, ∆tobs ∼ 26 ms and ∆tsim ∼ 1 ms. We tested the following values of Wk:
• Wk = 10−6 mm2, for the level of expected noise in the observations
Wobs ∼ (0.25 mm)2
• Wk = 10−5 mm2, for the level of expected noise in the observations
Wobs ∼ (0.60 mm)2
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(a) Wk = 10
−6 mm2, P0,θθ = 12diag(10
−3, 1)
































(b) Wk = 10
−5 mm2, P0,θθ = 12diag(10
−3, 1)
































(c) Wk = 10
−6 mm2, P0,θθ = 121
































(d) Wk = 10
−5 mm2, P0,θθ = 121
Figure 8.7: Parameter of relative contractility θ estimated in a 2-region mesh of stage
T0+38 with the non-infarcted and the infarcted region using synthetic observations.
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Figure 8.7 shows that by increasing the level of expected noise, the sensitivity of the
estimator decreases. At the same time, we either fixed the contractility value in the non-
infarcted tissue (using a low value corresponding to the healthy tissue in the covariance
matrix P0,θθ) or we used the unit covariance matrix (in order not to fix the contractility
anywhere). As we can see also in Figure 8.7, the two choices of the covariance matrix did
not substantially change the results.
8.4.2 Estimation using real MR images as observations
In this section, we focus on some other issues in the setup of the joint state-parameter
estimator, in order to detect the infarcted (hypokinetic) regions in the left ventricle, without
any a-priori knowledge. From now on, we will be using real observations obtained by
segmenting the Cine MR images, as was discussed in Section 8.2.4. We will keep the value
of expected noise Wk = 10
−6 and we will be using the unit covariance.
Passive tissue stiffness
From the histological analysis of the infarcted stages we should assume that the passive
tissue stiffness would vary between the infarcted and the non-infarcted regions. Due to the
remodeling of the antero-septal part of the apex at stage T0+38 by means of a thinning
of the akinetic wall and replacement of the myocardium by fibrous tissue, we may expect
an increase of the passive tissue stiffness at this location. However, the edematous recent
infarct at stage T0+10 can be associated with a decreased passive tissue stiffness.
In this work, we are not focusing on estimating the passive tissue properties. Since we
would like to find the infarcted region without any a-priori knowledge of its location we
will keep the value of the passive tissue stiffness constant in the whole myocardium and for
all 3 stages.
Nevertheless, in Figure 8.8 we tested the impact of the actual value of the passive tissue
stiffness on the estimation of the system. A very high value of the tissue stiffness prevents
the myocardium from contracting and the difference between displacements when varying
the contractility is getting lower. Hence, the observability of the infarct decreases. For
this reason, we would rather be using a lower value of the stiffness. However, the thin wall
infarcted tissue may tend to bulge, especially if the modeled tissue stiffness is lower than
the actual correct value. In our case, the bulging will be prevented by boundary conditions
representing a contact with the surrounding tissues (thoracic cage).
Gain of the state estimator γ
As in Section 8.3, we performed the state estimation – and further the joint state-parameter
estimation – first using the optimal state estimator gain γ with respect to the state estima-
tor by means of an analysis of eigenvalues and eigenfrequencies of the linearized problem
(γ = γ0), and also with larger gains (8γ0, 20γ0 and 40γ0).
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(a) T0+38, the passive tissue stiffness as in Table
8.2
































(b) T0+38, increased passive tissue stiffness (multi-
plied by factor 2)
Figure 8.8: Parameter of relative contractility θ estimated in a 2-region mesh of stage
T0+38 with the non-infarcted and the infarcted region using real observations. The ob-
servability of the infarct is reduced if the stiffer tissue is assumed.
We compared the direct (uncorrected) simulation performed with constant contractility
values, either with the correction just by the state estimator or by the state-parameter
estimator. In Figure 8.9(a), we can see separately the role of each of them. Depending on
the gain of the state estimator, the model either gets closer to the observations (for the
large state estimator gain γ) or stays almost exactly at the position of the direct model.
When performing the joint state-parameter estimation, the model is well corrected even if
the low gain γ is used, as illustrated in Figure 8.9(b).
Figure 8.10 shows that no matter which value of γ was used, the contractility parameters
were well retrieved. To assess which value of γ is the best, we will have to perform further
tests on a more refined subdivision of the left ventricle.
Finally, in Figure 8.11 we can see a comparison of the contractility estimation in the 2-
region meshes for the infarcted stages (T0+10 and T0+38), using settings of the estimator
according to Table 8.2. The same parameters of the estimator will be used in all the
following estimations, with the exception of testing several values of the state estimator
gain γ.
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(a) Comparison of the state estimation in purple
and the joint state-parameter estimation (in blue).
γ = 20γ0, in both cases.
(b) Comparison of the joint-state parameter esti-
mation using the gain γ with an optimal value wrt.
state estimator (γ = γ0, in orange) and γ = 20γ0
(in blue).
Figure 8.9: End-systolic image at stage T0+38. Direct model with constant contractility
in red, observations (the segmented surfaces) are in green.
Parameter Value Note
γ 20γ0 state estimator gain
Wk (mm
2) 10−6 level of expected noise in the observations
P0,θ,θ
1
n1 an identity covariance matrix
κ1 (Pa) 5 · 103 constant passive tissue stiffness in the myocardium
κ2 (Pa) 40 constant passive tissue stiffness in the myocardium
bulk modulus (Pa) 5 · 105 constant passive tissue stiffness in the myocardium
Table 8.2: Setup of the joint state-parameter estimator used for automated detection of
the hypokinetic regions of the left ventricle. Parameter γ0 stands for the optimal gain of
the state estimator discussed in Section 8.3, parameter n stands for the number of regions
in which the unknown parameter is to be estimated and 1 is a unit matrix of size n.
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(a) γ = γ0
































(b) γ = 8γ0
































(c) γ = 20γ0
































(d) γ = 40γ0
Figure 8.10: Parameter of relative contractility θ estimated in a 2-region mesh of stage
T0+38 with the non-infarcted and the infarcted region using real observations, with dif-
ferent values of the state estimation gain γ.
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Figure 8.11: Parameter of relative contractility θ estimated in a 2-region mesh of stages
T0+10 and T0+38 with the non-infarcted and the infarcted region using real observations.
8.5 Automatic contractility personalization and detection of
hypokinetic regions
In this section we will try to retrieve contractility parameters using a general subdivision of
the left ventricle myocardium that does not take into account the infarct location. The ob-
jectives are twofold. First, the parameter estimation provides an automatic personalization
of the model, which enables further applications for predictive purposes as in therapy plan-
ning. Secondly, the estimated parameters may help to localize and quantify the infarcted
region automatically with respect to the ventricle subdivision.
8.5.1 Subdivision of the myocardium
We created computational meshes with 6(+1) volumic regions in the following way: First,
the left ventricle was truncated by two short-axis planes that detached the apical and the
basal parts of the left ventricle in which the observations are missing. These parts of the
left ventricle together with the myocardium of the right ventricle form a volumic region
#0 that will be considered as a non-observable region. Then, the observable left ventricle
myocardium was divided into 6 circumferential regions. These regions correspond in their
upper third to the basal segments of the standard 17-segment LV subdivision according to
AHA ([21]). See Figure 8.12 and Table 8.3 for the subdivision of the meshes into 6(+1)
regions. Tables 8.4 and 8.5 show the proportion of tissue marked by the late enhancement
in each region.
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Regions #1 #2 #3 #4 #5 #6
Figure 8.12: Mesh of T0+38 subdivided into 6(+1) volumic regions. The part of my-
ocardium not filled with color represents the non-observable regions with the volumic ref-
erence #0.
Region AHA segments Note
0 – all parts without observations
(RV, apex and base of the LV around valves)
1 1+7+extension to the apex anterior part of the LV
2 2+8+extension to the apex antero-septal part of the LV
3 3+9+extension to the apex infero-septal part of the LV
4 4+10+extension to the apex inferior part of the LV
5 5+11+extension to the apex infero-lateral part of the LV
6 6+12+extension to the apex antero-lateral part of the LV
Table 8.3: The 6(+1)-region mesh subdivision based on the circumferential subdivision of
the left ventricle according to AHA.
Region Name of the region volume of the region proportion of the infarct
0 non-observable 152mL 2%
1 anterior 12mL 36%
2 antero-septal 14mL 53%
3 infero-septal 12mL 19%
4 inferior 15mL 0%
5 infero-lateral 11mL 0%
6 antero-lateral 11mL 3%
Table 8.4: Relative extent of the infarct for each region in the 6(+1)-region mesh of T0+10.
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Region Name of the region volume of the region proportion of the infarct
0 non-observable 121mL 3%
1 anterior 11mL 45%
2 antero-septal 15mL 64%
3 infero-septal 10mL 20%
4 inferior 16mL 0%
5 infero-lateral 12mL 0%
6 antero-lateral 13mL 0%
Table 8.5: Relative extent of the infarct for each region in the 6(+1)-region mesh of T0+38.
8.5.2 Joint state-parameter estimation at baseline, T0+10 and T0+38
stages using a 6(+1)-region mesh subdivision
The subdivision of the observable tissue was performed according to Section 8.5.1. We
used the setup of the estimator according to Table 8.2. In Section 8.4.2 we have found that
the estimated contractility parameters did not markedly depend on the value of the state
estimator gain γ when using the 2-region mesh subdivision of the stage T0+38. We tried
the same type of estimations using the 6(+1)-region subdivision.
Figure 8.13 shows estimation results for all the stages using 3 values of the state estima-
tor gain γ. On the first sight we can see that a lower value of γ increases the sensitivity of
the parameter estimator – the spread of the parameter values is larger than for the higher
γ values. However, by analyzing in detail some artifacts in the parameter estimation, this
test shows some important aspects of the state estimation and gives us some clues how to
tune the gain γ.
The state estimator tends to compensate for the discrepancy between the model and the
observations, given e.g. by modeling errors. If the state estimator is weak and the model is
far from the observed surfaces, the parameter estimator tries to correct the model. Since
the parameter estimator may be correcting mainly for instance the modeling errors, the
true parameter values may be masked by those corrections. Figure 8.13(i) shows a decrease
of contractility in region #5, caused by the relaxation that is not perfectly synchronous
between the model and the data. This little discrepancy can be corrected by the stronger
state estimator.
However, a strong state estimator may correct the model to such an extent that the
parameter estimator does not detect any need for other corrections, namely this would
correspond to a loss of observability. Even more, Figure 8.14 demonstrates that excessive
correction by the state estimator can cause some non-physiological tissue displacements,
that may affect the estimated parameters.
For the real observations, the best results were obtained using the intermediate value
γ = 20γ0, as can be seen in the middle column of Figure 8.13. In the baseline case, the
contractility values do not vary more than by 10%. At stage T0+38 the lowest values
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(a) Baseline, γ = 40γ0
































(b) Baseline, γ = 20γ0
































(c) Baseline, γ = 8γ0
































(d) T0+10, γ = 40γ0
































(e) T0+10, γ = 20γ0
































(f) T0+10, γ = 8γ0
































(g) T0+38, γ = 40γ0
































(h) T0+38, γ = 20γ0
































(i) T0+38, γ = 8γ0
Figure 8.13: The 6(+1)-region subdivisions for each stage, using several values of the state
estimation gain γ and real observations.
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(a) The blue contour with excessive correction of the
state on the inferior wall around the attachment of
the left ventricle and the right ventricle in the early
diastole (region #4).
































(b) A sudden drop of estimated contractility in region
#4 in the early diastole (t ∼430ms).
Figure 8.14: Non-physiological deformation when using overly large value of the state
estimator gain (γ = 40γ0).
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Figure 8.15: Comparison of the estimated contractility parameters for the baseline (solid
line), T0+10 (dashed line) and T0+38 (dash-dot line) for γ = 20γ0 using real observations.
Note a narrow range of the contractility values for the baseline stage, and a wide range for
the infarcted stages with the lowest values in regions #2 and #3 (infarcted zone) and the
highest values in regions #5 and #6 (healthy – lateral LV wall).
of contractility are located in regions #2 and #3 that correspond to the actual infarcted
regions. The lateral wall of the left ventricle situated opposite to the infarction (regions
#5 and #6), contracts even more – which may be caused by a compensation hypertrophy.
Figure 8.15 illustrates that the contractility values are quite comparable in between
the baseline stage and T0+10, except for regions #2 and #3. In both affected regions,
we observe a drop of contractility of the order of 10%. At stage T0+38, we can see an
even more pronounced drop of contractility in the same regions and a large increase of
contractility in regions #5 and #6.
Finally, in Figure 8.16 we compare the joint state-parameter estimation using either
the synthetic or the real observations at stage T0+38 with γ = 20γ0. The synthetic
observations are perfect surfaces with respect to the model and the resulting estimated
parameters are very accurate. Nevertheless, we obtained similar results when using the the
real observations created from the Cine MR images.
8.6 Simulations with estimated values of contractility
As a direct validation of the contractility parameters estimated in Section 8.5.2, we per-
formed direct simulations of the stage T0+38 using the estimated parameter values. In
Figure 8.17 we compare the direct model with constant contractility, the joint-state param-
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(c) Synthetic observations, 2nd run of estimation



























(d) Real observations, 2nd run of estimation
Figure 8.16: The 6(+1)-region subdivisions of stage T0+38, using either synthetic or real
observations. γ = 20γ0. The second run of estimation was initialized by contractility values
θ obtained during the first run.
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Figure 8.17: Two slices of the end-systolic phase at stage T0+38. Comparison of direct
model with constant contractility (yellow contour), direct model using the estimated values
of contractility (red) and joint state-parameter estimation (black).
eter estimation and finally the direct model using the estimated contractility parameters.
As expected, the best results were obtained by the joint state-parameter estimation. Al-
though the direct model with the estimated contractility parameters does not completely
coincide with observations, the estimated parameters clearly correct the direct model in
the right direction and push it closer to the observed surfaces.
8.7 Electrical activation
In the previous simulations we used the simple analytically prescribed electrical activa-
tion pattern in which the depolarization times were given by a planar wave propagating
from the apex to the base of the heart along the long axis, as shown in Figure 8.1. The
propagation velocity was adjusted so that the whole myocardium is activated in a time
period corresponding to the measured QRS duration. The action potential duration in the
simulation was kept constant over the whole myocardium, and was adjusted according to
the Cine MRI data.
We tried to modify the activation pattern, so that it would become even more phys-
iological. The analytically prescribed planar wave propagates from the apex to the base
while activating only the subendocardial part of the myocardium. The transmural prop-
agation is represented by the traveling wave with a lower propagation velocity. The two
velocities are adjusted in the baseline case so that the periods for the wave propagation
would correspond to the physiological situation, in particular:
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(a) 0 ms – end-diastole (b) 30 ms (c) 40 ms (d) 50 ms (e) 60 ms
(f) 70 ms (g) 80 ms (h) 90 ms (i) 100 ms (j) 300 ms – end-
systole
Figure 8.18: Analytical prescription of the electrical activation at the baseline stage: the
planar wave activating the subendocardial part propagates fast from the apex to the base,
together with the slow transmural propagation.
• the period of the activation of the whole endocardium is ∼ 30–35 ms.
• the period for the endocardium–epicardium propagation is ∼ 30–35 ms.
• the whole myocardium is activated in ∼70–80 ms, which corresponds to the measured
QRS duration.
Figure 8.18 shows the electrical activation pattern for the baseline stage prescribed accord-
ing the these constraints.
We compared the direct simulations and also the joint state-parameter estimations for
each stage using the two types of electrical activation. We observed that the new electrical
activation changes the direct model only in a few details and Figure 8.19 shows that also
the estimated contractility parameters are nearly the same. It means that if the simplified
electrical activation is well adjusted with respect to the measured QRS duration and the
initiation of the contraction according to the Cine MRI data, and in case there are no serious
blocks in the activation propagation, the more physiological transmural propagation does
not substantially change the resulting model and we can keep using the simpler activation
pattern.
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Figure 8.19: Comparison of two analytical electrical activation patterns: simple planar
apex–base wave (the left column) and planar apex–base wave combined with a slow trans-
mural conduction (the right column). The 6(+1)-region mesh subdivisions, γ = 20γ0, using
real observations.
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(a) Visco-elastic boundary condition

































(b) Sliding boundary condition
Figure 8.20: The 6(+1)-region subdivisions for the stage T0+38 using synthetic observa-
tions and applying two types of boundary conditions applied on the anterior wall. γ = 20γ0.
8.8 A contact boundary condition
The visco-elastic boundary conditions given by (4.13) applied on the anterior wall prevent
to some extent the anterior wall from thickening. The hypokinesis of the anterior wall
is corrected by the state-parameter estimator. Unfortunately, the parameter estimator
causes an increase of the estimated parameter of contractility in region #1, although a
large part of region #1 is infarcted, see Figure 8.24 (c) and (e). This is a typical example
of a modeling error and of the correction of this error by an inadequate modification of the
parameters. For this reason, we will test a new type of the boundary condition – which
enables sliding of the epicardial surface of the anterior wall along the pericardium. This
boundary condition is given by (4.14).
By implementing such a type of boundary condition, we obtain the physiological thick-
ening of the anterior wall in the direct model. As we can see in Figure 8.20, the estimation
using the synthetic observations (the same as in Section 8.5.2), gives very good results in-
cluding region #1. However, before applying the model with the new boundary conditions
to the joint state-parameter estimations using the real data, we would need to re-calibrate
the model so that it would correspond adequately to the Cine MRI data. Figures 8.21 and
8.22 show that although the new boundary conditions corrected one modeling error (the
thickening of the LV anterior wall), some other modeling errors were introduced.
The anterior wall has become more kinetic after applying the sliding boundary condi-
tion. At the same time the more contractile anterior wall prevents the inferior wall inward
motion, as we can see in Figure 8.21. The estimator corrects this discrepancy by increasing
the contractility value in the inferior and infero-lateral wall (regions #4 and #5), as can
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(a) Baseline, visco-elastic boundary condition
































(b) Baseline, sliding boundary condition
Figure 8.21: Comparison of direct models at the baseline stage in 2 MRI slices using the
following boundary conditions applied on the anterior wall: the visco-elastic (in orange)
and the sliding boundary condition (in blue). The observations are in green. The end-
diastolic images are on the left, the end-systolic images on the right. The plots shows the
estimated contractility parameters for each type of boundary condition.
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(a) T0+38, visco-elastic boundary condition
































(b) T0+38, sliding boundary condition
Figure 8.22: Comparison of direct models for stage T0+38 in 2 MRI slices using the
following boundary conditions applied on the anterior wall: the visco-elastic (in orange)
and the sliding boundary condition (in blue). The observations are in green. The end-
diastolic images are on the left, the end-systolic images on the right. The plots shows the
estimated contractility parameters for each type of boundary condition.
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(a) γ = 8γ0
































(b) γ = 20γ0
Figure 8.23: Contractility parameter θ estimated in a 2-region mesh for the stage T0+38
with the non-infarcted and the infarcted region using the boundary condition that enables
sliding of the anterior wall along the pericardium and real observations.
be seen in the plot of the estimated parameters in the same figure.
Figure 8.22 shows a comparison of direct simulations at the stage T0+38 using either
the visco-elastic or the sliding boundary conditions. In both cases, the tissue contractility
was set to a constant value since we did not aim at modeling the infarct at this time. While
the septum is well kinetic when using the visco-elastic boundary condition, it is hypokinetic
when the sliding boundary condition is applied. This is most probably an indirect effect of
the irregularities of the contact surfaces that prevent the surfaces from free sliding in any
direction. Then, the septum seems to be hypokinetic and the estimator does not need to
correct the contractility value e.g. in the infarcted region #2 (the antero-septal part of the
LV).
As we have shown, without any model re-calibration the direct model is not sufficiently
accurate. It finally causes that the parameter estimator is less sensitive, when using the
real observations. Nevertheless, we performed the join state-parameter estimations at each
stage of the infarction in order to see the behavior of the estimator when using such a
preliminary model. Figure 8.23 shows that the estimator fails using the 2-region subdivi-
sion. In the 6(+1)-region subdivision, the estimator recognizes the decreased contractility
in regions #2 an #3, but it fails in the estimation in some other regions, see Figure 8.24.
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(a) Baseline, visco-elastic boundary condition
































(b) Baseline, sliding boundary condition
































(c) T0+10, visco-elastic boundary condition
































(d) T0+10, sliding boundary condition
































(e) T0+38, visco-elastic boundary condition
































(f) T0+38, sliding boundary condition
Figure 8.24: The 6(+1)-region subdivisions for each stage, two different types of boundary





An important part of the estimator setup is a pre-calibration of the direct simulation. The
model can be pre-calibrated using constant mechanical parameters over the myocardium,
but it must behave as in the observations in the following aspects:
• The initial geometry needs to be as close as possible to the observation, in order to
reduce the initial error. This is why the computational mesh used for the joint state-
parameter estimation was created from the original segmented mesh, and corrected
by running the state estimator with a large gain γ, during one cardiac cycle. Hence,
the estimation procedure was used for image processing purposes. Figure 8.25 shows
a comparison of the original initial mesh, the corrected mesh by means of the state
estimation with a large gain γ and the observation surfaces. Such a corrected mesh
was used for the joint state-parameter estimations afterwards.
• The initiation of the model contraction and of its relaxation needs to be as syn-
chronous with the observations as possible. Any offset in the electrical activation of
the model can cause sudden changes of the estimated parameters in any direction.
The electrical activation pattern is often impaired by the myocardial infarction. Any
large dyssynchrony in the contraction (for instance the pronounced septal flash in left
bundle branch block) has to be taken into account in the model activation. In our
case, the ECG obtained for each stage of the study showed no irregularity and the
contractions were visibly synchronous. For this reason, we were able to keep using
the same – physiological – electrical activation pattern in all stages.
• The timing of the prescription of the ventricle pressures needs to be compatible with
the electrical activation imposed in the model. This was managed by exporting the
pressure values from the direct model. The exported pressure curves were close to the
measured pressures. We thus avoided any problem in the synchronization between
the pressure and the electrical activation in the model.
• The adjustment of correct boundary conditions is a difficult problem. The atria
and the attachment to the large vessels have to be replaced in the model. This is
achieved by using visco-elastic boundary conditions. In addition, we need to represent
the contact of the heart with the surrounding structures (mainly the thoracic cage
and the diaphragm). For this, we first used the same type of visco-elastic bound-
ary condition as for the base and the apex of the heart. Unfortunately, this type
of boundary condition applied on the anterior wall (part of region #1) to some ex-
tent prevented its contraction. The hypokinesis of the region was corrected by the
state-parameter estimator, but it caused an increase of the estimated contractility
parameter in region #1, see Figure 8.24(c) and (e). For this reason, we lost the
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Figure 8.25: Comparison of the original initial mesh (pink color) and the mesh obtained
by running the state estimation with a large gain γ (blue color) with the observations (in
green). Since the corrected mesh is closer to the observations than the original mesh, the
initial error was reduced.
sensitivity in the parameter estimator for region #1. By implementing a new type
of boundary condition that enables the sliding of a part of the epicardium along the
parietal pericardium, we obtained physiological thickening of the anterior wall in the
direct modeling. However, on the whole the direct model was not as good as the
model with the previous, less physiological, boundary conditions. It is known that
such boundary conditions require very smooth surface meshes to allow adequate slid-
ing. If the sliding is prevented due to some surface irregularities, the correction of
estimator may induce some incorrect behavior. We saw in Figures 8.21 and 8.22
some issues that would need to be solved in the direct model before using the contact
(sliding) boundary conditions in the estimations. The second column of Figure 8.24
shows that the parameter estimator was less sensitive and in some regions indeed
failed. It demonstrates that even when changing only the boundary conditions the
model needs to be well re-calibrated in all aspects. Nevertheless, even though the
re-calibration was not optimal, the estimator recognized the decreased contractility
in regions #2 and #3 at the infarcted stages.
8.9.2 Synthetic observations
The synthetic data consisted of the LV endocardial and LV epicardial surfaces, truncated in
the same way as for the estimations using the real data. The synthetic data were produced
by the direct model with the contractility reduced by a factor 4 in the infarcted region.
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We did not add any noise in the synthetic observations.
When performing the estimation with the mesh subdivided into the non-infarcted and
the infarcted region, we could expect that the estimated contractility parameter θ may
reach the value 0.25 – the value used for creating the synthetic observations. However,
the minimum estimated parameter θ was around 0.5. The estimated contractility may
decrease further if performing a second run of estimation process, with θ initialized by the
values obtained during the first run. In such a case, we obtained the value of 0.3. We
still did not reach the value of 0.25, probably because of the limited observability caused
by the fact that the observations are available only for the parts of the LV endocardial
and epicardial surfaces, which is why we miss any information about the intramyocardial
parts. Some additional tagged MR images, when adequately post-processed, could provide
crucial information about the inner part of the myocardial wall.
When running the estimation with the left ventricle subdivided into 6 regions, we
retrieved the contractility parameters in a good agreement with the late enhancement
proportions in regions #2–6. The contractility was overestimated in region #1, which was
explained by the modeling error caused by the artificial visco-elastic boundary conditions
applied on the anterior wall. The correctly estimated contractility values in regions #2–6
show that the infarcted part is well observable using our estimation approach.
8.9.3 Cine MRI observations (the real data)
The estimated contractility parameters in the baseline did not vary more than by 10%, as
expected for a healthy heart.
At stage T0+10, the ventricle does not show any evidence of remodeling in the form
of infarcted wall thinning. Visually, except for 1–2 slices, we can hardly find an akinetic
part and the hypokinetic parts of the LV wall are quite small. The variations of estimated
contractility parameters between the healthy and the infarcted regions are lower than at
stage T0+38. As in the case of synthetic observations, the reason may be due to limitations
in the observations, and missing information from the inside part of the LV wall. Another
reason may be the incomplete calibration of some other mechanical parameters, e.g. the
passive tissue stiffness. Although there will be an increase of the tissue stiffness in the
infarct at stage T0+38 (the fibrous tissue), the stiffness may be reduced at stage T0+10 due
to tissue edema (and the acute inflammation that accompanies the infarction). In Figure
8.8 we showed that a lower passive tissue stiffness makes the estimator more sensitive for
detecting the parameters. However, we would not like to use an a-priori knowledge of the
infarct location by means of modifying the tissue stiffness in the infarct regions. Later on,
we could perform estimations of both parameters – the contractility and the passive tissue
stiffness.
Although the tissue marked by the late enhancement is quite large, the hypokinetic
region does not seem to be as extended at stage T0+10 as in the last stage. It can be
due to the fact that the late enhancement in a very recent infarct overestimates the final
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infarct extension. Each of our 6 regions is relatively large and their infarcted part may be
comparable with the volume of the healthy part of the region. In such a case, the estimator
would not really be able to detect large changes in the contractility. The subdivision into
smaller regions could help in the detection.
At the final stage (T0+38), the hypokinetic and akinetic regions are very extended,
especially in the septal regions (regions #2 and #3), where the contractility parameters
drop, while they rise in other regions. The increase in the opposite regions could be
caused by a hypertrophy of the non-infarcted parts. First, the animal grew between the
acquisition of the baseline stage and the stage T0+38, and the increased contractility
could be just attributed to a normal growth. In addition, the non-infarcted part could
have undergone a compensatory hypertrophy – the decreased performance of the heart
causes the hypertrophy of the healthy myocardium. We cannot distinguish between those
two explanations.
In both infarcted stages, the contractility was overestimated in region #1, for the same
reasons as in the case of synthetic observations (the modeling error).
When running the direct model of infarcted stages using the estimated parameters, the
resulting simulation does not completely correct the direct model with constant values of
contractility. By adding the state estimator that was used during parameter estimation,
we obtained excellent results. Therefore, whereas the estimated parameters behaved as
could be expected for the increased or the decreased contractility, the estimated values
in the infarcted v.s. non-infarcted parts were not sufficient to correct the direct model
completely without any state correction. It is a similar situation as in the estimation with
the synthetic observations, where we did not retrieve the reference contractility value. The
reason can most probably be attributed to the limitations in the observations that we are
using (the endocardial and epicardial surfaces), to the modeling errors discussed above and
to the partial corrections performed by the state estimator during the joint state-parameter
estimation.
8.10 Conclusions and perspectives
In this chapter, we successfully applied the methodology of the sequential joint-state pa-
rameter estimation with real cardiac Cine MRI data. We were able to detect myocardial
infarction in several stages, while in the healthy stage the estimated contractility values
were nearly constant over the myocardium of the left ventricle. The estimator is very
sensitive if the diseased region is akinetic or dyskinetic. For small hypokinetic regions, the
estimator is less effective, at least with the observations coming from the Cine MR images.
For our future work, we can apply the algorithm on even more detailed subdivisions of
the mesh (e.g. a 17-segment AHA subdivision of the left ventricle). After post-processing
the tagged MRI data, we could use a combination of observations coming from the endo-
cardial and epicardial surfaces, and from the inner part of the myocardium as well. We
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can either consider directly extracting the myocardium displacements from the tagged MR
images, or applying in a straightforward manner the estimator used in this work based
on measuring distances between the simulated and observed surfaces. In addition to the
endocardial and epicardial surfaces from the Cine MR images, we would use surfaces rep-
resenting the tag planes in the tagged MR images.
Another challenging goal would be an estimation of the contractility parameters in
human patients with extended myocardial infarction – including patient-specific electrical
activation patterns. Concurrently, we can work on improvements of the direct model,
e.g. by prescribing more physiological boundary conditions. Finally, some other mechanical
parameters could be estimated, for instance the passive tissue stiffness or directly some




Each chapter of the applied modeling part contains conclusions of the performed work and
possible perspectives. Here, we will conclude the main achievements of the PhD study in
short paragraphs that are transverse to the chapters topics. Then, we will suggest what
the future work related to the thesis could be.
9.1 Work realized
Experimental part
We performed ambitious experiments with big animals during which we obtained non-
invasive image data and invasive pressure data of two healthy hearts. In one of the subject,
we acquired the same data sets as in the baseline also after creating a controlled myocardial
infarction. The animal data were applied in Chapter 6 – in which a validation study
was performed and a strategy for adequately modeling an infarct was verified – and in
Chapter 8, in which state and joint state-parameter estimations using real image data
were performed. A side-effect of these experiments was the optimization of various MR
sequences used in Cardiac MRI at Henri Mondor Hospital in Cre´teil, France.
Validation studies
In Chapter 5 we validated the model at a 1D level using experimental data of fiber con-
traction. We showed that the model is able to reproduce the experiments. We observed
some non-physiological phenomena caused by inadequate values of several parameters. We
were able to avoid some of them by readjusting the parameters related to these effects.
A validation of the full 3D heart model was performed in Chapter 6. We showed
that our biomechanical model can be personalized and calibrated to accurately reproduce
the pressures and motion measured in a healthy subject. Then, by changing only the
parameters directly related to the state of myocardial infarction (contractility and stiffness
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in the infarcted area) we demonstrated that we can also adequately represent the behavior
of the acutely infarcted heart.
Patient-specific modeling
We showed that we are able to adjust the model so that it can represent healthy hearts,
hearts with a controlled myocardial infarction and hearts of real patients with ischemic
heart disease or dilated cardiomyopathy. In the case of healthy hearts we can use the
constant values of mechanical parameters in the whole myocardium. For the controlled
infarct, we need to modify the mechanical parameters only in the infarcted region (as was
discussed in the previous paragraph). The personalization is substantially more difficult if
we need to set up the model of a real patient – as was performed in Chapter 7. Since the
ventricles may consist of healthy zones, completely akinetic or dyskinetic parts, and regions
of several levels of hypokinesis, we need to adjust the mechanical parameters locally.
The setup of these patient-specific models can be performed manually – without any
automatic feedback. We demonstrated that this strategy is feasible and the manual ad-
justment was effective in first clinical applications. The automatic personalization will be
discussed in the paragraph related to joint state-parameter estimation.
Model predictivity
In Chapter 6 we showed the model predictivity by means of the volume changes (ejection
fraction) and local kinematics caused by an acute myocardial infarction. In the preclinical
study with patients undergoing cardiac resynchronization therapy (CRT) performed in
Chapter 7, we demonstrated the model predictivity with respect to a global indicator of
tissue contractility – max LV dp/dt. This preliminary clinical validation showed that the
modeling of CRT procedures is a very promising approach as an assistance to medical
therapy planning, in order to pre-operatively optimize the procedure in a patient-specific
framework.
State and joint state-parameter estimation using real data
In Chapter 8, we demonstrated that the simulations can be corrected by means of the state
estimation, using observations coming from Cine MR images (endocardial and epicardial
contours). The algorithms developed by the MACS team proved to be efficient also in
the joint state-parameter estimation. When using the same type of observations, the data
assimilation procedure succeeded in the detection of the controlled myocardial infarction in
the animal heart. The estimation of the contractility parameters failed for real clinical cases
in which the contrast between the non-infarcted and infarcted tissue is not so pronounced
and the electrical activation of the model must be jointly personalized in detail with respect
to the activation propagation in the patient’s heart.
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Co-operations with clinical partners
During the PhD study, we extended interesting co-operations with Henri Mondor Hospital
in Cre´teil and with Hospital Biceˆtre, both in France. During the animal campaign, an
important role played my personal co-operation with Institute for Clinical and Experimen-
tal Medicine (IKEM) Prague, Czech Republic, that showed to be open for further joint
projects as well. Thanks to the preclinical study related to CRT modeling, we strength-
ened our relation with the Department of Imaging Sciences of King’s College London and
St. Thomas’ Hospital in London, UK.
9.2 Perspectives
Animal data
The data acquired during the animal experiments served already in several projects – in
the validation study, infarct modeling and in the infarct detection by means of joint state-
parameter estimation. Until now, we have not used tagged MRI that are available for each
data set, except in visual comparison with the model outputs. This type of data could be
used for further validations or in estimation procedures.
Model improvements
In Chapter 8 we performed a preliminary test of more physiological boundary conditions
representing the contact of epicardial part of ventricles with surrounding structures (thorax,
diaphragm). By solving some issues in the setup of these boundary conditions, we may
improve both direct models and the estimation procedures.
In co-operation with other groups, we may use more realistic electrical activation pat-
terns. In Chapter 8 we showed that for physiological activation we can keep using simplified
analytically prescribed patterns with correct timing with respect to the available data (Cine
MRI, ECG) and we can obtain good results both in the direct simulations and in the esti-
mations. However, in a dyssynchronous contraction – which is often the case for patients
– the estimation process is sensitive to the activation pattern and we need to personalize
it adequately.
We can further explore some parts of the model using the 1D implementation – in
particular material laws and implementation of the Frank–Starling mechanism – that are
likely to improve simulation results with the fiber, and the model itself. We may also design
our own experiment in order to obtain exactly the type of data that we need.
The modeling of fully coupled mechano-electrical feedback can be interesting from the
pre-clinical point of view, e.g. in explaining some physiological phenomena or in future
testing of some pharmacological and non-pharmacological treatment of arrhythmias.
In some diseases, the modeling of the RV behavior would be of a great importance.
We can mention the arrhythmogenic right ventricle dysplasia (ARVD) and some congen-
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ital heart diseases as examples in which modeling may help in a diagnosis process, or to
predict the future evolution, and propose a good timing for the treatment. In our anatom-
ical models, the thickness of the RV is often overestimated – due to difficulties in the
mesh creation of this thin structure. We can consider shell elements for this part of the
computational mesh.
The modeling of fluid-structure interaction in the heart requires intensive computing.
Therefore a targeted clinical motivation is crucial. The modeling of valve disorders or some
congenital heart diseases (in order to suggest a good planning of surgery e.g. in some septal
defects) could be of clinical interest.
We may consider the validation of perfusion models being developed by the MACS and
REO teams at INRIA (see [24]). Although obtaining the truly quantitative perfusion data
from MRI is very challenging, we can investigate the possibilities both of quantitative and
semi-quantitative perfusion data, or suggest an in vitro experiment that would provide
required data.
Clinical applications
The first objective is to fulfill the preclinical study started in the co-operation with
St.Thomas’ Hospital and King’s College London. We should study in detail the sensi-
tivity of the estimated max LV dp/dt values e.g. depending on the position of the pacing
leads. The challenging work is to apply the model before the CRT implantation itself,
which would be the next step for the therapy planning.
We should follow-up the patients included in the study in order to observe long-term
CRT effects. In fact, these effects are likely to be directly related to the pathology itself
– the chronic heart failure (CHF). Due to a high prevalence and a poor prognosis of CHF,
it is a topic of high importance in clinical practice and another modeling challenge. In most
aspects of long-term modeling, we should couple the systemic and pulmonary circulations.
By adding some regulatory circuits (e.g. long-term pressure and fluid controls by kidneys),
we could model some phenomena particularly important in CHF.
We can consider using some other indicators computed by the model (e.g. strains and
stresses) to better understand some processes as for instance the already mentioned long-
term CRT effects or the remodeling of the myocardium after the infarction. For example
Figure 9.1 shows the distribution of wall stresses in the model in which the contractility was
decreased in a region corresponding to one particular AHA segment in order to represent
an infarct.
Parameter estimation
We should continue the work started in Chapter 8 on the joint state parameter-estimation
using real data. The subdivision of LV into 17 AHA segments would be a natural contin-




Figure 9.1: Model with artificially decreased contractility in a part of the anterior wall. We
plot the circumferential strain (left) and the first eigenvalue of Cauchy stress tensor (right).
Note the low stress values in the akinetic zone and the stress concentrations around.
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the observability of the infarct. We may think about estimating some other mechanical
parameters from the real data – as for instance the passive tissue stiffness.
We mentioned an idea to validate the perfusion model [24] using MRI. We can also think
the other way around. Once the perfusion model is validated – using any experimental
setup – it may be used to quantify the myocardial perfusion locally from the MR perfusion
data, by means of data assimilation techniques.
In Chapter 7, we showed that analytical activation patterns prescribed by using some
typical signs in the images can represent the electrical activation quite accurately, including
those particular patients with LBBB in the CRT study. This illustrates that the estimation
of some electrical parameters from image data is very promising. An approximate depo-
larization times obtained in a non-invasive way – by using a biomechanical model – could
provide for instance some indices of dyssynchrony that could be of great importance for
patients with some diseases affecting the electrical activation. Indeed, for example ARVD
in the initial stages often does not show any pronounced morphological signs but sudden
death due to ventricle fibrillation may occur. The contraction dyssynchrony is unfortu-
nately hard to precisely assess with the naked eye in images, but some quantitative indices
could be a clue for a timely diagnosis.
9.3 Final conclusions
Research in the field of biomechanical modeling – and this thesis in particular – shows that
modeling is extremely promising in the clinical environment. The cardiovascular system is a
prototype example. Thanks to a long tradition of the cardiac modeling, some sophisticated
models were already created and they are waiting for their right applications. However,
the thesis also shows that – as in any branch of research – at each step of our learning,




Appendix: Animal data acquisition
During planning of the animal experimental campaign, the following experimental protocol
was created.
10.1 Introduction
The objectives of this interdisciplinary work are to validate mathematical models of the
heartbeat developed by INRIA1 (project MACS2) and to bring new pathophysiological
consequences that come along with the formation and acute stage of myocardial infarction,
including mathematical modeling of the tissue remodeling in the first days and weeks after
coronary artery occlusion.
A source of data for the mathematical model will be an animal (a young farm pig)
with a controlled myocardial infarction. The animal will be examined and data acquired
before creation of the infarct (healthy animal) and at regular intervals afterwards, so that
the possible remodeling of the myocardial tissue will be observed.
The following notation will be used:








MR, MRI magnetic resonance, magnetic resonance imaging
GE gradient echo
PC MRI phase contrast MRI
bSSFP balanced steady state free precession (also known as TrueFISP)
FLASH GE sequence with gradient spoiling (fast low-angle shot)
IR, STIR inversion recovery, short tau inversion recovery (a fat suppression sequence)
DTI diffusion tensor imaging
CT computerized tomography
TDI tissue Doppler imaging
LAFB left anterior fascicular block
LBBB left bundle branch block
10.2 Mathematical model
A mathematical model was developed by INRIA within the CardioSense3D3 initiative. The
heart is modeled as a 3D viscoelastic material with 1D active component representing the
contraction of muscle fibers. The mathematical model including the numerical solution is
fully described in [95].
The geometry is obtained by the segmentation of cardiac data acquired by the mag-
netic resonance imaging (MRI) or by the computerized tomography (CT). A diastolic time
frame image preceding the atrial contraction is taken as a reference configuration of the
heart (stress-free configuration). Segmentation of the left and right heart ventricles in this
particular time-frame image is performed using the software CardioViz3D ([107]) being
developed by INRIA, project Asclepios4. Afterwards, the computational mesh is built in
the segmented geometry using tools developed by INRIA, in particular in project Gamma5.
The active contraction consists of 1D deformation of the myocardial fibers. This con-
traction is triggered by an electrical activation. As an example, the electrical activation can
be prescribed by defining the onset and the duration of the action potential for each node
of the computational mesh. Full electrical activation of the heart (based on the modeling
of transmembrane ionic flows and spread of the action potential from cell to cell) is also
modeled by INRIA, project REO6 (see [15]).
The main parameters of the model are calibrated so that the initial geometry (given






the acquired image data. The main parameters of the model are material properties which
consist of active components (given by the contractility and direction of the myocardial
fibers) and passive components (e.g. the tissue stiffness, elastic properties, viscosity).
Some other crucial indicators are the pressures in the heart chambers, pressures in the
systemic and pulmonary circulations, flow through the valves, etc. Varying the parameters
we can represent typical cardiac physiological and pathophysiological states such as:
• Change of inotropy – this can be achieved by varying the contractility of the myocar-
dial fibers. By this approach, global or local systolic dysfunctions can be modeled.
Cardiac effects of positive/negative inotropic agents can be studied as well.
• Change of chronotropy (heart rate) – by varying the duration of the systole and dias-
tole (directly on the cellular level – by changing the duration of the action potential
on membranes of myocardial cells).
• Change of dromotropy (velocity of the conduction of the electrical activation) and
the whole electrical activation scheme (modeling of disorders of the heart electrical
conduction system).
• Diastolic dysfunction – by varying parameters of the passive component of the tissue.
• Change of resistance and capacitance of ventricle outflow tracts, large arteries or
pulmonary and peripheral circulation, which can serve as models of valvular diseases
(stenosis or regurgitation) or models of systemic or pulmonary hypertension (with
possible study of the effect of treatment/non-treatment on the heart function).
• Change of the electrical activation scheme – as a model of conduction system disorders
and effect of the treatment, e.g. by cardiac resynchronization therapy (CRT).
• Change of the fiber directions (e.g. study of possible consequences in the hypertrophic
cardiomyopathy).
• Congenital heart diseases (using the actual geometry of the particular pathology).
10.3 Measured data
10.3.1 Cardiac MRI
The main source of data is Cardiac MRI. By this imaging modality we will acquire data
necessary for the model creation and calibration. The model will be entirely specific to the
examined subject. During the same acquisition sessions we will also obtain the main data
for the validation of the mathematical model.
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Cardiac MRI will be performed on MR system Philips Achieva 3.0 T at Henri Mondor
hospital7 in Cre´teil in a collaboration with A. Rahmouni and J.F. Deux and with the
participation of J. Garot (Centre Hospitalier Jacques Cartier, Massy).
Data needed for creation and validation of the mathematical model
• CINE MRI enables to cover the whole organ with very good spatial resolution and
capture the whole cardiac cycle in a good temporal resolution. It gives us the first
knowledge about the anatomy and kinematics of the heart. The heart geometry
(computational mesh) will be built from the diastolic time-frame image preceding
the atrial contraction. For the model calibration, we use global indicators derived
from the CINE MR images (typically evolution of the LV and RV volumes during the
cardiac cycle) and local indicators of the heart kinematics (thickening of each AHA
segment8 during the cardiac cycle, longitudinal displacement of the fibrous rings of
atrioventricular and semilunar valves and information about fixation of the apex).
Electrical activation of the heart will be built in the correspondence with CINE
MR images of high temporal resolution (obtained typically by using non-cartesian
trajectories of the data acquisition).
• Tagged MRI in which the tissue magnetization is modulated in a regular grid so
that the ‘tagged’ part of the volume does not give any MR signal (and that is why
it appears black in the MR images)9. The grid follows the deformation of the heart
during the cardiac cycle. By extraction of the grid nodes we are able to measure
actual local deformations of the heart wall. The displacement fields coming from
the tagged MR CINE images will serve as a source of data for the validation of the
mathematical model.
• First pass of the contrast agent with an infusion of adenosin10 will give us very
good information about the perfusion of the myocardium. The imaging slices will be
focused with respect to the infarcted tissue.
• Late enhancement are necessary data for the quantification of the infarcted tissue.
The late enhancement images will be a source of information about the infarct ex-
tension, together with the perfusion data and kinematical CINE (which will inform
us about local myocardial hypokinesis).
7http://chu-mondor.aphp.fr/
8Division of the ventricles into circumferential segments according to the American Heart Associations,
see [21].
9The so called SPAMM technique – SPatial Modulation of Magnetization.
10The stress induced by dopamin will not be performed for the reason to avoid ventricular tachyarrhytmias
which often appear in this animal species after the myocardial infarction.
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Optional data coming from cardiac MRI
• Phase contrast imaging (PC MRI) will be used for estimation of flow in the
ascending aorta, pulmonary trunk and through tricuspidal and mitral valve (only
the component of velocity vector which is parallel to the direction of flow will be
measured). The flow information is needed especially if some of the pressure data
are missing (see Section 10.3.2).
• T2 STIR11 can give us information about the extension of edematous tissue (which
has high signal on T2-weighted images due to increased free water contents) in the
acute stage of the myocardial infarct. The edematous tissue may correspond to the
region with the decreased tissue stiffness in an acute stage of the infarct.
• Diffusion tensor imaging (DTI) will give us the directions of the myocardial
fibers to be prescribed in the mathematical model. DTI data will be acquired only
in the last imaging session since it needs to be performed on a non-beating heart.
10.3.2 Pressure data
Pressure conditions are necessary for the model calibration. The pressure data needs to be
estimated approximately in the same time as the image acquisition takes place, so that the
pressure data would correspond to the state of the anesthetized animal during the imaging.
Since we expect evolution of the pressures along the development of the myocardial infarct,
we need to get pressure data in each image acquisition session. The missing pressure data
can be to some extent substituted by the inflow/outflow information (see Section 10.3.1)
and / or by the usage of typical physiological values with respect to the known pathology.
For optimal calibration of the model, the following pressure data are needed:
• RA pressure
• RV pressure




The RA, RV, pulmonary artery pressure and pulmonary capillary wedged pressure
(PCWP, as a reflection of the LA pressure) will be measured using the Swan-Ganz catheter.
A high fidelity catheter will be used for direct measurement of the aortic and LV pressure.
11T2 weighted images with an additional 180o pulse (Short Tau Inversion Recovery) which nullifies MR
signal from fat.
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10.3.3 Electrocardiography and echocardiography
A few 2D echocardiography12 loops will be obtained in standard projections (4-chamber
view, 2-chamber view, several short axis views) and the flow data through all the heart
valves (using pulse and continuous Doppler imaging).
For the proper calibration of the model we need to obtain a correct electrical activation
of the heart. For the right timing of the systole and diastole we will use the 2D echocar-
diograhic data and the Doppler data with the recorded one lead ECG curve. Velocity of
the propagation of the electrical activation will be adjusted according to the width of QRS
complex.
Optional: The longitudinal motions of the lateral, septal, anterior and posterior parts
of the fibrous rings of AV valves can be measured by the tissue Doppler imaging (TDI).
The TDI data would be used for the calibration of the boundary conditions in the model.
10.4 Principal objectives
On INRIA’s side, there are two principal objectives. These are the validation of the model
representing a physiological heart and the modeling of the myocardial infarction (with the
perspective to build a model of tissue remodeling after the myocardial infarction).
10.4.1 Validation of the physiological heart model
In the first stage, we will perform direct simulations without an a-priori knowledge of the
detailed displacement fields. The input data will be: Stress-free geometry obtained from
one particular time frame image of CINE MRI, volumes of the ventricles during cardiac
cycle, wall thickening in each AHA segment (both obtained from CINE MRI) and pressure
data. Doppler flow data and TDI will be used for better calibration of the model. Then,
the simulations will be compared with displacement fields extracted from the tagged MRI
data.
10.4.2 Direct simulations of the infarcted heart
The goal of this part is to perform direct simulations of the infarcted heart based on the
geometry of the infarcted heart and with the knowledge of the extension of the infarct and
the location and the level of the tissue hypocontractility. The model will be validated in
the same manner as in Section 10.4.1 using the detailed displacement fields extracted from
the tagged MRI data.
12For transthoracic echocardiography in minipigs, see [61].
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10.4.3 Remodeling of the heart
Using the geometry of a healthy animal (before the infarction) and the data concerning the
extension of the infarcted tissue, we would like to predict a geometry of the heart N-days
after the coronary artery occlusion (mathematical model of the acute stage of myocardial
infarct). The validation will be based on the tagged MRI data coming from N-days after
the coronary artery occlusion.
10.5 Detailed protocol of the data acquisition
10.5.1 Examination of healthy animals, creation of the infarct
Young farm pigs will be taken as an animal model. 1–3 days before creation of the infarct
the animals will be examined according to the imaging protocol described in Section 10.5.3.
In Day 0 the controlled occlusion of the left anterior descending coronary artery (LAD)
will be performed by a balloon catheter. The occlusion will last 120 minutes. By shorter
occlusion we would protect the animals from fatal arrhytmias but instead of the truly
infarcted tissue we would be more likely to obtain myocardial stunning (see [63]). For the
detailed description of the animal model see [42].
10.5.2 Follow-up of the animals
The animals will be examined by the imaging protocol described in Section 10.5.3 in the
following days after the coronary artery occlusion:
• Day 2: Hyperacute reaction on the occlusion.
• Day 16: Acute stage of the myocardial infarction.
• Day 30: ‘Later acute’ stage of the myocardial infarction.
10.5.3 Examination protocol
Cardiac MRI
The most of the measurements will be performed in induced breath-hold, true 3D data
will be acquired using the breath navigator. If more slices will be acquired, then multislice
scan mode is to be used. To reduce MR susceptibility artifacts, each instrument
used for the intubation or the catheterization must be from the MR compatible
material.
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• CINE TFE13 (segmented FLASH), retrospective triggering, slice thickness: 7 mm,
measured voxel size: 1.2 x 1.5 x 7.0 mm, SENSE = 1 (no parallel imaging), Trigger Delay
= minimal (time delay between the detection of the R-peak of the QRS complex and start of the
acquisition), phase percentage 80% (echo sharing)
– short axis view: 10–15 slices covering the whole heart from the apex to the
base (with no gap between the imaging slices)
– long axis view – 4-chamber projection: 5-8 slices of 4-chamber projections
covering the whole heart volume (standard 4-chamber view + parallel slices
with no gap between the slices
– long axis view – 2-chamber projection in LV: 3-5 parallel slices
– long axis view – 3-chamber projection: 3 parallel slices
– long axis view – 2-chamber projection in RV: 1 slice
– Optional: Non-cartesian data acquisition (radial or spiral) used either for ac-
quisition of all the preceding CINE MR images or at least in some projections
(e.g. 5 short axis views, the 4-chamber and the 2-chamber view).
• Full 3D dataset of the morphological data in the diastole using breath navigator
(according to the protocol discribed in [44]). Spatial resolution: 1.0x1.0x3 mm (in-
terpolated to 0.5x0.5x1.5 mm), with TD corresponding to the diastole preceding
atrial contraction.
• TFE + SPAMM (tagged data), the same voxel size as in the CINE MRI to be used,
2D grids inclined 45o to the axes of the imager, tag spacing 7.0 mm, TD = minimal,
SENSE = 1, maximal water-fat shift, field of view as small as possible. The following positions will
be copied from the preceding CINE MRI:
– short axis view: 10–15 slices covering the whole heart from the apex to the
base (with no gap between the imaging slices)
– long axis view – standard 4-chamber projection
– long axis view – standard 2-chamber projection in LV
– long axis view – standard 3-chamber projection
– long axis view – 2-chamber projection in RV
• Dark blood technique: T2 STIR in the short axis and 4-chamber view (respectively
the slices focused on the pathology)
13Turbo Field Echo on Philips. The offset frequency for bSSFP sequence (the so-called delta TrueFISP
frequency on Siements) is a sequence parameter that cannot be changed in the user mode on Philips Achieva
3.0 T. Since it is crucial for the optimal quality of bSSFP CINE images at 3.0 T field, we are acquiring the
segmented FLASH images (TFE).
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• First pass of the contrast agent: Snapshot FLASH sequence focused on the pathol-
ogy
• Late enhancement: segmented FLASH (or bSSFP) sequence with inversion recovery
pulse, slice thickness: 7.0 mm, measured voxel size: 1.2 x 1.5 x 7.0 mm (1 slice per
single breath-hold) with both types of reconstruction:
– magnitude-reconstructed images
– phase-sensitive images (if supported by the MR system).
• Optional: Late enhancement – acquisition of a full 3D dataset (using a breath navi-
gator)





• DTI – in the last imaging session (on the non-beating heart) with the reconstruction
of the myocardial fibers; spatial resolution: 2.0 x 2.0 x 2.0 mm, 15 diffusion direction
+ B0 image, EPI sequence with SENSE = 2, good magnetic field shimming and as low number
of the lines in the phase encoding direction as possible)
Pressure data
• Antegrade catheterization using the Swan-Ganz catheter:
– inferior (superior) caval vein pressure
– RA pressure
– RV pressure
– pressure in the pulmonary trunk
– pulmonary capillary wedged pressure
• Retrograde catheterization using the high fidelity catheter:





• 2D mode: recording of heartbeat kinematics with one lead ECG at the same time in
the following projections:
– long axis view – 4-chamber projection in LV
– long axis view – 2-chamber projection in LV
– long axis view – 2-chamber projection in RV
– short axis view – 1-3 slices
• Pulse (continuous) Doppler imaging in:
– mitral valve
– LVOT, resp. flow in ascending aorta
– tricuspidal valve
– RVOT, resp. flow in the pulmonary trunk
– caval veins, pulmonary veins
• Tissue Doppler Imaging – fibrous rings of tricuspidal and mitral valves (lateral, an-
terior, septal and posterior part of the rings)
In the last session, cardiac MRI will be performed as the last imaging technique with
final DTI on a non-beating heart. The histological verification of the infarct extension may
be performed later on.
10.6 Data processing
Three months after the data have been collected, the INRIA researchers will deliver a
synthetic technical report to summarize the preliminary results obtained when using the
data in the simulations. The conclusions of this report will include an assessment of the
perspectives regarding potential further experimental campaigns.
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